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This section provides a medium through which Canadian surgeons can declare themselves, briefly 
and informally, on the day-to-day affairs of surgery.
Crude, but Effective
v y
►
The titles of three papers that appear 
in this issue of the Journal caught my 
attention for what seemed at first to 
be very different reasons. After read­
ing the three articles and reflecting on 
what enticed me, I became aware that, 
for all their divergence of topic, they 
provoked an “ethical” feeling regard­
ing the importance and problems of 
testing and reporting what we do for 
our patients.
Gahhos and colleagues (page 613) 
have reported a detailed, carefully 
designed, prospective, randomized, 
double-blind, clinical comparison of 
two antibiotics given prophylactically 
to patients scheduled to undergo elec­
tive colectomy. They have made a 
careful assessment of several para­
meters. In current jargon, this work 
may justifiably be called “an elegant 
study”. Part of my interest was 
stimulated when I simultaneously 
received the Sept. 16, 1982 issue of 
the New England Journal of Medicine, 
wherein I read Arthur Schafer’s “The 
ethics of the randomized clinical 
trial”.1 Schafer raises many important 
issues relating to whether patients 
should know they will be selected on 
a random basis for one or another 
mode of treatment; whether such trials 
sacrifice the patient’s right to com­
pletely individualized treatment for the 
benefit of scientific progress; and how 
we can balance traditional patient- 
centred medicine against the potential 
wider social benefits of strict random­
ization. Unfortunately, without the 
rigour of the double-blind, random­
ized trial, truth may not be served.
Although these and other consider­
ations are important, they do not con­
cern me in connection with the study 
by Gahhos and associates. What 
bothers me is that I do not use either 
form of treatment tested. Moreover,
I am afraid that I may be fooled by 
differences, albeit small, that were 
likely due to chance. In fact, in the 
study of Gahhos and colleagues, the 
only difference between the two 
groups that was statistically significant 
was the number of Bacteroides organ­
isms remaining in the gut; neverthe­
less, I cannot avoid noticing that no­
body receiving clindamycin had a 
wound infection whereas three pa­
tients who received metronidazole did. 
On the other hand, I worry about 
pseudomembranous colitis and find 
myself in a kind of ethical dilemma 
regarding which treatment my patients 
should receive. My biggest problem 
is, how do I compare this careful 
study of two prophylactic regimens 
that I am not using with my own ex­
perience and with the many other 
careful and not-so-careful studies of 
other treatment regimens? What we 
all long for is a good, big, healthy . . . 
difference! The problem seems to be 
that we have so finely tuned things 
that such differences will be hard to 
come by.
The article by Crabtree and col­
leagues (page 644) describes a lethal 
complication, necrotizing choledocho- 
malacia, quite likely due to the use 
of monooctanoin. It would not be 
described as an elegant study. It is, 
in fact, the type of report that inertia 
and perhaps a sense of dismay dis­
courage us from publishing. The sti­
mulus to share such an experience is 
more an ethical thing. It certainly does 
not come from some sense of victory. 
However, such a report serves the 
medical fraternity and our patients 
well. Whether such a tragedy is a 
never-to-be-repeated fluke or a per­
vasive danger, we must all now take 
this event into consideration. Perhaps 
this kind of report would fit what
Ralph Nader has called “blowing the 
whistle”. It is not elegant. Rather, it 
is “crude, but effective”.
I found the paper by Martin and 
Gelfand on mid-trimester abortion 
(page 641) difficult to read because 
I was distracted by my own emotional 
and religious bias against abortion for 
sociologic reasons, even though this 
issue is not discussed in the paper. For 
me, the ethical dilemma related to a 
conflict in my mind between the Hip­
pocratic commitment to the health and 
life of my patient versus the Hippo­
cratic commitment to respect all life 
from conception. Interestingly, the 
only mortality in the experience re­
ported was a patient for whom a mid­
trimester abortion was performed to 
try to save her life. From a purely 
professional point of view, I am 
concerned that decisions regarding 
“health” in the sociologic realm are 
being made, at least in my community, 
by gynecologists who may have little 
or no training in evaluating sociologic 
criteria. The report nevertheless im­
pressed me as a useful contribution 
by outlining the carefully documented 
experience of mid-trimester abortions 
in one hospital.
As members of the surgical com­
munity, we find the ethical climate 
blows with many winds. We must try 
to evaluate quickly and carefully the 
benefits of what is new (monooc­
tanoin), and need to report to one 
another the problems; we are pres­
sured by society’s desires and mores 
(liberalized abortion), which may con­
flict with our own perception of the 
professional mandate; and we are con­
fronted by a barrage of data obtained 
by agonizingly difficult studies that 
are sometimes expensive, that possibly 
intrude on patients’ rights, and that 
may, discouragingly, reveal only small
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differences. In such a climate I believe 
that we must maintain an open, ami­
cably critical, communication and con­
tinuing review of all that we do and 
intend to do for our patients and for 
society. We should not only receive 
and evaluate spoken and published re­
ports but we, ourselves, should also 
contribute by voice and print with de­
termined candour and precision —
whether our contribution be elegant or 
controversial, or crude but effective.
R .J . B la n c h a r d , m d , f r c s [c ]
Member,
Editorial Board
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The Unstable Ankle
It is quite some time since the subject 
of ankle stability was discussed in 
these pages.1-3
The problems of knee stability arise 
because of the complex nature of the 
hinge mechanism which allows (nay, 
demands) rotation and mediolateral 
motion in addition to flexion and ex­
tension. The ankle is closer to a pure 
hinge in which only a small amount of 
rotation and inversion-eversion motion 
are possible in addition to dorsi- and 
plantar-flexion. Inversion and eversion 
occur mainly at the subtalar joint. Ac­
quired symptomatic instability is usu­
ally the result of rupture of the lateral 
ligaments, which are really a com­
bination of ankle and subtalar 
elements.
The osseous part of the ankle joint 
is more stable than that of the knee. 
The mortise of the ankle is much deep­
er than the quite shallow cups of the 
tibial plateaux. As in the knee, the 
medial and lateral ligaments are the 
strong ones and account for the stab­
ility afforded by the soft tissue com­
ponent. The knee is really two unequal 
joints, separated by the cruciate liga­
ments; the ankle is not complicated 
by such an arrangement. The fact that 
the tenon of the ankle, the dome of 
the talus, is narrower in the back than 
in the front does not complicate the 
action too much.
Thus, the repair of ruptured lateral 
ankle ligaments, done immediately or 
late as a reconstruction, is not plagued 
by the problems that befall repairs of 
the knee ligaments. Most of the many 
already described reconstructions are 
a combination of ankle and talocalca­
neal repair, using the peroneus brevis 
tendon, usually left attached to the 
base of the fifth metatarsal. It is of 
adequate length and strength. The 
operation is usually satisfactory and 
the ankle becomes stable. Often the
price to pay is some loss of inversion 
which may be an inconvenience when 
walking on uneven ground. Pieron in 
this issue (page 672) presents a new 
approach, that of leaving the tendon 
of the peroneus brevis attached to the 
muscle belly to create a dynamic re­
pair that should obviate the 1o„j of 
inversion. Unfortunately, when a ten­
don is passed through a long tunnel in 
bone, especially cancellous bone, it 
will adhere to the walls of the tunnel, 
effectively cancelling the pull of the 
muscle. The tendon does not slide in 
the bone. This was proven in two of 
the author’s patients who required re­
operation, but was not demonstrated 
in the other patients. The presence of 
a sclerotic border seen in the roent­
genogram is not proof of sliding of the 
tendon. The pulley described by Lip­
scomb and associates4 for the thumb 
is not a bony, but a tendinous one. 
Sliding does occur around a tendinous 
pulley, but not within a bony canal.
What Pieron has described is a 
tenodesis operation which no doubt 
works well, as do the other tenodesis 
operations long established.
J o s e p h  L. S h u g a r , m d , f r c s [c ]
Senior associate editor
References
1. C lark BL, D erby AC, P ow er  G R I: Injuries 
of the lateral ligament of the ankle. Con­
servative vs. operative repair. Can J Surg 
1965 ; 8: 358-63
2. L aurin  C A , O u ellet  R, St- J acques R: T alar 
and subtalar tilt: an experimental investiga­
tion. Can J Surg  1968; 11: 270-9
3. G ross AE, M a c in to sh  DL: Injury to  the 
lateral ligament of the ankle: a  clinical study. 
Can J Surg 1973; 16: 115-7
4. L ipscom b  PR, E l k in s  EC, H enderso n  E D : 
Tendon transfers to restore function of 
hands in tetraplegia, especially after fracture- 
dislocation of the sixth cervical vertebra  on 
the seventh. J Bone Joint Surg [Am] 1958; 
40: 1071-80
“STEMETIL"
(prochlorperazine)
stops nausea, helps keep
the patient calm and alert
Indications: nausea and vomiting of various 
etiologies: gastrointestinal disorders, drug 
intolerance, motion and radiation sickness, 
post-operative conditions, pregnancy, vertigo and 
migraines.
Dosage: Adults, oral route -  Usual effective 
dosage is 5 to 10 mg, 3 or4 times daily; in very 
mild cases, a single dose of 5 to 10 mg is often 
adequate. This dosage may be increased as 
required by increments of 10 mg every 2 or 3 days 
until symptoms are controlled. For maintenance 
therapy the dosage should be reduced to the 
minimum effective dose. Rectal route -  The 
suggested adult dose is 20 to 50 mg daily. 
Children: oral and rectal routes -  up to 10 mg 
per day in divided doses according to body weight. 
Parenteral route (not to exceed 40 mg per day) -  
In general practice: 5 to 10 mg I.M., 2 or 3 times a 
day. In surgery: 5 to 10 mg I.M., 1 to 2 hours 
before anesthesia. Repeat once during surgery if 
necessary. Post-operatively, same dose of 5 to 10 
mgl.M., repeated every3 to 4 hours. Maybe 
given I.V. during and after surgery in the infusion 
solution at a concentration of 20 mg per litre. In 
obstetrics: 10 mg I.M. during first stage of labor:
Contraindications: comatose or deeply de­
pressed states of the CNS due to hypnotics, 
analgesics, narcotics, alcohol, etc.; 
hypersensitivity to phenothiazines; blood 
dyscrasias; bone marrow depression; liver 
damage.
Warnings and precautions: etiology of vomiting 
should be established before using the drug as its 
antiemetic action may mask symptoms of 
intracranial pressure or intestinal obstruction.
Patients with a history of convulsive disorders 
should be given an appropriate anticonvulsant 
while on therapy. Tardive dyskinesia may occur in 
patients on long-term therapy. If used with CNS 
depressants, the possibility of an additive effect 
should be considered. Use with great caution in 
patients with glaucoma or prostatic hypertrophy.
The drug may impair the mental and/or physical 
abilities required for the performance of potentially 
hazardous tasks such as driving a car or operating 
machinery, especially during the first few  days ot 
therapy. Keep in mind that all medications should . 
be used cautiously in pregnant patients, especially 
during the first trimester.
Side effects: extrapyramidal reactions, disturbed 
temperature regulation and seizures have been 
encountered. Other side effects due to 
phenothiazine derivatives should be borne in mind; 
for complete list, see product monograph. 
Overdosage: no specific antidote; symptomatic 
treatment. If a pressor agent is required, 
norepinephrine may be given (not epinephrine as it 
may further depress the blood pressure). 
Dosageforms: tablets 5 and 10 mg; ampoules 
2 m L/IOmg; liquid 5 mg per teaspoonful (5 mL); 
suppositories 5 and 10 mg 
Full prescribing information available on 
request.
References: 1. Int. Rec. Med., 170; 469, 1957.
2. Curr. Ther. Res., 14 (9): 590-598, 1972.
3. Today’s Drugs, Brit. Med. J., 481, 1970.
4. Antiseptic, 73: 16, 1976.
RHONE POULENC PHARMA Inc.
8580 Esplanade 
Montreal, Quebec 
^authorized user
600 VOLUME 25, NO. 6, NOVEMBER 1982 /  THE CANADIAN JOURNAL OF SURGERY
REVIEW ARTICLE
Hyperthermia as a Treatment for Neoplasia
A. D reznik , md, R  E. Falk , md , frcs[c], V. H oward, L. M akowka, md and D. V en tu r i
The use of hyperthermia to treat 
malignant neoplasms is currently a 
“hot” issue. It has been demonstrated 
that heating tumour cells to 42°C or 
above leads to their self-destruction 
by decreased cellular metabolism and 
aerobic respiration. The selective 
accumulation of heat in the malignant 
tissue at 42° to 44°C, compared with 
the temperature of normal tissue, is 
probably related to the different blood 
supply within the tumour. The 
historical background and the 
experimental and clinical results of 
hyperthermia are reviewed. The 
advantages and disadvantages of the 
different thermotherapy techniques 
currently in use are discussed. 
Hyperthermia is probably more efficient 
if combined with other antitumour 
treatment modalities.
L'utilisation de I'hyperthermie dans le 
traitement des neoplasies malignes 
fait presentement I'objet d’une 
controverse “chaudement” debattue.
II a ete demontre que le chauffage 
des cellules tumorales a 42°C ou plus 
entraine leur autodestruction par une 
diminution du metabolisme cellulaire 
et de la respiration aerobie. 
L'accumulation selective de chaleur 
entre 42° et 44°C dans le tissu 
tumoral, comparativement a la 
temperature dans le tissu normal, 
est probablement reliee a I'apport 
sanguin different a I’interieur de la 
tumeur. On revoit le contexte 
historique de meme que les resultats 
experimentaux et cliniques de 
I'hyperthermie. Les avantages et 
desavantages des differentes 
techniques d'hyperthermie presente­
ment en utilisation sont discutes.
From the Goldie Rotman oncology unit, 
Toronto General Hospital, Toronto,
Out.
Accepted for publication June 17, 1982
Reprint requests to: Dr. R.E. Falk,
1-140 Gerrard Wing, Toronto General 
Hospital, Toronto, Ont. M5G 1L7
L'hyperthermie est probablement plus 
efficace lorsqu’elle est associee a 
d’autres therapies antitumorales.
The development of cancer cells can 
be prevented by avoiding exposure to 
known carcinogens such as tobacco, 
sunlight and some industrial chem­
icals; but once cancer cells have de­
veloped, the treatment is limited to 
surgical, chemical and physical meas­
ures. An unresectable or disseminated 
malignant neoplasm can be treated 
with chemotherapy, radiotherapy, im­
munotherapy or hormonotherapy.
Hyperthermia as a treatment for 
malignant neoplasms was mentioned 
in the medical literature as early as 
the 19th century. In recent years, an 
interest in hyperthermia as a cancer 
treatment has arisen because new and 
accurate appliances have been devel­
oped that have a high degree of se­
lective tumour hyperthermia and 
cause only minimal damage to sur­
rounding and superficial tissues.
Experimental in vitro and in vivo 
studies using local, regional or total 
body hyperthermia with different 
heating systems show a high degree of 
tumour necrosis when the temperature 
is above 42°C. A limited number of 
clinical trials, with promising results 
in treating malignant neoplasms by 
hyperthermia alone and in combina­
tion with chemotherapy or radiother­
apy have been reported.
Historical Review
The original interest in “fever ther­
apy” is usually attributed to Busch.1 
In 1866 he described a complete cure 
of histologically proven sarcoma in a 
43-year-old woman after an accident­
ally acquired erysipelas. Coley,2 in 
1893, published the results of inten­
tionally produced erysipelas for the 
treatment of malignant tumours. He 
reported complete recovery in TO of 
34 patients (29%). This interesting 
phenomenon led Coley to prepare an
extract of different types of bacteria, 
mainly Streptococcus pyogenes and 
Bacillus prodigiosus. This preparation, 
called mixed bacterial toxins (MBT), 
was given to induce fever in patients 
with cancer.
The side-effects following inocula­
tion of MBT, the lack of standardiza­
tion and the different biologic be­
haviour of various malignant tumours 
made this treatment unpredictable.
Clowes3 found in 1906 that malig­
nant cells heated to 45°C were irre­
versibly damaged and attempts to in­
oculate them in other animals failed. 
In 1921 Rohdenburg and Prime'1 noted 
that diathermy and irradiation poten­
tiated each other and it made no dif­
ference which was given first. Warren5 
reported encouraging results in the 
treatment of terminal cancer patients 
with whole body hyperthermia, main­
taining the rectal temperature at 
41.5°C. He found an immediate im­
provement in 29 of 32 patients, but 
not in prognosis. Johnson,6 using 
short radio waves, was the first to 
emphasize the different temperatures 
recorded at the core and the periphery 
of the malignant tumour.
Some investigators713 have demon­
strated the efficacy of hyperthermia 
alone or in combination with other 
antitumour treatment modalities. It 
was also shown by Dickson and Su- 
zangar14 and LeVeen and associates15 
that malignant tumour cells are irre­
versibly damaged when heated to 
42°C or more.
Despite the vast experimental in­
terest by many scientists, only limited 
clinical trials have been carried out.
Effect of Thermotherapy 
on Malignant Tumours
There is mounting evidence that hy­
perthermia has a destructive effect 
upon malignant tumours.16,17 Heating 
malignant cells causes: (a) impaired 
DNA and protein synthesis, probably 
related to enzymatic destruction, (b)
VOLUME 25, NO. 6, NOVEMBER 1982 /  THE CANADIAN JOURNAL OF SURGERY 603
impaired RNA synthesis due to de­
creased incorporation of uridine into 
the nucleolar pre-RNA, (c) an increase 
in cellular membrane permeability 
that allows low-molecular-weight sub­
stances access into the cells and (d) 
increased tumour cell antigenicity, 
either by structural changes of the cel­
lular membrane or by a release of 
antigens as a result of tumour cell 
necrosis. These are probably weak 
antigens that could evoke increased 
antibody formation. The dividing 
cells, especially during the synthesis 
and mitosis phases, seem to be more 
susceptible to heat. This preferential 
heat sensitivity has clinical and ther­
apeutic implications, since both phases 
are resistant to radiotherapy.
Dickson and Oswald18 found that 
heating malignant cells to 47°C 
caused cell respiration and glycolysis 
to decrease by 50% and 70% respec­
tively compared with the values at 
38°C. Cessation of oxygen consump­
tion and carbon dioxide production 
was found after heating to 50°C for 
2 hours.
Herman and associates19 found re­
cently that the dihydrofolate reductase 
activity decreased to about 50% of 
the control values after heating at 
43 °C for 4 to 5 hours. The reaction 
of tumour tissue to hyperthermia dif­
fers from that of normal tissue. Heat­
ing a tumour to 42° to 44 °C produced 
a selective accumulation of heat in 
the malignant tissue.7,20'23 This differ­
ence is probably related to the blood 
supply within the heated structure. 
Cancer cells begin their growth as a 
nest of cells between normal blood 
vessels. As the tumour cells grow they 
push aside the normal blood vessels. 
Urbach24 and Gullino and Grantham25 
found that malignant cells produce an 
angiogenic factor that causes a rapid 
proliferation of capillaries. Unlike 
normal organs, the tumour does not 
generally possess a single major ar­
terial or venous supply, but merely a 
capillary network and sinuses con­
nected with the peripheral capillary 
system.26 At the periphery of the tu­
mour, physiologic, if not anatomic, 
arteriovenous communications are 
formed. As a result, malignant tu­
mours have only 5% to 10% of nor­
mal tissue blood flow.2’ This has also 
been demonstrated by the use of ra­
dioactive microspheres.27 The reduced 
blood supply, absence of major blood 
vessels and the thermoregulatory sys­
tem in tumour tissue prevent the dis­
sipation of heat that occurs in normal 
organs.
Tumour cell acidosis, caused by de­
creased oxygen tension and increased
anaerobic metabolism in which lactic 
acid is accumulated, may be respon­
sible in part for the increased sensi­
tivity to hyperthermia. Intravascular 
coagulation necrosis caused by the 
hyperthermia prevents further dissipa­
tion of heat28 and may also contribute 
to intratumoral heat conservation.
Amount of Heat and Tumour Necrosis
Tumour cells are more sensitive to 
heat than normal cells at temperatures 
of 42° to 44°C.28 Heating to 45°C or 
more may also cause irreversible dam­
age to normal cells.7,21,23,29'31 Selective 
heating creates a core tumour temper­
ature of 45° to 50°C with demon­
strable tumour necrosis but spares the 
normal surrounding tissue.15,32"34 The 
lethal effect of hyperthermia on can­
cer cells depends on the intensity and 
duration of treatment. For every 
1°C increase in temperature above 
42 °C, the time required to produce 
tumour necrosis with hvperthermia is 
halved.15,23,33,34 Dickson35 noted from 
the results of in vitro and in vivo 
studies that to produce cell death, 
more than 30 hours at 42°C, 3 to 4 
hours at 45 °C and only a few minutes 
at 50°C were necessary. The differ­
ence between the tumour core tem­
perature and its peripheral tempera­
ture was 2° to 3°C.
Histologic Changes Produced by Heat
The histologic changes that heat 
produces in malignant tumours were 
studied in detail by Sugaar and Le- 
Veen.36 They examined the changes in 
primary lung cancer heated before 
operation and compared them to those 
of 15 untreated primary lung cancers.
Three stages can be discerned fol­
lowing repeated local treatment with 
radiofrequency hyperthermia.
•  Stage I. There are early, variable 
degenerative changes accompanied by 
focal aggregation of granulocytes. The 
stromal interstitium is extensively in­
filtrated with plasma cells and there 
is hyperplasia of regional lymph ag­
gregates. Acute congestive changes 
are present in the surrounding lung 
parenchyma. These alterations are not 
specific to thermotherapv and might 
also occur in tumour tissue treated 
by other methods.37-14
•  Stage II. There are focal areas 
of fibrinoid necrosis in the capillary 
stromal wall while the tumour tissue 
is profuselv infiltrated with small lym­
phocytes. These changes are charac­
teristic after hyperthermia treatment 
and are comparable to some of the 
histologic changes present during the 
course of acute allograft rejection.38
•  Stage III. Focal areas of coagu­
lation necrosis are present around the 
necrotic vessels at the core of the 
tumour. The capillary wall shows mas­
sive infiltration with small lympho­
cytes surrounded by pools of lympho­
cytes, necrotic tumour tissue and he­
mosiderin deposits.
Storm and associates28 also observed 
that heating at 45° to 50°C caused 
vascular and tumour necrosis with fo­
cal hemorrhage. They postulated that 
vascular thrombosis could contribute 
to the selectivity of the tumour heat­
ing by preventing the dissipation of 
heat from the tumour mass to circu­
lating blood. Moreover, these vascular 
changes may prevent the absorption of 
necrotic tissue, which is therefore re­
placed by fibrotic tissue without ap­
preciable change in the size of the 
neoplastic lesion.
Methods of Producing Hyperthermia 
for Malignant Tumours
Clinically, there are three main 
ways of giving thermotherapy: by
whole body, regional and local hyper­
thermia.
Whole Body Hyperthermia
A variety of means have been used 
to increase total body temperature. 
These include: inhalation of hot air, 
hot water baths, hot wax, infrared 
rays, thermally controlled “space-suits” 
and extracorporeal circulation.
Pettigrew and associates39-40 treated 
82 patients with advanced metastatic 
disease under general anesthesia, using 
molten paraffin wax. Clinically, 49 
patients improved but 4 died as a re­
sult of cardiac arrythmias, dissemin­
ated intravascular coagulation and 
burns. Because of the advanced state 
of the disease, responses were difficult 
to evaluate.
Larkin41 reported the results of 77 
patients treated with a heated mod­
ified water blanket'under general an­
esthesia for 2 hours. He found either 
subjective or objective responses in 
58%. Five patients died as a result 
of cardiac arrythmias, pulmonary 
edema and severe burns.
Bull and associates42 treated pa­
tients with the combination of total 
body hyperthermia and Adriamycin 
for metastatic sarcoma. Evidence of 
tumour shrinkage was seen in only 
two patients. Ventricular arrythmias, 
which responded to lidocaine infusion, 
were noted. Whole body hyperthermia 
with the use of radiofrequency waves 
is being investigated but no clinical 
data are yet available. All the tech-
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niques for whole body hyperthermia 
have serious side-effects and are cost­
ly and time consuming. Results of ini­
tial studies at various institutions may 
provide a simple and easy method for 
whole body thermotherapy with min­
imal side-effects, but most investiga­
tors regard this as unlikely.
Regional Hyperthermia
In this method a limb is isolated 
and perfused with heated solutions. 
Stehlin and colleagues43,44 used region­
al thermotherapy with .melphalan to 
treat malignant melanomas. They pro­
duced a 5-year survival rate of 74% 
compared with 22% in a historical 
control group. No amputations were 
necessary in patients treated with re­
gional hyperthermia. Moricca and as­
sociates45 reported regression of mela­
nomas and sarcomas treated by re­
gional heated perfusion to 43 °C for 
up to 8 hours.
Local Hyperthermia
Three main types of local hyper­
thermia are currently in clinical use: 
(a) Ultrasonic heat transfer. This has 
been investigated mainly by the Stan­
ford University and the MIT groups. 
The major advantage of this method 
is the precise localization of the ap­
plied energy to depths of 10 to 15 cm 
and effective heating of deep-seated 
tumours. The disadvantages are those 
related to the difficulty of heating 
lung tumours and those located behind 
bony structures. Since the magnitude 
of ultrasonic energy required for heat­
ing adipose tissue, muscle, skin and 
bone increases for each tissue, and 
since the absorption coefficient of ul­
trasound waves is constant, skin cool­
ing is essential, (b) Microwave heat 
transfer. Microwave absorption in the 
usable frequency ranges of 2.9 to 200 
MHz is determined by the specific re­
sistance of the tissue. As a result, 
fatty tissue, due to its relative specific 
resistance will heat to a point of fat 
necrosis. Beneath the skin level, tem­
perature distribution will depend upon 
the amounts of fatty tissue to be 
traversed. With this method there are 
theoretical advantages to heating su­
perficial tumours or tumours derived 
from muscle. This method of heating 
may be suitable for local but not 
whole body use. (c) Radiofrequency 
hyperthermia. By this method heat is 
generated through electromagnetic 
fields. There are two general modes 
of radiofrequency heating: capacitive 
coupling and inductive heating. Capa­
citive coupling may be used to pro­
duce current field to generate heat in 
tumour tissues. Since skin and fatty 
tissue absorb little of the heat it can 
be used in obese patients. The use of 
intratumour core thermistor probes 
does not change the temperature read­
ing during the treatment. Inductive 
heating has the advantage of heating 
larger volumes than the capacitive 
type, but it lacks the concentration 
and localization of the dispersed heat.
Several basic requirements are nec­
essary for adequate local heating, (a) 
The amount and intensity of energy 
have to be high enough to heat every 
part of the tumour, (b) In treating 
deep-seated tumours dispersal of en­
ergy by, as well as damage to, super­
ficial structures should be avoided, 
(c) The energy supply in different 
parallel body sections should be con­
stant. (d) Low-frequency beams are 
necessary, since these are most effi­
cient.48 In spite of the high level of 
technical development of heat gener­
ating instruments for medical pur­
poses, there is still no standardization 
of dielectric constants for conductivity 
of different tissues. Atkinson47 found 
that several physical characteristics of 
tumour tissue are necessary for op­
timal response to thermotherapy. They 
are electric conductivity, heat conduc­
tivity, ability to be heated and per­
fusion rate.
Experimental and Clinical Results
The methods of production of hy­
perthermia for the treatment of malig­
nant tumours include the use of the 
whole electromagnetic spectrum — 
from conventional diathermy using a 
frequency of 1 MHz for Crocker tu­
mours in mice48 to microwaves with a 
frequency of 200 MHz for hepatoma 
223 in rats.49 The main hazard of 
heating deep tumours is the relatively 
high absorption of heat by superficial 
tissues.50
Westermark,23 in treating superficial 
Jensen tumours in rats with hyperther­
mia, found considerable damage to 
the skin and subcutaneous tissue at 
temperatures above 46 °C. The tumour 
was not heated uniformly and its peri­
phery was colder than its core. Cava- 
liere and associates7 studied the effect 
of hyperthermia on Walker and Jen­
sen tumours and found no damage to 
the superficial tissues at temperatures 
below 47 °C. Overgaard and Over- 
gaard12 treated tumours in mice with 
microwaves of 27.12 MHz frequency 
and found 25% tumour cell necrosis 
at tumour core temperatures of 46° 
to 47 °C without damage to superfi­
cial tissue. The use of hyperthermia
gained renewed attention only in the 
last decade as a result of experimental 
and clinical investigations.10’12-23,51 This 
method was used alone or in com­
bination with chemotherapy or irradi­
ation.62,53 Most of the clinical studies 
were limited to superficial tumours 
using relatively low intensity hyper­
thermia20 or during operation in order 
to avoid superficial tissue damage. 
Storm and associates28 studied the ef­
fect of hyperthermia on normal and 
tumour tissue in animal models and in 
clinical trials. Using the inductive type 
of radiofrequency heating, they found 
first degree burns at 42 °C, second 
degree burns at 46 °C and full-thick­
ness skin and muscle necrosis at and 
above 50°C. Heating internal organs 
for 15 minutes at 42° to 45 °C did 
not produce any clinical evidence of 
internal organ injury; however, pro­
longed, continuous heating at even 
this temperature universally produced 
fatal cardiac arrythmias. These au­
thors tried to define the thermal death 
time of different human cancers.54 
Treatment of 44 tumours in 32 pa­
tients was carried out and repeated 
tumour biopsy specimens were exam­
ined. They found that short duration 
thermotherapy at 50 °C resulted in 
20% to 100% tumour cell necrosis; 
2 to 3 weeks at 45° to 50°C were 
necessary to provoke 70% to 100% 
tumour cell necrosis and double that 
time was necessary at temperatures 
between 40° and 45°C. Treatment 
was on an outpatient basis; no seda­
tion was used. The recorded tumour 
temperatures were high and side- 
effects were negligible.
LeVeen and associates55 reported 
their clinical retrospective experience 
with hyperthermia between 1974 and 
1977. In 6 of 32 patients with lung 
cancer treated with hyperthermia the 
disease was eradicated. Regression of 
tumour was noted in 11 of 32 patients 
and 27 patients reported subjective 
improvement. The physiologic changes 
resulting from local thermotherapy are 
usually of minor importance. There is 
an increase of systolic blood pressure 
of 20 to 25 mm Hg with only a mod­
erate increase in diastolic pressure. 
The average pulse rate increases 8.5 
beats/min with each degree increase 
in temperature. These manifestations 
are temporary and occur as a result 
of the gradual increase of heat. They 
tend to stabilize with stabilization of 
the temperature.
Immunologic Aspects 
of Hyperthermia
Circumstantial evidence shows that
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the immune system is involved in tu­
mour regression following thermo­
therapy. The immunologic response to 
hyperthermia is indicated by local in­
filtration of macrophages and by non­
specific cellular and humoral re­
sponse.56 An indirect observation of 
immunologic activity is indicated by 
the disappearance of secondary lesions 
after heating the primary tumour. 
This is called the “abscopal antitu­
mour effect” and was noticed in hu­
man cancers as well.45,57 It was also 
found that animals which were cured 
were immune to challenge with tu­
mour cell inocula many times greater 
than those of untreated animals. In 
rabbits bearing bilaterally implanted 
Brown-Pearce carcinoma, thermother­
apy of the tumour in one testis was 
followed by regression of the contra­
lateral tumour. Following tumour 
heating a rise of antitumour antibody 
titres occurred. The titres increased to 
about 1:100 by 2 to 3 weeks after 
heating. They were maintained for the 
following 3 to 4 weeks and then de­
creased to zero after 3 to 4 months.58
Cured rabbits were immune to chal­
lenge with Brown-Pearce carcinoma 
and inoculation of their sera into nor­
mal rabbits produced rejection of fur­
ther tumour challenge while injection 
of the immune sera into tumour-bear­
ing animals led to tumour regression.
The immunologic enhancement of 
hyperthermia has led some, such as 
Moricca and associates45 and Stehlin 
and associates,59 to perform a delayed 
amputation, 4 to 12 weeks after re­
gional thermotherapy. They believe 
that during this period antigens are 
released from the necrotic cells. These 
antigens lead to an increased anti­
tumour response that destroys meta- 
stases.58
Microwave heating to 43 °C of 
Guerin epithelioma in rats caused im­
munologic stimulation with indirect 
cellular and humoral responses asso­
ciated with increased lymphoid toxi­
city and macrophage infiltration. 
These results suggest that, as a result 
of hyperthermia, an immunologic re­
sponse is produced that may play a 
prominent role in the destruction of 
malignant tumours.60 The mechanism 
that provokes the immunologic reac­
tion as a result of hyperthermia is not 
yet known. Several authors have pos­
tulated that changes in the cell mem­
brane may increase its immunogeni- 
city.61 In support of this theory, 
Jasiewicz and Dickson62 found that tu­
mour cells heated at 42°C caused an 
increased reaction with specific anti­
tumour serum. The changes in the cell 
membrane facilitate the action of an­
tibodies against the surface antigens. 
These hypotheses are related to local 
thermotherapy. The influence of 
whole body hyperthermia on the im­
munologic system is not yet known. 
Dickson and Muckle29 reported better 
results after treating VX2 carcinomas 
in rabbits with local hyperthermia than 
with whole body hyperthermia. They 
suggest that whole body hyperthermia 
causes depression of the immune sys­
tem. Other investigators noticed an 
increase in the number of metastatic 
lesions as a result of whole body hy­
perthermia, probably due to immuno­
suppression.16,63
For many reasons the immune re­
sponse to local and whole body hyper­
thermia is difficult to assess: (a) chem­
ically induced tumours in experimental 
animals behave differently from spon­
taneous human tumours, (b) many 
experimental tumours are known to 
be immunogenic, enhancing the host’s 
immunologic response56 and (c) there 
is no laboratory evidence of immuno­
logic suppression as a result of whole 
body thermotherapy.
Combined Hyperthermia 
and Irradiation
The combination of thermotherapy 
and irradiation to treat malignant neo­
plasms has been utilized by several 
groups.64,65 An increased tumour cell 
killing effect was noticed when this 
combination was used.66"68 Cells that 
are in radioresistant S-phase are fre­
quently sensitized and killed by 
heat.69 70 Heat also inhibits the repair 
of radiation damage. Ben-Hur and 
associates71 demonstrated that the re­
pair of sublethal radiation damage was 
inhibited by hyperthermia. Experi­
mental studies performed on TED.™ 
tumours showed that the radiation 
dose necessary to cause tumour necro­
sis decreased by 50% if combined 
with local hyperthermia.72,73 These 
methods combined were more efficient 
than either modality alone in treating 
malignant melanoma.74 Marmor and 
Hahn75 compared the results of com­
bined hyperthermia and irradiation 
with irradiation alone for the treat­
ment of metastatic superficial tu­
mours. In the same patient, different 
areas were treated either with radio­
therapy alone or in combination with 
hyperthermia at 43 °C for 45 minutes. 
In 7 of 15 patients a better response 
was observed with the two modalities 
combined than with irradiation alone. 
The tumour regressed completely in 
four patients using both methods of 
treatment. Two patients did not re­
spond to either modality and in two
others only a partial response was 
noted.
Combined Hyperthermia 
and Chemotherapy
In vitro studies have demonstrated 
increased efficiency of some chemo­
therapeutic agents when combined 
with hyperthermia.76 Only limited in 
vivo studies have been done, and even 
fewer clinical reports are available.
Increased efficacy has been noted 
with the combination of hyperthermia 
and BCNU (bischloroethyl nitro­
sourea), bleomycin and cis-platinum. 
The clinical use of BCNU seems to 
be most favourable at 41° to 42°C 
while bleomycin exerts its maximal 
effect at 42° to 43°C.77 Hyperthermia 
probably increases the efficacy of 
chemotherapeutic drugs by increasing 
absorption of alkylating agents by ma­
lignant cells. Hyperthermia is syner­
gistic with several chemotherapeutic 
agents.78"81 Drugs considered inefficient 
in the treatment of various tumours, 
such as amphotericin and misonida- 
zole, became effective when given in 
combination with hyperthermia.82"84 It 
was found also that the synergistic 
effect of thermotherapy was not spec­
ific for chemotherapeutic agents be­
longing to any one class of activity 
but increased the effectiveness of 
drugs of various groups.
The combination of chemotherapy 
with irradiation is generally associated 
with increased toxicity.85,86 No such 
increase in toxicity has been reported 
when chemotherapy is given in com­
bination with hyperthermia. Recorded 
tumour core temperature during ther­
motherapy facilitates the use of con­
comitant chemotherapeutic agents 
which exert their major activity at 
40°C and above. Hyperthermia may 
delay or prevent tumour resistance to 
certain chemotherapeutic drugs; as far 
as is known, no tumour resistance to 
hyperthermia has been recorded. Sev­
eral studies reported the possibility of 
“thermal tolerance”.87,88 This pheno­
menon is probably a result of sub- 
lethal heating of tumour cells and is 
always reversible. No data has yet 
been published about the combination 
of local hyperthermia with local ar­
terial infusion chemotherapy.
Future Prospects
The different modalities used in 
cancer therapy demonstrate the lack 
of one effective treatment. Hyperther­
mia represents an additional relatively 
nontoxic therapeutic maneuver. It is 
apparent that regional thermotherapy
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is safer and has fewer complications 
than whole body hyperthermia. Hy­
perthermia evidently yields the best 
results when combined with other an­
titumour treatments. The effectiveness 
of thermotherapy is not related to the 
histologic type of the tumour and is 
as efficient for treating superficial as 
deep-seated tumours. It is difficult to 
predict the exact future clinical im­
plications of hyperthermia; however, 
considering the negligible side-effects 
and the initial promising results, it is 
probable that hyperthermia has a 
place in cancer therapy. Regional hy­
perthermia induced by radiofrequency 
offers the best and most controlled 
form of therapy. Further work will be 
necessary to develop equipment to 
permit rapid, consistent and safe 
heating.
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Elective Colon Surgery:
Clindamycin versus Metronidazole Prophylaxis
Fivos N. Gahhos, md, Geoffrey K. R ichards, md, frc path, frcp[c],
E. John Hinchey, md, facs, frcs[c] and John J. Prentis, fimls
Orally administered clindamycin- 
neomycin as a prophylactic antibiotic 
in patients scheduled to undergo 
colon surgery was compared to 
orally administered metronidazole-neo­
mycin. Clindamycin levels of the colon 
contents and the mucosa were 8 to 
10 times higher than the serum levels. 
Three of the 43 patients who received 
metronidazole had wound infection 
whereas none of the 38 patients who 
received clindamycin did. Clindamycin 
may help to prevent staphylococcal 
infection, a known problem associated 
with metronidazole use. It may also 
play a role in preventing infection at 
the anastomosis in patients who 
undergo colon resection.
L'administration par voie orale de 
clindamycine et de neomycine a titre 
d'antibiotherapie prophylactique a ete 
comparee a l'administration par voie 
orale de metronidazole et de neomycine 
chez des patients qui devaient subir 
une chirurgie du colon. Les taux de 
clindamycine dans le contenu et la 
muqueuse coliques etaient 8 a 10 fois 
plus eleves que les taux seriques. 
Trois des 43 patients qui avaient 
recu du metronidazole ont eu des 
infections de plaie comparativement 
a aucun des 38 patients sous 
clindamycine. La clindamycine peut 
contribuer a prevenir les infections 
staphylococcique, un probleme identifie 
avec I'usage du metronidazole. II peut
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aussi jouer un role preventif a I’egard 
des infections d’anastomose chez 
les patients qui subissent une resection 
du colon.
The frequency of wound infection 
following operations on the colon is 
reduced by the preoperative admin­
istration of appropriate antibiotics. 
Without antibiotic prophylaxis, the 
wound infection rate ranges from 
32% to 58%' and the rate of infec­
tious complications is as high as 
75%.2 The combination of neomycin 
and metronidazole given orally has 
been shown to reduce markedly the 
incidence of wound infection follow­
ing operations on the colon3'5 and the 
incidence of anaerobic infection falls 
towards zero. These drugs are almost 
entirely free of serious side-effects.6'8 
In recent studies3’5 at the Montreal 
General Hospital, involving 138 pa­
tients who received metronidazole, 
orally or intravenously, in conjunc­
tion with neomycin orally as prophy­
laxis, there were six wound infections; 
five were staphylococcal and one was 
due to bacteria originating in the in­
testine. Since the antibacterial activity 
of metronidazole is confined to anae­
robic organisms, we decided to study 
clindamycin, which is effective against 
anaerobes such as Bacteroides sp.7 as 
well as aerobes such as staphylococci. 
Clindamycin is present in wound fluid 
in adequate concentrations following 
preoperative administration.9
A prospective, randomized, double­
blind, clinical trial was, therefore, 
undertaken to compare the effective­
ness of metronidazole to that of clin­
damycin, orally administered, as part 
of a prophylactic regimen in elective 
colon surgery. Anergy testing was per­
formed perioperatively.
Patients and Methods
Clinical Study
The study population consisted of
patients admitted to the Montreal 
General Hospital for elective colon 
surgery. Patients were included in the 
study if the bowel was incised at oper­
ation. Excluded were those who had 
received antibiotics during the 2 
weeks preceding operation, who had 
evidence of infection before surgery, 
leukopenia (leukocyte count less than 
2.5 X 109/1), thrombocytopenia, renal 
disease (serum creatinine value greater 
than 114.9 ^umol/l or creatinine clear­
ance less than 50 ml/min), or active 
degenerative neurologic disease. Fully 
informed, written consent was ob­
tained from each patient. Patients 
were assigned to two groups by a 
pharmacist, using a table of random 
numbers. The codes were known only 
to the pharmacist.
Patients in both groups received 
clear fluids and 30 ml of magnesium 
citrate for 2 days before operation. 
Enemas were administered the night 
before the operation until the return 
was clear.
Group 1 received metronidazole, 
750 mg orally three times and neo­
mycin, 1 g orally three times on the 
day before operation. Group 2 re­
ceived clindamycin, 450 mg orally 
three times and neomycin 1 g orally 
three times on the day before surgery. 
No antibiotics were given postoper- 
atively.
The wounds were inspected for evi­
dence of infection on days 4 and 8 
after operation and on the day of dis­
charge. Infection was defined as in­
flammation and induration in the 
wound with the discharge of pus, re­
gardless of the culture results.
All patients were checked daily for 
signs of elevated body temperature, 
tachycardia and diarrhea. Patients 
who had diarrhea (three or more li­
quid stools a day or, in patients with 
a colostomy, an effluent in excess of 
500 ml/d) after or during the admin­
istration of the drugs, underwent the 
following investigations: proctosig-
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moidoscopy with biopsy and the 
testing of stools for the presence of 
Clostridium difficile cytotoxins.
Anergy Testing
Delayed hypersensitivity skin test­
ing was performed perioperatively, 
using six recall antigens (purified pro­
tein derivative, histoplasmin, Vari- 
dase, Candida, Trichophyton, dini- 
trochlorobenzene) injected intraderm- 
ally. Injection sites were examined 
after 48 hours. The skin test was con­
sidered to be positive if two or more 
of the six recall antigens produced an 
induration of 5 mm or more. The pa­
tient was considered relatively anergic 
if only one of the antigens reacted 
and anergic if none of the antigens 
produced induration of 5 mm or 
more.
Microhiologic Studies
Quantitative bacteriologic cultures 
were made of feces before antibiotic 
administration and of colon contents 
and peritoneal fluid obtained at the 
time of operation. Decimal dilutions 
of the material were inoculated onto 
the surface of selective and nonselec- 
tive media using a calibrated multiple 
loop applicator.3 Surface viable counts 
were recorded for total aerobes, en­
terobacteria (coliforms), Streptococcus 
faecalis (enterococci), staphylococci, 
Candida sp, Pseudomonas aeruginosa, 
lactobacilli, bifidobacteria, Bacteroides 
sp, clostridia, anaerobic cocci and total 
facultative anaerobes.
Qualitative cultures of infected 
wounds were made for both aerobes 
and anaerobes. Biologic assays of 
metronidazole and clindamycin in 
blood, colon content and separated 
colon mucosa and muscularis muco­
sae, obtained at the time of operation, 
were carried out using the variable 
volume and plate diffusion tech­
nique.10 All samples for assay were 
first screened to ensure the absence of 
unsuspected interfering antibiotics. 
The carriage rate of Staphylococcus 
aureus was determined by cultures of 
abdominal skin and nose made before 
the administration of antibiotics.
Statistical analysis was carried out 
using the unpaired, Student’s f-test.
Results
Clinical
One hundred and three consecutive 
patients entered the trial. Twenty-two 
patients were rejected for reasons 
listed in Table I, leaving 81 patients
eligible for study. When the code was 
broken, a number of factors were ex­
amined to validate the randomization 
carried out by the hospital pharma­
cist. There were 43 patients in group 
1 (metronidazole) and 38 patients in 
group 2 (clindamycin). The following 
characteristics of the patients in both 
groups were similar: age distribution, 
disease process, type of operation, 
operating surgeon, duration of opera­
tion, duration of hospital stay pre- 
and postoperatively, drainage of 
wounds and type of anastomosis (hand 
versus stapler). There were no differ­
ences between the two groups in the 
extent of primary disease or associated 
systemic disease (such as diabetes mel- 
litus). All wounds were closed pri­
marily.
Of the 43 patients in group 1, 3 
had wound infections. Two infections 
were associated with aerobic fecal or­
ganisms (coliforms) and one was sta­
phylococcal (S. aureus). There were 
no abdominal wound infections in the 
38 patients in group 2. This difference 
in the number of wound infections in 
each group is not statistically signif­
icant. No wound infections developed 
during a 6-month period following 
discharge from the hospital. Thirty- 
seven patients were tested preopera- 
tively for delayed hypersensitivity 
reactions according to the method of 
Pietsch and Meakins.11 In group 1, 11 
of 23 patients tested were anergic, 4 
were relatively anergic and 8 were 
normal. In group 2, 3 of 14 patients 
tested were anergic, 2 were relatively 
anergic and 9 were normal. These dif­
ferences were not significant. In the 
three infected patients, one was aner­
gic and one was relatively anergic; the 
third patient was not tested. Our study 
population contained a majority of pa­
tients having cancer (38 in group 1 
and 32 in group 2) and some had mal­
nutrition which is a known depressant 
of delayed hypersensitivity.11
Two types of bowel anastomosis 
were used: hand and stapler. In group 
1, 27 anastomoses were done by hand, 
the stapler was used in 12, and for 
group 2 the figures were 28 and 5, 
respectively. In the three infected pa­
tients, anastomosis was carried out by 
hand in two and with a stapler in the 
third. These differences were not 
significant. The mean duration of hos­
pital stay after operation was 12.9 
days (standard deviation ± 3 . 2  days) 
in group 1 and 14.4 days (±  5.7 days) 
for group 2, a difference that is not 
statistically significant. In the infected 
patients, the mean duration of hospital 
stay was 19.3 days (±  6.4 days).
Ten group 1 patients were drained
through a separate stab wound and 5 
through the operative incision while 
the remaining 28 patients were not 
drained. In group 2, of 38 patients, 5 
were drained through a separate stab 
wound, 12 through the operative inci­
sion wound while 21 patients were not 
drained. Of the three infected pa­
tients, two were drained through a 
separate stab wound while no drainage 
was employed in the third. These dif­
ferences were not significant. A 2.5- 
cm Penrose drain was used in each 
case.
Adverse effects from the drugs 
were minimal. Two patients in group 
1 and one in group 2 vomited more 
than one dose of the antibiotics. One 
patient in group 2 had pseudomem­
branous colitis postoperatively, diag­
nosed by sigmoidoscopy and biopsy. 
The organism isolated was heat re­
sistant Clostridium perfringens and no 
C. difficile was identified. The colitis 
resolved quickly with a 10-day course 
of metronidazole and no relapses were 
noted during the 6 months of follow­
up.
Bacteriologic Findings
Carriage rate of S. aureus.—In 
group 1, 6 of 26 patients (23%) had 
S. aureus in the pretreatment feces, 
an average of 103'4 organisms per 
gram, and 3 of 40 patients (7.5%) 
had S. aureus in nose or abdominal 
skin, or both.
In group 2, 8 of 36 patients (22%) 
carried S. aureus in the admission 
pretreatment specimen of feces, an 
average 103 5/g, and 11 of 33 patients 
(33%) had this organism in the nose 
or abdominal skin cultures, or both. 
No clinical infections with S. aureus 
were noted.
Pretreatment feces.—No significant 
differences were noted between clin­
damycin and metronidazole for any 
of the bacterial populations examined 
(log. normal distribution: unpaired 
two-tailed Student’s f-test) (Table II).
Colon contents.—Twenty-eight sam­
ples of colon content were analysed 
for the clindamycin group (group 2) 
and 35 samples for the metronidazole
Table I-R e a so n  for Exclusion of Patients
Reason for exclusion
No. of 
patients
No bowel incision 10
Other preoperative antibiotics 2
Postoperative antibiotics 6
No preoperative antibiotics 1
Code broken 3
Total 22
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group (group 1). There was no statis­
tical difference between the two groups 
for coliforms, the median concentra­
tion being nil (less than lOVg). In 
group 2, only 2 of the 28 samples 
were positive for Bacteroides fragilis, 
at a concentration of 102/g (a level 
regarded as biologically not signif­
icant).3,3 For group 1 patients, the scat­
ter was greater, 6 of 35 samples being 
positive for B. fragilis, with concen­
trations ranging from lOVg to 106/g. 
Two of these samples exceeded 
1 O'5/g, a figure previously regarded 
as a critical level for biological sig­
nificance.3,5 A statistical comparison 
of the bacterial data for the two 
groups gave a single tail P value of 
0.03 consistent with a marginal su­
periority of clindamycin in eliminating 
anaerobes in the colon, under the con­
ditions of this trial (Table III).
Peritoneal fluid.-—Twenty-two sam­
ples of peritoneal fluid in group 2 
yielded coliforms (102/g), 1 yielded 
enterococci (lOVg) and 20 were bac- 
teriologically sterile. No patients were 
clinically infected.
Of 30 samples in group 1, 1 yielded 
coliforms (103/g), 1 enterococci
(lOVg) and the remaining 28 samples 
were bacteriologically sterile.
Assays of serum and colon content. 
—Seventeen samples of serum were 
assayed for clindamycin, yielding a 
mean of 2.2 /xg/ml (±  1.7 /xg/ml). 
Twenty-seven samples of colon con­
tent yielded a mean of 19.2 /xg/ml 
(±16.9 /xg/ml). The mean level in 
the colon was approximately nine 
times higher than in serum.
Twenty-four samples of serum were 
assayed for metronidazole, yielding a 
mean of 11.2 /xg/ml (±7.3 /xg/ml). 
Thirty-five samples of colon content 
had a mean concentration of metro­
nidazole of 12.3 /xg/ml (±12.3 
Ug/ml). Seven samples were below 
the threshold of sensitivity of the test 
(3 /xg/ml). The mean level of anti­
biotic in the colon approximated that 
in serum.
Tissue assays.—Seven samples of 
colonic mucosa and muscularis mu­
cosae were assayed for clindamycin. 
They yielded a mean concentration of 
the antibiotic of 15.9 /xg/g of tissue 
(±17.3 /xg/g) and 3.7 /xg/g (±1.9 
/xg/g) respectively.
Five similar samples, assayed for 
metronidazole, yielded a mean of 8.8 
/xg/g of tissue (±12.6 /xg/g) and 13.6 
/xg/g (±18.9 /xg/g) respectively.
The ratios of antibiotic concentra­
tions were determined in each patient 
for serum to mucosa, mucosa to mus­
cularis mucosae and serum to muscu­
laris mucosae. The metronidazole ra­
tios were compared with the clinda­
mycin ratios using one-tailed Student’s 
/-test to determine if they were of 
the same order. Comparison of the 
mucosa to muscularis mucosae ratios 
for the two antibiotics gave a P value 
of 0.04, while the serum to muscu­
laris mucosae ratios gave a P value 
of 0.025 and for serum to mucosa 
ratios the P value was 0.005.
Metronidazole appears in mucosa 
in concentrations similar to those 
found in serum. By contrast, clinda­
mycin appears to accumulate actively 
in the mucosa. The reason for this 
is not known.
Discussion
Bacterial concentrations of 10” to 
10”  cfu/g are found in the colon.” 
Anaerobic bacteria make up 99.9% 
of the fecal flora. The dominant or­
ganism in the colon is B. fragilis in a 
concentration of 109 to 1010/g  of feces 
in healthy individuals.”  Leigh13 re­
ported pure growths of B. fragilis in 
half the wounds that became infected 
following intestinal operations. A 
complication of oral antimicrobial 
prophylaxis against anaerobes is the 
overgrowth of Candida sp. and sta­
phylococci.14 We found, in a series of 
138 patients3-5 treated with metronida­
zole and neomycin, that five out of 
six wound infections were staphylo­
coccal alone and only one was due 
to bacteria of intestinal origin. Anti­
biotics that are effective against anae­
robes, particularly B. fragilis, include 
clindamycin, metronidazole, rifamy- 
cin, lincomycin, erythromycin and 
chloramphenicol. We chose clinda­
mycin because of its activity against 
staphylococci and anaerobic gram­
positive cocci in addition to its effi­
cacy against B. fragilis.”  Wagner and 
associates16 found that after adminis­
tering a single 250-mg dose of clinda­
mycin, the mean half-life of the anti­
biotic was 2.3 hours. Only 6.4% of 
the dose is excreted in the urine” 
while high concentrations are found 
in the bile.18
As in previous studies with metro- 
nidazole3'5’14 no anaerobic infections 
were found in our series, as was the 
case with clindamycin, which has not 
previously been tested in elective 
bowel preparation. No infections were 
noted with clindamycin in this study 
while three patients in the metronida­
zole group had wound infections (two 
coliform, one staphylococcal). De-
Table II-Bacteriology: Pretreatment Feces
Count, 
log. 10/g
Coliform organisms Bacteroides organisms
Clindamycin Metronidazole Clindamycin Metronidazole
Nil 2 1 1 _
102 — 1 _ _
103 3 6 _ _
10* 9 8 5 9
10s 10 5 4 9
106 4 6 3 6
107 _ 4 9 7
108 — 3 6 3
108 - - 1
Mean 4.7
1
5.3 
__ I
6.2
1
6.6 
__ |
P = 0.3 P = 0.3
Table III-Bacteriology: Colon
Count, 
log. 10/g
Coliform organisms Bacteroides organisms
Clindamycin Metronidazole Clindamycin Metronidazole
Nil 23 28 26 29
102 3 — 2 2
103 2 3 _ 1
104 — 2 _ 1
105 _ _ _ 1
106 _ 1 _ 1
107 1 -
Mean 1.3
L -
1.7 1.1 
1____
1.5
P == 0.2 P = 0.03 (single tail)
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spite the fact that, when statistically 
analysed, the distribution of infection 
is not significant, our quantitative 
cultures show a significant difference 
(P =  0.03) between the two drugs in 
eliminating anaerobes in the colon, 
clindamycin being more effective. 
This may be secondary to high levels 
of clindamycin in colonic mucosa and 
contents, as shown by our tissue as­
says. This is in agreement with the 
work of Berger and associates19 who 
found high penetration of clindamy­
cin into inflamed appendices.
Clindamycin protected against sta­
phylococcal infections despite the fact 
that 11 of 33 patients were carriers 
in nose or skin, or both, compared 
with 3 of 40 in the metronidazole 
group. This could be due to the ac­
tivity of clindamycin against staphy­
lococci and also to its high concentra­
tion in wound fluid.9 Clindamycin has 
also been found to be more effective 
in the treatment of anaerobic lung 
abscesses than metronidazole.20
When the findings of this study were 
combined with those of our previous 
studies3,5 in 181 patients who received, 
as prophylaxis, metronidazole orally 
or intravenously in conjunction with 
orally administered neomycin, there 
have been nine infections (4.9%), of 
which six were staphylococcal and 
three were due to bacteria of gut 
origin, compared with no infections 
in the 38 patients who received clin­
damycin and neomycin orally.
Responding to reports that diarrhea 
and pseudomembranous colitis oc­
curred relatively frequently among pa­
tients who received clindamycin,21 we 
followed all our patients carefully for 
development of diarrhea. In one pa­
tient who had anterior resection for 
peridiverticular abscess and ulcerative 
colitis, pseudomembranous colitis de­
veloped; it was confirmed by sigmoid­
oscopy and biopsy. However, only C. 
perfringens was isolated, and for tech­
nical reasons we were unable to check 
for C. difficile toxins in stool. This 
patient had received clindamycin as 
bowel preparation. Clostridium dif­
ficile is known to be responsible for 
the majority of cases of pseudomem­
branous colitis.22,23 Clindamycin as 
the cause of this condition has been 
disputed both in prospective23 and 
retrospective24,25 studies. Any antimi­
crobial drug capable of altering the 
normal intestinal flora can be respon­
sible for precipitating pseudomem­
branous colitis.25 Diarrhea has not 
been reported after a 1-day course of 
clindamycin, which is in agreement 
with our data. Two patients receiving 
metronidazole and one receiving clin­
damycin vomited more than one dose 
of antibiotics but no nausea, macu- 
lopapular rash, urticaria, transient ab­
normality of liver function tests, 
transient leukopenia or eosinophilia 
was reported in either group.
Conclusions
The results of a prospective, ran­
domized, double-blind, clinical trial, 
assessing the relative effectiveness of 
metronidazole-neomycin and clinda­
mycin-neomycin as a preoperative 
bowel preparation, indicate no signif­
icant difference in the reduction of 
aerobic bacteria of feces and colon 
content between the two groups. 
There was, however, a significantly 
greater reduction in anaerobic bac­
teria in the feces of patients receiving 
clindamycin. Tissue assays showed ac­
cumulation of clindamycin in the 
colonic mucosa, while the colon con­
tent to serum drug level ratio was 
9:1.
Both clindamycin and metronida­
zole are equally effective in reducing 
postoperative wound sepsis, but clin­
damycin may aid in preventing sta­
phylococcal infection, a known resid­
ual problem in metronidazole pro­
phylaxis.
The accumulation of clindamycin 
in such high concentration in the wall 
of the colon may play a significant 
role in preventing infection at the 
anastomotic site.
We thank Dr. Shirley Chou for carry­
ing out the tissue assays for clindamycin 
and metronidazole.
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Variations of Cardiac Rate and Hemodynamic
Criteria of Rejection
Robert Parent, b sc, Gilles Ducharme, m sc, Paul Stanley, md and Claude Chartrand, md, frcs[c]
Since heart rate influences the values 
of many hemodynamic parameters, the 
authors have examined the effect of 
heart rate variations noted after cardiac 
transplantation on the hemodynamic 
criteria of rejection. They have 
undertaken serial studies at intrinsic 
rate and at a paced atrial rate of 
150 beats/min in 11 resting 
homotransplanted dogs. The authors 
analysed cardiac index, stroke volume, 
peak velocity, acceleration, stroke 
power and stroke work. Results at 
intrinsic and paced atrial rates were 
compared during each of three phases 
of postoperative evolution: phase II 
(2 to 3 days after transplantation), 
phase III (4 to 5 days) and phase IV 
(6 to 7 days postoperatively).
Phase II, being the period of maximum 
recovery, served as a baseline for 
comparing the cardiac parameters 
in phases III (the initial phase of 
rejection) and phase IV (24 hours 
before death).
The authors found that the patterns 
of change were similar at intrinsic 
and paced atrial rates and concluded 
that heart rate variation does not 
significantly influence the hemodynamic 
criteria of rejection.
Puisque le rythme cardiaque influence 
plusieurs parametres hemodynamiques, 
les auteurs ont etudies les effets d’une 
variation du rythme cardiaque apres 
greffe cardiaque sur les criteres 
hemodynamiques du rejet. Ils 
ont entrepris des etudes en 
serie, a rythme intrinseque et a un
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rythme auriculaire stimule de 150 
pulsations/min, chez 11 chiens au 
repos, porteurs d'une homogreffe. Les 
auteurs ont analyses I’index cardiaque, 
le debit systolique, la velocite 
maximum, (’acceleration, la puissance 
de contraction et le travail systolique. 
Les resultats a rythme intrinseque 
et a rythme auriculaire stimule ont 
ete compares pour chacune des trois 
phases devolution postoperatoire: la 
phase II (2 a 3 jours apres la greffe), 
la phase III (4 a 5 jours) et la phase 
IV (6 a 7 jours apres I'operation). 
Comme la phase II correspond a la 
periode de retablissement maximum, 
elle a servi de valeur de depart pour 
comparer les parametres cardiaques 
en phase III (la phase initiale de rejet) 
et en phase IV (24 heures avant la 
mort).
Les auteurs ont decouvert que les 
caracteristiques de changement etaient 
les memes, que ce soit a rythme 
intrinseque ou a rythme auriculaire 
stimule. Ils concluent que les variations 
du rythme cardiaque n'influencent pas 
de facon significative les criteres 
hemodynamiques de rejet.
Hemodynamic criteria of acute car­diac rejection have been reported pre­
viously,1 and it was found that the 
hemodynamic measurements in which 
velocity was a component were ex­
tremely sensitive and revealing in the detection of the initial phase of re­jection. However, variations of cardiac 
rate from one subject to another and from one postoperative phase to an­
other were observed.Aware of the effects that variations in cardiac rate can have on the hemo­dynamic parameters used to indicate the initial phase of rejection,2-4 we de­cided to assess the importance of 
these variations, to establish their functional effects on the parameters mentioned above and to verify our diagnostic criteria of early rejection.1We undertook a series of experi­ments in the orthotopic transplanted heart to evaluate the effects of daily changes in cardiac rate on the hemo­dynamic measurements used in the diagnosis of rejection. Serial studies of ventricular function were per­formed in dogs at intrinsic rate and at a rate of 150 beats/min, controlled by auricular pacing. Our aim was to
verify if the evolution curves of ven­tricular function were identical at 
intrinsic and at controlled heart rates.
M aterial and M ethods
Eleven mongrel dogs, weighing 
from 15 to 29 kg, were chosen in ac­cordance with our biochemical and hematologic normograms.5 Following 
induction of anesthesia with pentobar­bital sodium (25 mg/kg), left thora­cotomy was carried out, peripheral vessels were cannulated and the dog was connected to the heart-lung ma­
chine and perfused according to the techniques previously reported.®Orthotopic homotransplantation of 
the heart was performed following the 
technique of Lower, with modifica­tions.1,7 During the ischemic period 
(53.5 minutes) the heart was protected with a cooling bag.8 Following com­pletion of the anastomoses, circulatory 
assistance was continued for a period of 1 hour to allow functional recovery of the graft and insertion of instru­ments for measuring the hemodynamic status: suture of conduction wiresto the left atrial wall, insertion of 
an electromagnetic flowmeter probe around the ascending aorta (Gould 
Statham Flo-Probe Blood Flow Trans­
ducer Model SP75115; Gould Stat­ham. Oxnard, Calif.), introduction of 
no. 8 French catheters through the left subclavian artery into the aortic 
arch and into the right atrium through 
the left jugular vein. The left atrial wires, the transducer cables and the catheters were exteriorized at the base 
of the dog’s neck dorsally.This experimental preparation al­
lowed for daily evaluation of the car­diac function of the nonsedated, rest­ing animal at intrinsic rate and at a rate of 150 beats/min stabilized by left atrial pacing. The following data were recorded during each study: heart rate, electrocardiographic find­ings, cardiac index, stroke volume in­dex, maximum systolic flow index, peak velocity, maximum acceleration index, stroke work index, stroke pow­er index, and systolic, diastolic and mean arterial pressures; the methods of recording, conversion, calculation, indexation and analysis that have been reported previously in detail were fol­
lowed.1
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Only the dogs that remained well 
were retained in the study. Experi­
mental conditions were identical in 
both groups, thus allowing valid com­
parisons. The dogs were grouped ac­
cording to the heart rate (intrinsic or 
stabilized) and to the period of evolu­
tion as defined previously.1 These pe­
riods correspond to the phases of 
postoperative evolution that are ident­
ified in terms of both time lapse and 
functional status of the animal.
Phase II (days 2 and 3 after opera­
tion) corresponds with a plateau of 
cardiac performance that is never sur­
passed in the later periods. The ab­
solute data of this period are used as 
reference points for comparison with 
the later periods. In phase III (days 
4 and 5 after operation) there are 
signs of decreased ventricular perfor­
mance corresponding to the functional 
initial stage of rejection. Phase IV 
(days 6 and 7 after operation) is ac­
companied by a severe deterioration 
of all the parameters of ventricular 
function and, in total rejection, oc­
curs in the 24 hours preceding death.
Comparisons between the different 
postoperative phases were carried out 
at intrinsic and at stabilized rates. The 
data obtained in all phases were used 
for comparison and statistical anal­
ysis by one-way analysis of variance. 
Multiple comparisons were performed 
using the paired Student’s f-test cor­
rected for the Bonferonni inequality.9
Results
The dogs survived an average of 
6.4 days. We accepted no other data 
than those obtained in the animals 
in which the atrial pacing at 150 
beats/min could be induced and main­
tained during the whole hemodynamic 
study and in which total rejection was 
confirmed at autopsy.
Tables I and II show the hemody­
namic data obtained in phases II and
III. Comparison of these results shows 
that during phase III there is a signif­
icant decrease of ventricular perform­
ance indices at both intrinsic and 
stabilized rates. The most important 
changes were in maximum accelera­
tion index, stroke power index and 
stroke work index. Arterial blood 
pressure decreased slightly but not 
significantly.
It is noteworthy that the decrease 
in ventricular performance both at in­
trinsic (Table I) and stabilized (Table 
II) rates was identical in spite of the 
variations in frequency. However, the 
variations in intrinsic rate were slight.
The results of the tests in phase
IV, 24 hours before death, showed 
that there was a severe deterioration
T a b le  1 -C o m p a riso n  o f P ha se  II and P ha se  III
at Intrinsic H eart Rate*
P hase
II ll-lll III
M e a su re m e n t (absolute values) (absolute values)! (% change)
H eart ra te , beatslm in  
(n =  9)
Cardiac in d e x , l/min ■ m  2
132.7 ±  6.6 6.9 ±  7.1 -5 .2  (NS)
(n =  9)
S troke v o lu m e  in d e x, ml/m2
5468.6 ±  527.3 1065.9 ±  330.1 -1 9 .5 *
(n =  9) 41.22 ±  3.19 5.86 ±  1.69 -1 4.2 *
M a xim u m  s y s to lic  f lo w  index, 
m ils ■ m  2 (n =  9)
Peak v e lo c ity ,  cm/s ■ m  2
355.29 ±  24.33 43.57 ±  13.24 -1 2.3 *
(n =  9) 192.14 ±  10.49 23.78 ±  7.56 -1 2.4 *
M a xim u m  acceleration index, 
cm/s2 ■ n r 2 (n =  9)
S tro ke p o w e r  index,
4003.0 ±  256.8 873.6 ±  148.2 -2 1 .8 §
103 erg/s • m '2 (n =  8) 63 954.0 ±  5634.0 12 352 ±  2712.2 -19.34!
S troke w o r k  index, 
103 d yn -c m fm 2 (n =  8) 
S ysto lic  arterial pressure .
7377.2 ±  650.3 1540.8 ±  284.5 -2 0 .9 §
m m  H g (n =  8) 
Diastolic arterial
133.26 ±  5.05 8.77 ±  7.87 -6 .6  (NS)
pressure, m m  H g (n =  8) 
M ean a rterial pressure .
87.87 ±  3.89 8.34 ±  6.76 -9 .5  (NS)
m m  H g (n =  8) 109.47 ±  4.36 8.69 ±  6.04 -7 .9  (NS)
'V a lu e s  are m ean ±  standard erro r o f  mean. 
tD iffe re n c e  b e tw e e n  absolute va lu e s  o f phases II and III.
* P  <  0.05.
§ P <  0.005.
H P  < 0 .0 1 .
N S  =  not sign ifica n t (P >  0.05).
Ta b le  1 1-C om parison o f P hase II and P ha se  III 
at Rate Stabilized b y  A tria l Pacing
P hase
M e a su re m e nt
II
(absolute values)
H il l
(absolute values)
III
(% change)
H eart rate, beatslm in  
(n =  9) 150 ±  0 0
N o  test. 
Controlled
Cardiac in d e x, l/min • m  2 
(n =  9) 5630.3 ±  395.4 781.8 ±  229.4
rate
-13.9*
S tro k e  vo lu m e  in d e x, ml/m2 
(n =  9) 36.43 ±  2.65 4.10 +  2.17 -11.3 (NS)
M a xim u m  s y s to lic  f lo w  index, 
ml/s ■ n r 2 (n =  9) 340.49 ±  23.50 37.62 +  9.24 - l l . O t
P eak ve lo c ity, cm/s • m  2 
(n =  9) 184.09 ±  29.93 20.46 ±  5.41 -11.1*
M a xim u m  acceleration index, 
cm/s2 ■ m  2 (n =  9) 3837.1 ±  247.0 667.04 +  86.04 -1 7.4 *
S tro k e  p o w e r  index,
103 erg/s ■ m  2 (n =  8) 61 864.0 ±  4872.0 9872.5 +  1688.6 -1 6.0 *
S tro k e  w o r k  in d e x,
103 dyn-cm /m 2 (n =  8) 6797.9 ±  481.9 1286.1 ±  229.5 -1 8.9 *
S ysto lic  arterial pressure , 
m m  Hg (n =  8) 136.23 ±  6.17 7.81 ±  5.71 -5 .7  (NS)
Diastolic arterial 
pressure, m m  H g  (n =  8) 94.05 ±  4.61 5.38 ±  4.03 -5 .7  (NS)
M e a n  arterial pressure , 
m m  Hg (n =  8) 112.03 ±  5.31 6.56 ±  4.55 -5 .9  (NS)
* P  <  0.05. 
t P  <  0.01.
* P  <  0.005.
N S  =  not sign ifica n t (P >  0.05).
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of ventricular function secondary to 
acute rejection (Tables III and IV). 
Moreover, there was a significant drop 
in the blood pressures. During phase 
IV, as in phase III, the decreases in
the values were similar during intrin­
sic (Table III) and stabilized (Table 
IV) rates in spite of a more notable 
change in frequency of the intrinsic 
cardiac rate.
Discussion
It is well known that variations in 
cardiac rate can modify the absolute 
values of certain measures of ventri­
cular function, particularly those in 
which velocity is a component.2-4 It 
has been shown that the changes dif­
fer, depending on the amplitude of 
these variations. For example, with 
only slight variations (a range of 
110 to 150 beats/ min), Nobel and as­
sociates10 have observed, in the con­
scious dog under atrial pacing, a slight 
decrease in the ventricular end-dia­
stolic pressure and volume and in 
stroke volume and work. In man, at 
rates ranging from 60 to 180 beats/ 
min, Benchimol and Ligget11 reported 
a progressive and moderate increase 
of cardiac index, tension time index, 
dP/dt (rate of rise in ventricular pres­
sure) and arterial pressure and a pro­
gressive and moderate decrease of 
stroke index, stroke power, stroke 
work, systolic ejection time and mean 
systolic ejection rate.
In a previous publication in which 
we reported on the hemodynamic 
signs of rejection in dogs with ortho­
topic heart transplants,1 the para­
meters of ventricular performance, 
where velocity was a component, were 
very sensitive in detecting the initial 
phase of rejection. However, during 
those experiments we had observed 
variations in cardiac rate from one 
animal to another and from one post­
operative phase to another. Aware of 
the fact that the velocity indices could 
be affected by variations of the heart 
rate, we questioned the validity of our 
diagnostic criteria of rejection and un­
dertook the present series of experi­
ments to test this.
Since each dog served as its own 
reference and since the experimental 
conditions were identical at both in­
trinsic and stabilized rates, our com­
parisons were reliable and controlled.
The results of the serial hemody­
namic studies at intrinsic rate and at 
stabilized rate can be superimposed 
and are expressed in phase III by a 
substantial decrease of 10% to 20% 
of the ventricular functional para­
meters and in phase IV by a marked 
fall of at least 40% in all functional 
indices.
This similarity allows us to con­
clude that the variations in intrinsic 
rate did not influence the hemodyna­
mic indices. However, it must be 
noted that the variations in cardiac 
rate were only 5.2% in phase III and 
10.9% in phase IV and that they may 
be insufficient to modify ventricular 
function indices.
However, if important daily varia-
Table III-Comparison of Phase II and Phase IV 
at Intrinsic Heart Rate
Phase
Measurement
II
(absolute values)
ll-IV
(absolute values)
IV
(% change)
Heart rate, beatslmin 
(n = 8) 137.1 ±  5.3 14.93 ±  11.07 -10.9 (NS)
Cardiac index, llmin - m 2 
(n = 8) 5055.5 ±  449.9 3259.3 ±  203.0 -64.5*
Stroke volume index, mllm2 
(n = 8) 36.86 ±  2.79 21.85 ±  1.44 -59.3*
Maximum systolic flow index, 
m l/s-nr2(n = 8) 330.40 ±  18.77 165.20 ±  8.42 -50.0*
Peak velocity, cmls ■ m 2 
(n = 8) 175.59 ±  9.37 88.17 ±  5.14 -50.2*
Maximum acceleration index, 
cmls2- m 2(n = 8) 3716.5 ±  270.2 2050.4 ±  194.2 -55.2*
Stroke power index,
103 erg/s-m 2(n = 7) 57 324.4 ±  4971.2 32 299.7 ±  2350.2 -56.3*
Stroke work index,
103 dyn-cm/m2 (n = 7) 6320.8 ±  584.3 3988.9 ±  248.0 -63.1*
Systolic arterial pressure, 
mm Hg In = 7) 129.61 ±  6.87 25.71 ±  6.65 -19.8t
Diastolic arterial 
pressure, mm Hg (n = 7) 87.17 ±  4.77 30.58 ±  4.45 -35.1*
Mean arterial pressure, 
mm Hg (n = 7) 104.04 ±  7.17 33.98 ±  5.02 -32.7*
*P <  0.005. 
tP  <  0.05.
NS = not significant (P >  0.05).
Table IV-Comparison of Phase II and Phase IV 
at Rate Stabilized by Atrial Pacing
Phase
Measurement
II
(absolute values)
HIV
(absolute values)
IV
(% change)
Heart rate, beatslmin 
(n = 8) 150 ±  0 0
No test. 
Controlled
Cardiac index, llmin - m 2 
(n = 8) 5208.0 ±  394.4 3089.89 ±  257.7
rate
-59.3*
Stroke volume index, mllm2 
(n = 8) 34.72 ±  2.63 20.60 ±  1.72 -59.3*
Maximum systolic flow index, 
m lls-m 2(n = 8) 315.26 ±  20.33 146.12 ±  12.12 -46.3*
Peak velocity, cmls ■ m 2 
(n =  8) 167.82 ± 10.65 77.77 ±  6.15 -46.3*
Maximum acceleration index, 
cmls2 ■ m 2 (n =  8) 3644.1 ±  276.5 1837.0 ±  176.5 -50.4*
Stroke power index,
103 ergls ■ m 2 (n =  7) 54773.7 ±  5431.1 27 622.9 ±  1720.0 -54.3*
Stroke work index,
103 dyn-cmlm2 (n =  7) 5994.1 ±  560.9 3676.0 ±  283.9 -61.3*
Systolic arterial pressure, 
mm Hg (n = 7) 130.78 ±  8.16 19.99 ±  6.19 -15.3t
Diastolic arterial 
pressure, mm Hg (n = 7) 90.65 ±  6.37 25.16 ±  5.69 -27.8*
Mean arterial pressure, 
mm Hg (n = 7) 108.04 ±  6.94 25.48 ±  4.85 -23.6*
*P <  0.005. 
IP  <  0.05. 
*P  <  0.01.
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tions of cardiac rate occur in a pa­
tient, comparison of the hemodynamic 
indices would most likely not be re­
liable and the functional consequences 
of rejection would not be detectable. 
In such an event, stabilization of the 
rate by atrial pacing would allow more 
valid comparison.
Comparison of the overall hemo­
dynamic tables shows that the drop 
in cardiac performance is a little less 
severe when the atrial rate is stabil­
ized at 150 beats/min. This observa­
tion suggests a beneficial effect of 
pacing during rejection.
In conclusion, analysis of the serial 
hemodynamic results shows that func­
tional evolution curves at intrinsic 
and stabilized rates are superimpos- 
able. Thus, the variations in cardiac 
rate observed in the unpaced heart did 
not have significant repercussions on 
the cardiac performance indices, pos­
sibly because these variations were 
slight. We conclude from this study 
that the results obtained at the stabil­
ized rate reflect the hemodynamic ex­
pression of cardiac rejection and that 
our diagnostic functional criteria of 
rejection already described remain 
valid.
We gratefully acknowledge the tech­
nical help of Gaston Angrignon, Suzanne 
Chartrand, Lise Langevin, and Gaetan 
Lagace and the secretarial help of 
Jocelyne Vachon and Sylvie Tasse.
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aid in hemostasis wherever oozing blood from 
capillaries and small venules is 
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solutions of Thrombostat may /  
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USP for hemostasis.
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clotting mechanism, Thrombostat must not be 
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neurosurgery, etc. solutions containing approx­
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package (Bio 2077) is suitable. Where bleeding is 
profuse, as from cut surfaces of liver and spleen, 
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(Bio 2073) dissolved in 5 mL or 2.5 mL respectively 
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Treatment of Pancreatitis Associated with Pancreas 
Divisum by Dorsal Duct Sphincterotomy Alone
Roger G. Keith, md, frcs[c], frcs, facs,* Theodore F. Shapero, md, F R C P [ c ] f  
AND FR ED R IC  G. SAIBIL, MD, F R C P [ c ] f
Of 480 patients seen with pancreatitis 
at the Sunnybrook Medical Centre, 
Toronto, in the past 5 years, 5 had 
pancreas divisum, demonstrated by 
pancreatography. Clinical presentations 
included recurrent acute pancreatitis, 
chronic pancreatitis and recurrent 
subcutaneous fat necrosis with 
steatorrhea. Pancreatography 
demonstrated dorsal pancreatic 
drainage through the duct of Santorini 
in all cases. The luminal diameter at 
the orifice of the duct of Santorini, 
assessed at operation, was inadequate 
to provide normal drainage from the 
gland.
Sphincterotomy of the duct of 
Santorini alone, without surgery to 
the duct of Wirsung or sphincter of 
Oddi, was performed in four patients. 
This relieved the pain of chronic 
pancreatitis, eliminated recurrent 
attacks of acute pancreatitis and 
curtailed recurrences of subcutaneous 
fat necrosis and steatorrhea during 
follow-up periods of 51, 27, 17 and 
28 months respectively. One patient 
who refused operation continued to 
have recurrent pancreatitis 41 months 
after diagnosis.
Des 480 patients souffrant de 
pancreatite qui ont ete vus au cours 
des 5 dernieres annees au Sunnybrook 
Medical Centre de Toronto, 5 
avaient une separation du pancreas 
demontree a la pancreatographie. Le 
tableau clinique comprenait pancreatite 
aigue recidivante, pancreatite 
chronique et necrose recidivante des 
tissus adipeux sous-cutanes avec 
steatorrhee. Dans tous les cas, la 
pancreatographie mettait en evidence 
un drainage dorsal du pancreas par 
le canal pancreatique accessoire. Le 
diametre a I'orifice de la lumiere du
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canal pancreatique accessoire a ete 
etabli a I'operation et il s'est revele 
insuffisant pour assurer le drainage 
normal de la glande.
Une sphincterotomie du canal 
pancreatique accessoire, sans chirurgie 
du canal de Wirsung ou du sphincter 
d’Oddi, a ete pratiquee chez quatre 
patients. Cette intervention soulagea 
la douleur de la pancreatite chronique, 
elimina les recidives de pancreatite 
aigue et ecourta les recidives de 
necrose des tissus adipeux 
sous-cutanes et de steatorrhee aux 
examens de controle effectues apres 
51, 27, 17 et 28 mois respectivement. 
Un patient qui refusa I'operation 
souffre toujours de pancreatite 
recidivante 41 mois apres le diagnostic.
By the seventh embryologic week, the 
ventral pancreas, along with the bile 
duct, has rotated posterior to the gut 
and fused with the dorsal pancreas. 
Normally, union of the ventral and 
dorsal ducts occurs, with secretions 
entering the gut through the orifice of 
the ventral duct (Wirsung). The dorsal 
duct (Santorini) persists in communi­
cation with the ventral duct in over 
85% of cases; however, the commu­
nication with the duodenum at the 
minor papilla is quite variable.1
As early as 1910 Opie2 recognized 
that ventral and dorsal ducts may not 
unite; secretions of the dorsal gland 
(cephalad head, body and tail) enter 
the duodenum through the minor ori­
fice of the dorsal duct (Santorini). The 
parenchyma is not cleaved and the 
caudad head and uncinate process 
drain through the ventral duct at the 
papilla of Vater (Fig. 1). Opie coined 
the term pancreas divisum to describe 
this anatomic variant.
Anatomists, using various injection 
techniques, have found the incidence 
of pancreas divisum, in an unselected 
population at autopsy, to be from 5% 
to 10%.1,3,4 Endoscopic pancreato­
graphy has defined the anatomic vari­
ant in large series of selected cases, 
in which the incidence varied from 
3% to 6% .5-8 Whether this anatomic 
abnormality can predispose to pan­
creatic inflammation remains contro­
versial. Possibly some cases of idio­
pathic, recurrent acute pancreatitis 
can be related to pancreas divisum
but the mechanism is unexplained. It 
has been postulated that drainage of 
secretions at the orifice of the dorsal 
duct (Santorini) is inadequate.
This report describes the manage­
ment of five selected cases of pan­
creatitis associated with pancreas divi­
sum. Operative findings and follow-up 
results support the use of dorsal duct 
sphincterotomy alone to provide ade­
quate drainage of the dorsal pancreas 
and thus prevent recurrent disease.
Patients
During 5 years beginning in 1976, 
480 patients were seen with pancrea­
titis at the Sunnybrook Medical 
Centre in Toronto. Not all underwent 
endoscopic retrograde cholangiopan­
creatography. Five patients without 
alcoholism or biliary tract disease 
were found to have pancreas divisum. 
In four the diagnosis was suggested 
by the findings of endoscopic pan­
creatography and confirmed by 
operative pancreatography. In one 
case endoscopic pancreatography was
FIG. 1—Fusion of ventral and dorsal pancreas. Nonunion of ducts results in pancreas divisum.
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Unsuccessful and the diagnosis was 
established at operation.
Case Reports
Case 1.—A 22-year-old man had had 
chronic recurrent pancreatitis since he 
was 15 years old. A background of dull, 
constant pancreatic pain was complicated 
by multiple recurrences of severe pain 
associated with elevation of the serum 
amylase level. There was no history of 
alcoholism. No family members had pan­
creatitis.
Serum glucose, calcium, lipid and tri­
glyceride levels and liver function were 
determined; all were normal. A secretin 
test showed normal volume but a bor­
derline low level of bicarbonate (90 
mmol/1). Cholecystography and ultra­
sonography indicated a normal biliary 
tract. An endoscopic retrograde cholan- 
giopancreatogram failed to show the pan­
creatic duct.
T ransduodenal operative pancreato­
graphy revealed pancreas divisum. The 
ventral duct (Wirsung) (orifice diameter 
1 mm) was short and did not commu­
nicate with the dorsal duct (Santorini). 
The minor duct papilla was 2.5 cm prox­
imal to the papilla of Vater. The dorsal 
duct (orifice diameter 0.5 mm) was 4 mm 
in diameter, coursing to the tail of the 
gland, without changes suggestive of 
chronic pancreatitis.
A sphincterotomy of the dorsal duct 
orifice enlarged its diameter to 4 mm. 
No surgical procedure was performed on 
the sphincter of Oddi or the orifice of 
the ventral duct.
Case 2.—On three occasions in the 
previous 4 years this 59-year-old man 
had required hospitalization for acute 
pancreatitis. Notable amylasemia was as­
sociated with severe abdominal pain on 
each occasion. Elevation of the alkaline 
phosphatase level without jaundice was 
noted on the last admission. There was 
no history of alcoholism.
Biochemical investigations indicated 
normal glucose, calcium, lipid and tri­
glyceride levels. Oral cholecystography 
and abdominal ultrasonography demon­
strated a normal gallbladder without 
stones. Intravenous cholangiography 
showed a normal extrahepatic biliary 
tract. Endoscopic retrograde cholangio­
pancreatography confirmed the normal 
biliary tree, but only a small ventral pan­
creatic duct was shown by pancreato­
graphy. The minor papilla was identified 
but could not be cannulated.
The patient refused operation. He was 
followed up over the next 36 months. 
Three episodes of acute pancreatitis 
necessitated hospitalization during this 
period. Transient jaundice, with maximal 
elevation of serum bilirubin to 90.6 
nmol/1, was noted on the last admission. 
He continues to refuse operative treat­
ment.
Case 3 .—A 58-year-old woman had 
been admitted to hospital with acute pan­
creatitis on five occasions in the previous 
3 years. Fourteen years before, she had 
undergone cholecystectomy. She never 
drank alcohol. Liver function studies 
gave normal results. Serum lipid, tri­
glyceride and calcium levels were nor­
mal. Fasting blood glucose values ranged 
from 3.33 mmol/1 to 5 mmol/1. Further 
studies failed to show organic hypoglyce­
mia. Abdominal ultrasonography demon­
strated a normal extrahepatic biliary 
tract. Pancreas divisum was suggested 
when endoscopic retrograde cholan­
giopancreatography visualized a small 
duct in the ventral pancreas but no com­
munication with the dorsal duct. A 
secretin test gave a low bicarbonate value 
(69 mmol/1) and reduced volume (1.5 
ml/kg).
At operation the head of the pancreas 
appeared atrophic. The body and tail 
were fibrotic. Transduodenal cannulation 
of the ventral pancreatic duct at the 
papilla of Vater enabled operative pan­
creatography to be carried out; it con­
firmed the endoscopic findings. The 
orifice of the ventral duct measured 3 mm 
in diameter. The minor papilla of the 
dorsal duct was identified 3 cm proximal 
to the papilla of Vater. Difficult cannula­
tion, using lacrimal duct probes, proved 
that the orifice was 0.5 mm in diameter. 
Pancreatography confirmed that the dor­
sal duct (Santorini) ran from the tail to 
this minor orifice. Sphincterotomy of the 
dorsal duct orifice enabled a 3-mm probe 
to be passed which corresponded to the 
luminal diameter of the duct itself.
Case 4.—A 48-year-old woman had a 
12-month history of intermittent abdom­
inal pains of sufficient severity to require 
hospitalization on three occasions. No 
elevation of the serum amylase level was 
recorded. A cholecystectomy had been 
done 2 years previously. She did not 
drink alcohol. Extensive investigations 
failed to define a gastrointestinal cause 
for the pain. Liver function, and serum 
calcium, lipid and glucose levels and all 
routine gastrointestinal films were nor­
mal. Abdominal ultrasonography also 
gave normal results. An endoscopic retro­
grade cholangiopancreatogram showed a 
normal common bile duct, but only the 
short noncommunicating ventral duct of 
the pancreas. A secretin test gave a low 
bicarbonate value (69 mmol/1) and low 
volume (0.3 ml/kg). Provocative testing 
with secretin/morphine reproduced the 
pain without elevation of the amylase 
level.
At operation, the pancreas appeared 
fibrotic. Transduodenal pancreatography 
indicated that the ventral duct commu­
nicated with only a small segment of 
the gland in the head. The bile duct was 
normal. The ventral duct orifice meas­
ured 2 mm in diameter. The orifice of 
the dorsal duct (Santorini) was located 
1.5 cm proximal to the papilla of Vater 
and measured 0.5 mm by lacrimal duct 
probing. Pancreatography demonstrated 
that the dorsal duct drained the entire 
gland. The duct was not dilated.
Sphincterotomy of the minor duct 
orifice increased the diameter to 3 mm.
Case 5.—For 30 months this 66-year- 
old man had had recurrent subcutaneous 
fat necrosis. Twelve separate lesions oc­
curred spontaneously on both arms, chest 
and abdomen at intervals of up to 3 
months. Biopsies confirmed the fat ne­
crosis and suggested pancreatic disease. 
The patient also had an 8-monfh history 
of steatorrhea, which responded to sup­
plementation with pancreatic enzyme. He 
also had a history of peptic ulcer dis­
ease.
The secretin test result was abnormal. 
Ultrasonography and computerized to­
mography demonstrated a normal gall­
bladder but an enlarged pancreas. Endo­
scopic retrograde cholangiopancreato­
graphy revealed a normal biliary tract, 
but only a small ventral pancreatic duct 
was visualized, indicating pancreas divi­
sum (Fig. 2).
At operation a fibrotic pancreas was 
seen. Transduodenal pancreatography 
confirmed that the dorsal duct drained 
the entire gland through the minor papil­
la, located 2 cm proximal to the papilla 
of Vater. The duct appeared normal. 
The dorsal duct orifice was 0.5 mm in 
diameter compared with the 1.5 mm dia­
meter of the ventral pancreatic duct ori­
fice. Sphincterotomy of the orifice of the 
dorsal duct enlarged it to 3 mm, the 
diameter of the duct itself.
Surgical Technique
The operation was designed to con­
firm the diagnosis and perform the 
appropriate procedure to prevent re­
current disease. Laparotomy requires 
thorough examination of the liver and 
biliary tract, stomach and duodenum, 
colon and retroperitoneum in order to 
rule out unexpected causes of “pan-
FIG. 2—Endoscopic retrograde chol­
angiopancreatography shows normal bili­
ary tree but small ventral pancreatic 
duct (arrow).
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creatitis-like” pain. The pancreas is 
examined in its entirety by division of 
the gastrocolic ligament and koche- 
rization of the duodenum and head of 
the gland. Gross features of pancreatic 
disease are recorded.
A transverse duodenotomy is made 
opposite the papilla of Vater, palpable 
through the intact duodenal wall. Ex­
posure of the papilla of Vater is fol­
lowed by location of the minor papil­
la, indicating the orifice of the dorsal 
(Santorini) duct. Lacrimal duct probes, 
graded from size 0000 to 8 (corre­
sponding to diameters ranging from 
0.45 mm to 1.75 mm) are used to 
define the dorsal duct orifice and 
record its diameter (Fig. 3). The 
largest probe that passes readily 
through the orifice determines this. 
Similarly, the orifice of the ventral 
(Wirsung) duct is probed and the 
diameter recorded. Thereafter, oper­
ative pancreatography of both ducts 
is performed (Figs. 4 and 5).
The sphincter of Oddi and the ori­
fice of the ventral duct are left in­
tact. The orifice of the dorsal duct 
is carefully dilated to the diameter 
of the duct itself. An incision is made 
1.5 cm long, positioned vertically at 
the superior margin of the duct ori­
fice (Fig. 6). Duct epithelium and 
duodenal mucosa are not sutured. The 
duodenotomy is closed transversely 
with adjacent drainage.
The gallbladder was not removed 
or the biliary tract incised in any 
case.
Results
Operative Findings (Table I)
In all cases, the pancreas was firm 
but not calcific. The parenchyma was 
moderately well preserved and no 
peripancreatic inflammation was ob­
served.
The orifices of the ventral duct 
ranged from 1 to 3 mm (mean 2 mm). 
The ventral duct was from 4 to 6 cm 
long, running in a transverse or super- 
omedial direction. Branching of the 
duct was noted on pancreatography 
but no signs of chronic pancreatitis 
were demonstrated. The diameter of 
each duct was equivalent to that of 
its orifice.
The orifice of the dorsal duct in 
all four patients who were operated 
on was only 0.5 mm in diameter. The 
dorsal duct diameters measured be­
tween 3 and 4 mm. Pancreatography 
showed that the dorsal duct extended 
to the tail of the gland in all cases. 
It did not communicate with the ven­
tral duct and there was no evidence 
of chronic pancreatitis (Fig. 5).
Follow-up
There were no surgically related 
deaths and only one subcutaneous 
wound infection. The mean duration 
of hospitalization postoperatively was 
12 days. In case 1, the sphincterotomy 
relieved the patient of the constant 
pain of chronic pancreatitis. He had 
no exocrine or endocrine insuffi­
ciency. Thirteen months after opera­
tion he was hospitalized with acute 
pancreatitis. Twenty-three months 
later another attack of pancreatitis 
necessitated admission and he had 
three further episodes over the next 
year; on each of these occasions, as­
sociated excessive alcohol intake was
FIG. 3— Lacrimal duct probe (size 
000) inserted into dorsal duct orifice.
FIG. 4— Catheters placed in dorsal 
and ventral ducts for operative pancrea­
tography.
documented. This had not been the 
case before operation or in the early 
follow-up period.
In case 2, the patient with recur­
rent acute pancreatitis who refused 
operation, three hospital admissions 
were required to manage episodes of 
acute pancreatitis occurring during 
the 41-month follow-up. Transient ex- 
trahepatic cholestasis was observed 
during the last episode.
Two patients (cases 3 and 4) have 
been followed up for 27 months and 
17 months, respectively, since opera­
tion for recurrent acute pancreatitis.
FIG. 5— Operative pancreatogram
showing normal dorsal duct which 
drained at minor papilla.
FIG. 6— No. 6 lacrimal duct probe in 
intact ventral duct orifice below and 
no. 8 probe in dorsal duct orifice above, 
following sphincterotomy.
Table 1 -Operative Findings in Pancreas Divisum
Case
no.
Condition 
of pancreas
Dorsal orifice 
diameter, mm
Dorsal duct 
diameter, mm
Ventral orifice 
diameter, mm Pancreatogram
i Fibrotic 0.5 4 1 Normal
2 Head atrophic; 
body and tail 
fibrotic 0.5 3 3 Normal
3 Fibrotic 0.5 3 2 Normal
4 Fibrotic and 
enlarged 0.5 3 1.5 Normal
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The first (case 3) has been pain free 
and has no evidence of pancreatic dis­
ease. After 11 months the other pa­
tient (case 4) had a single episode of 
abdominal pain without amylasemia 
or other features of pancreatitis.
During the 28 months since sphinc­
terotomy, the last patient (case 5) has 
had no recurrence of subcutaneous fat 
necrosis. His stools are not steator- 
rheic and he has not needed pancre­
atic enzyme supplements. He has had 
no pancreatic pain and no diabetes.
Discussion
Mitchell and associates,9 studying a 
series of 449 endoscopic retrograde 
cholangiopancreatograms, observed 
that pancreas divisum occurred equal­
ly with and without pancreatitis. They 
concluded that the anatomic variant 
did not predispose to pancreatitis. 
Others5'7'8,10 have also found that the 
frequency of pancreas divisum in pa­
tients suspected of having pancreatitis 
is no greater than that found at autop­
sy in an unselected group.
The 1 % incidence of pancreas divi­
sum in this series cannot be consid­
ered significant as pancreatography 
was not carried out in many cases. 
However, its association with idio­
pathic recurrent pancreatitis in all 
cases is important. Analysis of other 
series, separating cases of idiopathic 
recurrent pancreatitis, indicates a 
strong association with pancreas divi­
sum. Cotton8 reported an incidence of 
25.6%, while Richter and colleagues11 
noted a 12% incidence. Others10'12 
have found recurrent acute pancrea­
titis in 75% to 100% of their cases 
of pancreas divisum.
A 20% incidence of chronic pan­
creatitis has been attributed to pan­
creas divisum in a report by Kruse.7 
The diagnosis was based on pancreatic 
insufficiency (Lundh test meal), but 
was not confirmed in the majority of 
patients by an abnormal pancreato­
gram, nor was correlation with alco­
holism stated. Four of our patients 
with recurrent pancreatitis had ab­
normal secretin test results. Cotton8 
described abnormal dorsal duct pan­
creatograms in 7 of 19 patients with 
pancreas divisum and nonalcoholic 
recurrent pancreatitis. None of his pa­
tients underwent exocrine function 
tests. No reports associate pancreas 
divisum with nonalcoholic, calcific 
pancreatitis.
Operative pancreatography in our 
treated cases showed normal dorsal 
ducts without signs of chronic pan­
creatitis. Cooperman and associates10 
found no evidence of chronic pan­
creatitis in five patients who were 
operated on; however, pancreato­
graphy showed a dilated dorsal duct 
in one case. Richter and associates11 
described slight dilatation of the dor­
sal duct in two of six patients who 
underwent operative pancreatography 
for acute pancreatitis.
In view of the established (chem­
ical) pathogenesis of chronic alcoholic 
pancreatitis,13 it is difficult to accept 
similar pathologic and clinical effects 
from an incomplete obstruction to 
the flow of normal pancreatic secre­
tion (mechanical) produced by pan­
creas divisum. It is more plausible to 
entertain such a mechanism for re­
current acute pancreatic inflammation.
We established that the diameter 
of the dorsal duct orifice in the four 
natients who underwent operation was 
0.5 mm. The diameter of the duct 
itself was 3 to 4 mm. in keening with 
the normal diameter of the fused 
ventral duct (Wirsuna).14 Reflux of 
duodenal contents into the dorsal duct 
would be extremelv unlikelv through 
such a minute orifice. Disconnection 
from the bile duct precludes biliarv 
calculus or crvstal obstruction and 
avoids bile regurgitation into the dor­
sal duct. There were no abnormalities 
of calcium or lipid and no alcohol 
abuse in the patients operated on.
Operative pressure or flow studies 
would be affected bv the dilatation 
necessarv to introduce a flow probe. 
None the less, inadeauate secretion 
from the gland is indicated bv con­
sistently low flow and bicarbonate 
concentrations on secretin testing of 
our patients. In case 5 operative can- 
nulation of the dorsal duct for pan­
creatography allowed egress of cloudv 
secretions with white (noncalcific) 
precipitates.
We believe that episodes of acute 
parenchymal inflammation of the dor­
sal pancreas occur when intraductal 
secretory pressure rises excessively 
behind the minute orifice — produc­
ing microductal rupture and acinar 
disruption. This process may occur 
more frequently if plugging of the 
orifice occurs from abnormal protein 
precipitates.
Sphincterotomy of the dorsal duct 
orifice will increase its diameter to 
that of the duct itself. Impedance to 
flow of dorsal gland secretion disap­
pears and remission from further epi­
sodes of parenchymal inflammation 
should follow. This report describes 
the first four consecutive cases in 
which such a procedure was the sole 
surgical treatment for recurrent pan­
creatitis associated with pancreas div­
isum. Although one patient had late
alcohol-associated recurrence of pan­
creatitis, the results in the other three 
were gratifying. Of particular import­
ance is the purely objective monitor 
of freedom from recurrence of sub­
cutaneous fat necrosis 28 months after 
operation. Continued remission be­
yond 12 months without clinical 
evidence of restenosis in all cases in­
dicates the permanence of the sphinc­
terotomy. Follow-up endoscopic pan­
creatography and secretin studies will 
be performed.
Encouraging results have been pre­
sented by Cooperman and associates10 
and Richter and associates.11 Both 
series described dorsal duct sphinctero­
plasty for pancreatitis associated with 
pancreas divisum in six and four cases 
respectively. However, in both the 
procedure was complemented by chol­
ecystectomy and sphincteroplasty of 
the common bile duct and ventral 
pancreatic duct (Wirsung). The good 
results cannot be ascribed to a single 
aspect of this multifaceted technique.
Cotton15 has reported preliminary 
results in two patients following en­
doscopic papillotomy of the minor 
papilla. However, cannulation of the 
dorsal duct at endoscopy is difficult. 
Highly qualified endoscopists reported 
success in 4 of 15,5 10 of 27° and 
20 of 63s cases. Therefore, the appli­
cation of this technique and the lon­
gevity of the decompression require 
further evaluation.
It has been suggested that pancrea­
tectomy or pancreaticojejunal an­
astomosis be considered when dorsal 
duct pancreatography indicates that 
chronic pancreatitis is present.5,8,10 
Considering the most common patho­
genesis of chronic pancreatitis, a dili­
gent search for alcoholism is advised 
before major pancreatic surgery is 
performed.18
Conclusions
Pancreas divisum should be con­
sidered in cases of idiopathic recur­
rent acute pancreatitis. The diagnosis 
can be established by secretin testing 
and endoscopic retrograde pancreato­
graphy.
The orifice of the dorsal duct (San­
torini) is likely inadequate to drain 
dorsal gland secretions effectively. 
Parenchymal inflammation results 
from sustained high intraductal pres­
sure, possibly affected by abnormal 
protein precipitates.
Dorsal duct sphincterotomy affords 
relief from the pain of recurrent 
acute pancreatitis, improved fat diges­
tion and remission from fat necrosis, 
which have been sustained for 17 to 
28 months.
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Evidence is less convincing that 
pancreas divisum is a predisposing 
condition in the pathogenesis of 
chronic pancreatitis.
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Importance of the Serum Amylase Level 
in Patients with Blunt Abdominal Trauma
E dw ard  F arkouh , m b , b c h , fa c s , f r c s [c],* R a m ses  W a sse f , MD,f H en r i A t l a s , m d , fa c s , fr c s[c ]J
and M ic h el  A l l a r d , m d , fa c s , f r c s [c ]*
Possible intra-abdominal injuries were 
sought in 101 patients admitted with 
blunt abdominal trauma. The serum 
amylase level was measured in the 
first 12 hours after the accident. 
Twenty-five patients had hyper- 
amylasemia; 18 underwent laparotomy 
and 7 were treated conservatively.
At laparotomy all 18 patients exhibited 
at least one serious intra-abdominal 
lesion, and there was a total of 
28 lesions in the whole group (including 
only four pancreatic injuries).
The mean value of the serum 
amylase for those who had laparotomy 
was 1190 IU, while it was only 
363 IU for those not operated upon.
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The authors conclude that hyper- 
amylasemia in blunt abdominal trauma 
is not specific to pancreatic injury, 
but may suggest the presence of a 
serious intra-abdominal lesion.
Cent un patients admis pour 
traumatismes abdominaux fermes ont 
eu un dosage d’amylasemie dans les 
12 premieres heures consecutives 
a leur accident. Vingt-cinq patients 
presentaient une amylasemie elevee;
18 de ces patients ont ete operes 
et 7 observes. Tous les patients 
operes etaient porteurs d'au moins 
une lesion intra-abdominale severe 
et, au total, 28 lesions furent 
retrouvees (incluant quatre ruptures 
pancreatiques).
L'amylasemie moyenne du groupe 
opere etait de 1190 IU, et celle du 
groupe non opere de 363 IU.
Les auteurs concluent que 
I'hyperamylasemie dans les cas de 
traumatismes abdominaux fermes 
est souvent un temoin d'une lesion 
intra-abdominale severe. Elle ne reflete 
cependant aucune specificite quant au 
type de lesion intra-abdominale 
retrouvee (en particulier les lesions 
pancreatiques).
Elevation of the serum amylase level 
in patients with blunt abdominal 
trauma was thought in the past to 
indicate pancreatic injury.1-3 Recently, 
however, this opinion has not been
shared.4-5 Olsen4 in 1973 found that 
only 8% of patients with hyperamyl- 
asemia had pancreatic injuries, while 
33% of patients with hyperamylase- 
mia had no serious intra-abdominal 
injuries. Moretz and associates5 in 
1975 reached the same conclusion and 
stated that elevated serum amylase 
levels correlated poorly with pancrea­
tic injury in blunt abdominal trauma. 
Both papers stated that serum amylase 
levels measured within a few hours of 
blunt trauma to the abdomen had 
little prognostic significance.
We decided to re-examine the diag­
nostic value of elevated serum amyl­
ase levels in blunt abdominal trauma, 
to determine: (a) whether admission 
serum amylase levels correlate with 
the presence, severity and type of in­
tra-abdominal injuries and (b) whether 
hyperamylasemia in the recently in­
jured patient should be an indication 
for immediate abdominal exploration.
Patients and Methods
Over a period of 2Vz years, 101 
patients with blunt abdominal trauma 
seen in the emergency room of the 
Hopital du Sacre-Coeur in Montreal 
were investigated for possible intra­
abdominal injuries. Studies included 
the clinical, radiologic and laboratory 
investigations used for all trauma pa­
tients. In addition, the serum amylase 
level was measured in the first 12
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hours after the accident, but before 
laparotomy. Serum amylase determin­
ation was by the iodometric or amylo- 
clastic technique and its value was ex­
pressed in international units (IU); 
the normal value ranges from 80 to 
170 IU.
Results
Of the 101 patients, 29 had a serum 
amylase value greater than 170 IU. 
Four patients with facial injuries, 
which may have involved the parotid 
gland, a possible source of serum 
amylase, were excluded from the 
study. So 25 patients with hyperamyl- 
asemia form the basis of this report.
We reviewed the management of 
these 25 patients and found that 18 
had undergone emergency laparotomy, 
while 7 had been treated conservative­
ly. The decision to perform the emer­
gency laparotomy was based on clin­
ical criteria.
The 18 patients treated surgically 
had a substantially higher level of 
serum amylase than those treated con­
servatively. The mean value for this 
group was 1190 IU; 3 patients had 
a serum amylase value between 200 
and 400 IU, 5 patients had a value 
between 400 and 600 IU and 10 pa­
tients had a value higher than 600 
IU (Table I). The serum amylase lev­
el of the seven patients who were 
treated conservatively was only slight­
ly elevated (Table II) and the mean 
value was 363 IU. Five of these pa­
tients had a serum amylase value be­
tween 200 and 400 IU and two pa­
tients had a value between 400 and 
600 IU; thus, all seven patients who 
were treated conservatively had se­
rum amylase levels lower than 600 
IU.
All 18 patients operated on ex- 
hibited at least one intra-abdominal 
lesion at laparotomy; in total there 
were 28 lesions: 5 hepatic lacerations, 
4 ruptured spleens, 8 bowel lacera­
tions (of which 2 were located in the 
duodenum), 7 severe retroperitoneal 
hematomas (2 associated with kidney 
lacerations and 1 with a ruptured 
aorta) and 4 pancreatic injuries (Table
I).
Discussion
In investigating the patient with 
multiple trauma for possible intra­
abdominal injuries, clinical, radiologic
and laboratory data are analysed be­
fore an emergency laparotomy is un­
dertaken. The laboratory changes as­
sociated with abdominal injuries might 
be in the form of a drop in hemo­
globin level, leukocytosis, elevated 
sedimentation rate, increase in the 
serum levels of transaminases and 
possibly of amylase.
The value of serum amylase de­
termination in blunt abdominal trau­
ma has long been a controversial 
issue. White and Benfield6 believed 
that an elevation of the serum amylase 
level was a good indicator of pan­
creatic injury and that operation was 
indicated despite unremarkable find­
ings on physical examination; however, 
normal serum amylase levels do not 
exclude the possibility of pancreatic 
injury and the decision whether or 
not to operate must then be made on 
other grounds. Olsen4 and Moretz and 
associates5 considered that determina-
Table II-Serum  Amylase Levels and the Distribution of 
Lesions (+1 in Seven Patients Who Were Treated Conservatively
Patient
no.
Amylase.
IU Thorax
Spine
and
pelvis Extremities
Head
injury
1 206 + + +
2 340 + + +
3 242 +
4 551 + + +
5 313 +
6 496 + +
7 395 + +
Table 1-Serum Amylase Levels and the Distribution of Lesions (+) 
_________in the 18 Patients Who Underwent Laparotomy
Retro- Spine
Patient Amylase, peritoneal and Head
no. IU Pancreas Liver Spleen Bowel hematoma Thorax pelvis Extremities injury
i 695 + + + +
(aorta)
2 545 + + + +
3 2695 +
4 1326 + + +  + +
5 304 + + +
6 3325 + +
(duodenum)
7 402 +
8 1150 + + +
(duodenum)
9 350 + + +
10 855 + +
11 342 + +
12 3678 + +
13 448 + +  +
(kidney)
14 1415 + + +  +
15 405 +
16 2209 + + + + +
17 470 + +
(kidney)
18 810 + + +
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tion of the serum amylase level in 
blunt abdominal trauma has little 
prognostic importance, since it can 
neither identify nor exclude a pan­
creatic injury.
In our series, 25 patients with blunt 
abdominal trauma had hyperamylase- 
mia; 7 were treated conservatively, 
while 18 had an emergency lapa­
rotomy with the discovery of 28 se­
rious intra-abdominal lesions in the 
whole group. Only four pancreatic 
lacerations were found, an incidence 
of 16% of all patients with hyper- 
amylasemia. In this study, a serum 
amylase level of 500 IU was critical, 
since only one patient with a serum 
amylase level above 500 IU (Table 
II) was treated conservatively.
From our data, hyperamylasemia 
in the recently injured patient is ap­
parently not specific to pancreatic 
injury, but can often suggest the pres­
ence of a serious intra-abdominal le­
sion. However, hyperamylasemia in 
the absence of other signs (clinical or 
radiologic) of intra-abdominal injury 
does not constitute an indication for 
laparotomy.
With blunt abdominal trauma, hy­
peramylasemia may appear within a 
few hours of the accident, despite the 
absence of pancreatic injury, possibly 
resulting from extrapancreatic release 
of amylase. It is believed that several 
organs other than the pancreas can 
produce amylase: for example, the 
liver, striated muscle, adipose tissue
and Fallopian tubes, and trauma to 
these organs can cause elevation of 
amylase levels.4-7
To improve the clinical specificity 
of serum amylase, measurement of 
amylase isoenzymes has been sought. 
Using various methods (chiefly elec­
trophoresis, isoelectric focussing and 
column chromatography) it is believed 
that serum amylase can be fraction­
ated into two principal isoenzymes:8 
the pancreatic type (P-type) and the 
salivary type (S-type). The S-type iso­
amylase may arise not only from sali­
vary gland tissue but from many dif­
ferent tissues and thus lacks organ 
specificity.8-9 The P-type isoamylase 
is considered to arise solely from the 
pancreas. Hence, it may serve as a 
marker for pancreatic lesions.8'10 How­
ever, wide clinical use of isoamylase 
analysis in evaluating blunt abdominal 
trauma will require a test less com­
plex and time-consuming than those 
available now.
Conclusions
In blunt abdominal trauma hyper­
amylasemia is not specific to pan­
creatic injury, but can often suggest 
the presence of a serious intra-abdom­
inal lesion. However, hyperamylase­
mia in the absence of other signs of 
intra-abdominal injury does not con­
stitute an indication for emergency 
operation. The measurement of serum 
amylase in conjunction with other in­
vestigations, such as abdominal tap 
and peritoneal lavage, could be of 
help in selecting patients for early 
laparotomy.
References
1. Elman R, Arneson N, Graham EA: Value 
of blood amylase estimations in the diag­
nosis of pancreatic disease; clinical study. 
Arch Surg 1929; 19 : 943-67
2. Naffziger HC, McCorkle H J: Recognition 
and management of acute trauma to pan­
creas, with particular reference to use of 
serum amylase test. Ann Surg 1943; 118: 
594-602
3. N ick WV, Zollinger RW, W illiams RD: 
The diagnosis of traumatic pancreatitis with 
blunt abdominal injuries. /  Trauma 1965; 
5: 495-502
4. Olsen WR: The serum amylase in blunt
abdominal trauma. J Trauma 1973; 13:
200-4
5. Moretz JA iii, Campbell DP, Parker DE, 
W illiams GR: Significance of serum amyl­
ase level in evaluating pancreatic trauma. 
Am J Surg 1975; 130: 739-41
6. White PH, Benfield JR: Amylase in the 
management of pancreatic trauma. Arch 
Surg 1972; 105: 158-63
7. Joseph RR, Olivero E, Ressler N: Elec­
trophoretic study of human isoamylases. A 
new saccharogenic staining method and 
preliminary results. Gastroenterology 1966; 
51: 377-82
8. Berk JE, Fridhandler L, Montgomery
KA: Isoamylase analysis: methods and
clinical application in developments in di­
gestive disease: clinical relevance (1). In 
Berk JE (ed): Developments in Digestive 
Diseases, no. 1, Lea & Febiger, Philadel­
phia, 1977: 133-52
9. Warshaw AL, Lee KH: Characteristic al­
terations of serum isoenzymes of amylase 
in diseases of the liver, pancreas, salivary 
gland, lung, and genitalia. J Surg Res 
1977; 22: 362-9
10. Salt WB ii, Schenker S: Amylase — its 
clinical significance: a review of the litera­
ture. Medicine (Baltimore) 1976; 55: 269-89
SESAP III Question
241. Subungual melanoma often
(A) involves the fingers but not the toes
(B) occurs as a vertical pigmented band under the nail
(C) is accompanied by a pigmented halo on the eponychium
(D) migrates distally with the growth of the nail
(E) is effectively treated by early local excision
For the incomplete statement above select the one answer that is best of the five given. 
For the critique of Item 241 see page 649 of this issue.
(Reproduced by permission from SESAP III Syllabus: Surgical Education and Self- 
Assessment Program No. 3. For enrolment in the Surgical Education and Self-Assess­
ment Program No. 3, please apply to the American College of Surgeons, 55 East 
Erie St., Chicago, IL 60611.)
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Osteoid Osteoma of the Cervical Spine: 
Case Reports and Literature Review
T.J. Zwim pfer ,* W.S. T ucker, md, FRCs[c]f and J.F. Faulkner, md, FRCsfc]t
Osteoid osteoma, a benign 
osteoid-forming tumour, may be found 
in any bone in the body. Approximately 
10% of cases involve the spine, 
the lumbar region being the most 
common site and the cervical region 
the second commonest site for 
spinal osteoid osteomas. Two new 
cases of cervical spine osteoid 
osteoma are presented and the 21 
previously reported cases are 
reviewed.
This cervical spine tumour should 
be considered as a possible diagnosis 
in any young person complaining 
of neck or upper back pain, especially 
if the pain is worse at night, is 
relieved by salicylates and is 
accompanied by tenderness, neck 
stiffness and scoliosis of rapid 
onset. Detailed radiologic investigation 
aids in the diagnosis and accurately 
locates the lesion. Surgery is the 
definitive treatment and complete 
resection of the tumour results 
in rapid and permanent relief of pain.
L'osteoide-osteome, une tumeur 
osteoide-formatrice benigne, peut 
affecter n'importe quel os de 
I'organisme. Dans environ 10% des 
cas, il y a atteinte de la colonne 
vertebrale, les regions lombaire et 
cervicale etant, dans I'ordre, les 
localisations les plus frequentes des 
osteoides-osteomes spinaux. Deux
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nouveaux cas d'osteoi'des-osteomes de 
la colonne cervicale sont presentes 
et les 21 cas deja decrits sont passes 
en revue.
Cette tumeur de la colonne cervicale 
devrait etre consideree comme un 
diagnostic possible chez toute 
personne jeune qui se plaint d'une 
douleur au cou ou au haut du dos, 
surtout si la douleur est plus vive 
durant la nuit, si elle est soulagee 
par les salicylates et si elle est 
accompagnee d'une sensibilite et d’une 
raideur du cou ainsi que d'une 
scoliose d'apparition rapide. L'examen 
radiologique pousse aide au diagnostic 
et permet de localiser la lesion 
de facon precise. La chirurgie offre 
une cure definitive et la resection 
complete de la tumeur donne un 
soulagement rapide et permanent 
de la douleur.
Osteoid osteoma was first described 
by Jaffe1 in 1935 as a “benign osteo­
blastic tumour composed of osteoid 
and atypical bone”. It has been found 
in every bone of the body, with over 
50% of reported cases involving the 
femur or tibia.2 About 10% of these 
tumours are localized to the spine, 
with the lumbar region being the most 
common site, followed by the cervical, 
thoracic and sacral regions in decreas­
ing order of frequency.3 In this paper 
we restrict our discussion to osteoid 
osteomas of the cervical spine, pre­
senting two new cases and reviewing 
the clinical data of 21 previously re­
ported cases.
Case Reports
Case 1
A 23-year-old man was seen in Oc­
tober 1974. He complained of neck pain 
that had persisted since a wrestling in­
jury to his neck in 1972. The left-sided 
pain extended from the superior nuchal 
line to the upper border of the left scapu­
la, occasionally radiating into the left 
shoulder. Although the pain was constant 
it became much worse at night, making 
sleep very difficult without Aspirin, 
which was the only type of analgesic 
that produced appreciable pain relief. 
The pain was aggravated by stress and 
tension as well as neck movement. He 
had been able to keep working full time 
during the previous 2 years.
All neck movements were limited by 
pain, but extension, rotation to the left 
and lateral flexion to either side were 
especially painful. There was marked ten­
derness over the spinous processes of 
C2 and C3. There was no neurologic 
deficit and the findings on general physi­
cal examination were otherwise normal.
The patient was admitted on Oct. 2. 
1974 with suspected occipital neuralgia. A 
block of the C2 and C3 nerve roots pro­
vided partial but only temporary pain re­
lief. Plain films of the cervical spine and a 
myelogram were reported to be normal. 
Tomograms revealed a small circular 
radiodense area, about 1 cm in diameter, 
arising from the left lamina of C2 and 
surrounded by a radiolucent rim of bone. 
This area showed increased uptake on 
the nuclear bone scan, suggesting an 
active, bone-forming lesion. A provisional 
diagnosis of osteoid osteoma of the left 
lamina of C2 was made. At operation 
on Nov. 18, a red, circular tumour, 1.5 
cm in diameter, was found arising from 
the inferior and deep surfaces of the left 
lamina of C2. It had extended into the 
interlaminar space between C2 and C3 
but was still covered by a thin layer of 
cortex. The lesion was removed in one 
piece along with a small part of the 
lamina of C2. There was no involvement 
of the C3 vertebra. No instability of the 
C2-3 joint was anticipated and no fusion 
was required.
Grossly, the excised specimen con­
tained multiple fragments of firm, pur­
plish material that appeared calcified in 
some areas. Histologically, there were
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many large trabeculae of woven bone 
and osteoid surrounded by numerous, ac­
tive osteoblasts. The trabeculae were ar­
ranged within a stroma comprised of 
multinucleated giant cells amid a collec­
tion of vascular spaces (Fig. 1). This con­
firmed the diagnosis of osteoid osteoma.
The patient’s postoperative course was 
smooth and he left hospital 1 week after 
the operation. At follow-up 3 months 
later, the neck pain had totally disap­
peared and all neck movements were 
pain free. A few degrees of extension and 
rotation in both directions were lost. He 
was considered cured.
Case 2
A 19-year-old man had had neck pain 
for 2 years. The pain was worse on the 
left side and had gradually worsened. 
One year before admission, following a 
game of racquetball, the pain became 
much more severe and a few weeks later 
he noted pain in both upper extremities 
extending to the middle digits of both 
hands, involving the left side more than 
the right. The pain was particularly 
severe at night. Although worse than the 
arm and hand pain, the neck pain was 
better relieved by analgesics; Aspirin 
was the most effective. There was no 
neurologic problem. His past medical his­
tory was unremarkable.
On physical examination cervicothora- 
cic scoliosis was noted with a head tilt 
to the left. Neck movements were normal 
and pain free except for extension and 
rotation to the left which made the pain 
worse. No neurologic deficit was de­
tected.
Plain films of the cervical spine re­
vealed no abnormalities, but a nuclear 
bone scan showed an area of increased 
uptake in the neural arch of C6 (Fig. 2). 
Tomograms showed a lytic area in the 
left inferior facet of C6, with some cal­
cification. The bone surrounding this 
lesion, as well as the superior facet of 
C7, showed some sclerotic changes (Fig. 
3). A myelogram appeared normal. Os­
teoid osteoma of the left inferior arti­
cular facet of C6 was suspected.
At operation the left inferior facet of 
C6 was enlarged in a bulbous manner 
but was still covered by bone. The in­
ferior facet was decorticated and the 
lesion was found to involve both the in­
ferior facet and the pedicle of C6. The 
superior facet of C7 appeared normal 
and was left intact. The purple lesion, 
measuring about 1.5 cm in diameter, 
consisted of friable bone-like material. 
The tumour was completely curetted with 
some of the normal bone surrounding it. 
Because the C6-7 joint seemed to be 
unstable, a posterior fusion was per­
formed using bone grafts from the right 
iliac crest. Histologic examination of the 
lesion confirmed the diagnosis of osteoid 
osteoma.
The patient was fitted with a Forrester 
neck brace. At follow-up 2Vi months 
after the operation, his condition was 
much improved. He complained of mild
neck pain and intermittent shoulder and 
arm pain on both sides. He felt the qual­
ity of the neck pain had changed and 
that it had been steadily improving.
He held his head rigidly but with no 
evidence of scoliosis. The findings on 
neurologic examination were normal. 
Postoperative plain films of the cervical 
spine revealed the defect in C6 and the 
fusion of C6-7. There was no scoliosis 
and no evidence of tumour.
Review of Previously Reported Cases
Table I1,4'18 gives the relevant de­
tails of 21 patients (18 males, 3 fe­
males) with osteoid osteoma of the 
cervical spine, previously reported in 
the literature. They ranged in age 
from 8 to 34 years (mean 14.5 
years). The majority of patients were 
in the second decade of life.
Location
In 19 patients the lesion was located 
only in the posterior elements of the 
vertebra. Both the posterior elements 
and the body were involved in one 
case. The tumour was found only in 
the body of the vertebra in one pa­
tient.9
In 20 cases only one vertebra was 
involved, with no evidence of inter­
vertebral spread. One 34-year-old pa­
tient had multilevel involvement. Since 
the lesion was probably of much long­
er standing than the others, there 
would have been ample time for such 
extensive spread.
FIG. 1— Case 1. Trabeculae of woven 
bone and osteoid surrounded by active 
osteoblasts and multinucleated giant 
cells. Stroma contains numerous vascular 
spaces (heniatoxylin-phloxine-saffron  
stain, reduced by 50% from x80).
Symptoms
Neck pain, usually localized over 
the tumour site, was the major com­
plaint in all cases. Eight patients also 
experienced pain at sites distant from 
the tumour.
The pain followed a characteristic 
pattern, starting as a mild, intermit­
tent ache that slowly increased in se­
verity and frequency, eventually be­
coming constant, at which stage most 
patients sought medical advice. In half 
of the patients, the pain was particu­
larly bothersome at night.
Many types of analgesics were tried 
but the only group that consistently 
gave good pain relief were the salicyl­
ates. Of the 10 patients who used sali­
cylates, 7 obtained notable relief.
Physical Signs
Tenderness, localized over the tu­
mour site, was a prominent physical 
finding in 14 patients.
Scoliosis, rapid in onset and usually
FIG. 2 —Nuclear bone scan showing 
circular area of increased radionuclide 
uptake (arrow) on left at C6-7.
FIG. 3—Tomogram of cervical spine 
shows radiolucent area (arrows) of ero­
sion of left inferior facet of C6. Sur­
rounding bone shows sclerotic change.
638 VOLUME 25, NO. 6, NOVEMBER 1982 /  THE CANADIAN JOURNAL OF SURGERY
associated with paravertebral muscle 
spasm on the side of the lesion, was 
reported in nine patients. It usually 
was accompanied by torticollis. In all 
cases the convexity of the curvature 
pointed away from the side of the le­
sion, suggesting that unilateral muscle 
spasm was the underlying cause of 
the scoliosis. Neck stiffness with some 
limitation of movement was reported 
in most cases.
The neurologic examination gave 
normal results in 16 patients, abnor­
mal findings in 4 and was not re­
ported in 1. Weakness and atrophy of 
the muscles of the shoulder and arm 
were reported in three of the four 
patients and in two there was depres­
sion or absence of the deep tendon 
reflexes of the upper extremity. Sen­
sory changes in the upper extremities 
were found in two, one with hypes- 
thesia, the other with paresthesia.
Radiologic Findings
Plain films of the cervical spine 
in all 21 patients gave positive find­
ings in only 10 on initial examina­
tion. Other radiologic techniques used 
to identify the lesion were nuclear 
bone scanning, tomography, angio­
graphy and myelography. On plain 
films the lesion appeared as a circular 
radiolucent area surrounded by a rim 
of sclerotic bone. In several cases, ra- 
diodense spots representing calcifica­
tion were found within the radiolucent 
region. Myelograms were obtained in 
four of the eight patients who com­
plained of radicular pain but were 
negative in two, suggesting a cause 
other than irritation of the nerve root 
for the distant pain.
Diagnosis
The time between the onset of 
symptoms and diagnosis in the 19 pa­
tients for whom this information was 
reported ranged from 6 to 48 months 
(mean 14 months). The other diag­
noses most frequently considered were 
herniation of a cervical disc, cervical 
strain, arthritis, scoliosis and bone ab­
scess.
Treatment
All patients were treated surgically 
once an osteoid osteoma was diag­
nosed. The procedure consisted of 
complete removal of the tumour, 
either by en bloc excision or curettage. 
Before the correct diagnosis was made
some patients underwent other forms 
of treatment, such as bed rest, cervical 
traction or fusion, which resulted in 
partial but only temporary relief. In 
a few patients, such treatments re­
sulted in an increase in the pain. Total 
removal of the tumour was the only 
treatment that produced complete and 
permanent pain relief. Two patients 
required fusion because of extensive 
removal of the articular facets and 
instability.
Follow-up of 16 patients was re­
ported and generally the results were 
good. Most reported complete relief 
of pain within a few months of oper­
ation, while the remainder noted a 
great decrease in the severity of the 
pain with continuing improvement. 
There was no tumour recurrence up 
to 4 years after operation. All nine 
patients who had scoliosis or torticollis 
had improvement, many returning to 
normal within several months. Two 
patients complained of residual neck 
stiffness with some limitation of neck 
movement, but they believed this was 
improving with physiotherapy. Of the 
four patients who had had neurologic 
findings, two became normal while 
the other two continued to have some
Table 1--Reported Cases of Osteoid Osteoma o f Cervical Spine
Author and year
Age, Vertebra Night Radicular Asp irin Neurologic
yr Sex involved Portion pain pain relief Tenderness signs Sco lios is
Jaffe , 19351 16 M C7 Spinous
Hamilton, 19454
process Yes No _ Yes No No
19 M C2 Pedicle No Yes _ Yes No Yes
Sobel, 1946s 13 M C6 Lamina No No _ No Yes
Campos, 19466 11 F C4 Spinous
Walker. 19527
process No No Yes _ No No
14 F C5 Spinous
14
process Yes No - - No No
Ward, 1957s
M C5 Pedicle No No _ __ No
11 M C5 Transverse
Fett and Russo, 1959s
process No No _ _ No
9 ’/z M C3 Body No No Yes Yes No Yes
Freiberger, I96010 12 M C7 Lamina No No _ No Yes
Fountain and Burge, 196111 11 M C5 Pedicle Yes Yes Yes Yes Yes Yes
Gelberman and Olson, 197412 11 M C1 Spinous
Keim  and Reina, 197513
process Yes No Yes Yes No No
8 M C6 Lamina No Yes No Yes No Yes
9 M C5 Lamina and
Fielding and associates, 197714
pedicle No Yes _ Yes No Yes
- M C l Lamina No No No Yes No No
- M C7 Spinous and
articular
processes No No No Yes No No
- M C6 Lamina Yes Yes Yes Yes No Yes
M C5 Lamina and
Goldstein and associates, 197715
pedicle Yes No Yes Yes No Yes
27 M C7 Lamina and
Glasauer, 1979’ 6
pedicle Yes Yes Yes Yes Yes No
12 M C6 Lamina Yes Yes _ Yes Yes No
Banna, 197917 12 F C7 Spinous
Conley and associates, 197918
process and 
lamina Yes Yes Yes Yes
34 M C4 to C7 Neural arch
and body Yes No — _ — —
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residual arm and shoulder weakness 
and depressed reflexes.
Pathologic Features
In all patients the lesion consisted 
of a well-circumscribed, reddish mass 
that was hard and gritty and appeared 
vascular and hemorrhagic. Microsco­
pically, the tumour consisted of trabe­
culae and islands of uncalcified os­
teoid and atypical, immature bone, set 
in a vascular and cellular stroma. Ac­
tive osteoblasts and osteoclasts were 
the major cell types.
Discussion
It is clear that osteoid osteoma of 
the spine has some characteristic 
features and knowledge of them 
can be invaluable in diagnosing the 
cause of obscure, persistent pain in 
the neck or upper back, when plain 
films show a normal appearance.
The patients are most commonly 
males in the second or third decade of 
life. The sex incidence for spinal os­
teoid osteomas favours males in a pro­
portion of 6 to 1 compared to the 
2 to 1 male predominance for osteoid 
osteomas involving all bones.3,19
Osteoid osteoma of the cervical 
spine is quite rare. In Dahlin’s2" re­
view of 3987 primary tumours of 
bone, there were 28 osteoid osteomas 
involving all bones, an incidence of 
less than 1%.20,21 This rarity may ac­
count for the frequent delay in diag­
nosis and treatment.
Pain in the neck or upper back is 
the major complaint of almost all 
patients. It is usually well localized 
and increases progressively in severity 
and frequency. The pain is often more 
severe at night. Analgesics of the sali­
cylate group are particularly effective 
in relieving the pain. This feature is 
so characteristic of osteoid osteoma, 
involving any bone, that it alone should 
suggest the diagnosis. It is not under­
stood why salicylates produce such 
dramatic pain relief but one theory 
proposed by Saville22 is that tumour 
cells produce arachidonic acid, which, 
in the presence of cyclo-oxygenase, is 
metabolized, forming products that 
create and promote pain and bone re­
sorption. Aspirin, a cyclo-oxygenase 
inhibitor, prevents the formation of 
such products.
Saville also presented a case in 
which a 10-month regimen of Aspirin 
resulted in complete pain relief for 
lVi years after the medication was 
stopped and in radiologic healing of 
the lesion.
Sherman and McFarland23 in 1965 
proposed another theory. They found 
nerves accompanying the blood vessels
as they entered the tumour. They pos­
tulated that these nerves are derived 
from the autonomic nervous system 
and that vascular compression causes 
the pain.
Local neck tenderness, stiffness and 
limitation of neck movement are the 
usual physical findings. Rapidly devel­
oping scoliosis of the cervical spine is 
also sometimes seen. After surgical re­
moval of the lesion the scoliosis usual­
ly disappears within a few months but 
if the lesion is left untreated, over 
many years the scoliosis can become 
structural and irreversible, especially 
in growing children. For this reason, 
it is important that osteoid osteoma be 
suspected in any child or young adult 
complaining of neck pain or backache, 
especially if it is accompanied by 
scoliosis of rapid onset.13
Characteristically, the findings on 
neurologic examination are normal, 
but compression of nerve roots or the 
spinal cord can result in weakness and 
atrophy of the upper extremity, as 
well as sensory changes and depres­
sion of the reflexes.17
Once osteoid osteoma is suspected 
it is important that detailed radiologic 
investigation be performed for accu­
rate localization. Plain films of the 
cervical spine frequently are normal. 
If so, a nuclear bone scan should be 
done; osteoid osteoma appears as an 
area of increased radionuclide uptake, 
which suggests increased bone acti­
vity.24'26 A bone scan is an excellent 
screening test for osteoid osteoma but 
it is not diagnostic, so more specific
tests are required! Tomograms can
pick up very subtle lesions that are 
easily missed on plain films. If tomo­
grams are inconclusive, angiography 
can be helpful. Selective angiography 
of the artery supplying the involved 
vertebra produces a hypervascular
blush due to filling of mature dilated 
capillaries17'27 and often an increase in 
neck pain,15 which supports the hypo­
thesis of Sherman and McFarland that 
the pain is due to vascular compres­
sion of the nerves within the tumour. 
Myelography can also be useful, espe­
cially in patients who present with
pain radiating to the upper extremity. 
Such radicular pain is much more 
commonly seen with a herniated cervi­
cal disc.
These features, although they 
strongly suggest osteoid osteoma, do 
not rule out other diagnoses such as 
Gare’s sclerosing osteomyelitis, intra- 
cortical bone abscess and osteogenic 
sarcoma.4 The diagnosis can only be 
confirmed through histologic examina­
tion of the lesion, which is character­
istic.
Treatment consists of complete sur­
gical removal of the lesion with fusion 
if instability is expected. Because most 
patients undergo operation, the na­
tural history of osteoid osteoma has 
not been extensively studied, but 
Simm in 197528 reported on 20 pa­
tients with suspected osteoid osteomas, 
involving all bones, who were not 
operated upon. He found that over 
many years, the pain decreases and 
eventually disappears but that the ra­
diologic features may persist and the 
lesion may never totally heal.
Osteoid osteoma, if removed com­
pletely, rarely recurs and very rarely 
undergoes malignant degeneration.6 
Complete surgical resection of the tu­
mour is usually possible and the prog­
nosis is good. The patient’s signs and 
symptoms disappear or at least de­
crease substantially allowing return to 
a relatively normal life.
Conclusions
The signs and symptoms of osteoid 
osteoma of the cervical spine are so 
characteristic that it should be possible 
to make the diagnosis from the history 
and physical examination alone. The 
commonest presentation is neck or 
upper back pain, more severe at night, 
that is dramatically relieved by anal­
gesics of the salicylate group. Neck 
stiffness and limitation of movement, 
local tenderness and scoliosis are com­
mon. Radiologic investigation should 
include plain films, a nuclear bone 
scan and tomograms of the cervical 
spine. If these are inconclusive, angio­
graphy or myelography may prove 
helpful. The treatment of choice is^  
complete surgical removal. The prog­
nosis is good.
We thank Dr. J.M. Bilbao, depart­
ment of pathology, St. Michael’s Hos­
pital, for his assistance in preparing this 
paper.
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Mid-Trimester Abortions: 
a Decade in Review
M arkus C. M a r t in , m d , c m , f r c s [c ], facog , facs and M orrie  M . G e l f a n d , m d , c m , f r c s [c ], FAc o g , fa c s
At the Sir Mortimer B. Davis-Jewish 
General Hospital in Montreal, the 
total number of abortions increased 
over the 10-year period Jan. 1, 1970 
to Dec. 31, 1979 but the percentage of 
mid-trimester abortions performed 
fell after 1974 to 2.1% at the end 
of the study period. The authors 
reviewed the records of 1422 patients 
who underwent mid-trimester 
abortions over the 10 years of the 
study to determine which technique 
was the safest, the quickest and 
the most commonly performed. Initially, 
saline instillation was the commonest 
method but this has been replaced 
by injection of prostaglandin F2„, 
which was found to be the quickest 
acting of the fluids used. Hysterotomy 
and hysterectomy were associated 
with higher complication rates than 
other methods, confirming the 
authors' belief that they should be used 
only under exceptional circumstances.
A I'hopital General Juif-Sir Mortimer 
B. Davis de Montreal, le nombre 
total des avortements s ’est accru 
durant la periode de 10 ans allant du 
ler janvier 1970 au 31 decembre 1979 
alors que le pourcentage des 
avortements pratiques au cours du
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deuxieme trimestre s'abaissait apres 
1974 pour atteindre 2.1% a la fin 
de la periode etudiee. Les auteurs 
ont passe en revue les dossiers 
de 1422 patientes qui ont subi un 
avortement du deuxieme trimestre 
au cours de ces 10 annees afin 
de determiner quelle technique etait 
la plus sure, la plus rapide et la 
plus frequemment employee. Au debut, 
I’instillation d'une solution saline 
etait la methode la plus couramment 
utilisee mais elle fut remplacee 
par I'injection du prostaglandine F2„ 
qui s ’avera la plus rapide des 
preparations utilisees. L’hysterotomie 
et I’hysterectomie etaient reliees a 
un taux de complications plus eleve 
que les autres methodes, ce qui 
confirme I’opinion des auteurs que ces 
interventions ne devraient etre 
utilisees que dans des circonstances 
exceptionnelles.
Menstrual extractions and suction cu­
rettages are common in many hospi­
tals in Canada. In Quebec, however, 
because of the religious concerns in 
most hospitals, abortions are primari­
ly limited to the English, non-Cath- 
olic hospitals of Montreal. Elective 
mid-trimester abortions are less fre­
quently carried out in all institutions. 
We, therefore, wished to review our 
experience in the 1970s in order to 
plan for the 1980s.
Patients and Methods
We analysed 1422 consecutive mid­
trimester pregnancy terminations car­
ried out between Jan. 1, 1970 and 
Dec. 31, 1979 at the Sir Mortimer B. 
Davis-Jewish General Hospital.
The technique used in the majority 
of cases was intra-amniotic instillation 
or injection of abortifacients. The
Table 1 - Procedures U sed (N = 1422)
Procedure No. %
Instillation of saline alone 
Instillation of saline w ith
507 35.7
dilatation and curettage 
Injection of prostaglandin F2o
347 24.4
alone
Injection of prostaglandin F2o
94 6.6
w ith dilatation and curettage 98 6.9
Instillation of 50%  glucose 3 0 2
Hysterotom y alone 13 0 9
Hysterotom y and tubal ligation 
Hysterectom y, w ith or w ithout
300 21.1
bilateral salpingo-oophorectom y 
Dilatation and evacuation or
11 0.8
dilatation and curettage 48 3 4
Other 1 0.1
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f i g . 1__Procedures by year. D +  E /D  +  C =  dilatation and evacuation or
dilatation and curettage.
FIG. 2—Comparison of frequency of mid-term (black circles) and all abortions 
(white circles).
FIG. 3— Percentage of abortions by age group.
solutions used were 20% saline, pros­
taglandin Fta and 50% glucose. A 
number of patients also underwent 
hysterotomy. A few underwent dilata­
tion and evacuation.
All fetuses were of at least 13 weeks’ 
gestational age, confirmed by examin­
ation of specimens, ultrasonography 
or clinical dating. All terms and def­
initions used are in concordance with 
those used by the American College 
of Obstetricians and Gynecologists.1
Results
Table I and Fig. 1 detail the proce­
dures used in the study period. Intra- 
amniotic instillation of saline was the 
most common method being carried 
out in 854 cases (60.1%), but by the 
end of the decade we were using only 
prostaglandin injection (13.5%). The 
second commonest procedure was hys­
terotomy performed in 313 cases 
(22%); this was done with tubal liga­
tion in 91% of the 313 women.
As abortions became more avail­
able they were more commonly car­
ried out in the first trimester. There 
was a concomitant marked decrease 
in the number of second trimester 
abortions, although the total number 
of abortions increased (Fig. 2).
Abortions were performed predom­
inantly in the younger age groups. 
Teenagers constituted the largest 
group by the late 1970s (Fig. 3) and 
had a higher percentage of more ad­
vanced pregnancies before their ter­
mination than older age groups (Table
II).
The recidivism rate of 8.3% was 
not high (Fig. 4); those who needed 
another abortion rarely waited until 
the mid-trimester. The contacts for an 
early abortion had already been estab­
lished.
Table III shows the interval be­
tween instillation or injection of the 
various solutions and abortion. Both 
for nulliparous and multiparous pa­
tients, prostaglandin gave the shortest
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interval. Furthermore, whereas prosta­
glandin took the same time regardless 
of parity, saline took longer to be ef­
fective in the nulliparous patient. Oxy­
tocin infusion was usually started 
within 12 hours of the instillation to 
shorten abortion time.
Complications
Postoperative complications are de­
tailed in Table IV. Retained products 
of conception was the commonest 
problem, occurring in over half (51%)
of our prostaglandin injections. Al­
though common with saline, this prob­
lem occurred in only 40% of our pa­
tients. Prostaglandin injection also 
failed more commonly (4.2%) than 
saline instillation (3.4%) but was asso­
ciated with a lower incidence of infec­
tion and blood loss requiring trans­
fusion.
Hysterectomy gave the highest in­
cidence of complications. Hysterotomy 
gave a high incidence of postoperative 
morbidity.
There was one maternal death due
to cardiomyopathy, an incidence of 
0.07%. The procedure, a hysterot­
omy, was done to try to save the life 
of a woman with severe heart disease.
Discussion and Conclusions
With the liberalization in 1969 of 
the Canadian abortion law, the total 
number of abortions increased pro­
gressively over the 10 years analysed. 
Simultaneously, there was a marked 
decrease in mid-trimester abortions.
Our largest group was made up of 
teenagers, a group with a slowly ris­
ing abortion rate in Canada.2 Their 
pregnancies also tended to be more 
advanced than those of other age 
groups.3
Analysis of the complication rates 
confirms previous statements that 
“major surgery for abortion should be 
restricted to unique circumstances”.4
Prostaglandin acts most quickly but 
is associated with a greater proportion 
of retained products of conception 
resulting in subsequent curettage.
Many centres are now performing 
mid-trimester abortions at up to 16 
weeks by dilatation and evacuation 
after insertion of a laminaria tent.5 
Due to the impressive decline at our 
institution in mid-trimester abortions, 
our own experience with this method 
has been limited.
References
1. A m erican College o f O bstetricians and  G yne­
cologists: Technical Bulletin , no. 56, D ecem ­
ber 1979
2. Wadhera A, N air C : Legal abortions am ong 
teenagers in C anada, 1974 through  1978. 
Can M ed  A ssoc J  1980; 122: 1386-90
3. Hanson M S: A bortion in teenagers. Clin 
Obstet G ynecol 1978; 21: 1175-90
4. G rimes DA, Cates W  j r : C om plications 
from legally-induced abortion : a review . O b­
stet G ynecol Surv  1979; 34: 177-91
5. Cadesky K I, Ravinsky E, Lyons E R : D ila ­
tion and evacuation: a p referred  m ethod of 
m idtrim ester abortion. A m  J O bstet G ynecol 
1981; 139: 329-32
Table II- -Gestational Age and Patient Age
Patient age, yr
Gestational age, w k
Total no. 
of patients13-15 16-18 19-20 21 +
12-19 117 164 16 1 298
20-24 191 159 17 5 372
25-29 167 109 22 5 303
30-34 109 87 8 1 205
35-39 89 56 5 3 15340 + 53 32 6 - 91
Total 726 607 74 15 1422
Table II I - -P arity  and Interval between Instillation or Injection and Abortion
Parity No.
Interval betw een procedure 
and actual abortion 
Range, h M ean, h
Nulliparous
Saline 455 9-151 34.47
Prostaglandin 122 8-66 21.92
Glucose 3 31 -48 41 33
Multiparous
Saline 311 6-121 30.22
Prostaglandin 74 5-100 21 69
Glucose -
Total
Saline 766 6-151 32.73
Prostaglandin 196 5-1 00 21.83
Glucose 3 31-48 41.33
Table IV Number (and %) of Complications Associated w ith  Various Procedures
Dilation and
Complication
evacuation or 
curettage
Instillation Injection of 
of saline prostaglandin F,„ Hysterotomy
Total abdominal 
hysterectomyFever
Endometritis 
Urinary tract infection 
Wound infection
1 (2.1) 25 (2.9) 
15 (1.8) 
6 (0.7)
1 (0.5)
2 (1.0)
38 (12.1) 
5 (1.6) 
32 (10.2)
2 (18.2) 
2 (18.2)
Ileus 9 (2.9) 1 (9.1)
Retained products of 6 (1.9) -
conception*
Blood loss requiring
2 (4 .2 ) 347 (40.6) 98 (51.0) 1 (0.3) -
transfusion 
Cervical injury
1 (2.1) 
1 (2.1)
46 (5.4) 
1 (0.1)
8 (4 .2 )
1 (fL5)
10 (3.2) 3 (27.3)
Laminaria tent required 
Otherf -
9 (1.1) 
7 (0.8)
1 (0.5) 
3 (1.6) 4  (1.3) 1 (9.11
netained more than 2 h, necessitating a subsequent curettage. 
tAnemia, phlebitis, pyelonephritis, septicemia, pneumonia, pelvic inflammatory disease, diarrhea, seizure, suicide attem pt, lysis of adhesions.
VOLUME 25, NO. 6, NOVEMBER 1982 /  THE CANADIAN JOURNAL OF SURGERY 643
Necrotizing Choledochomalacia after Use of 
Monooctanoin to Dissolve Bile-Duct Stones
T S. Crabtree, md, R. D ykstra, md, frcs[c], J. Kelly, m b, mrc path, frcp[c] and
R.M. Preshaw, m d , frcs[c]
A 72-year-old man with choledocholi- 
thiasis, demonstrated radiologically, 
was treated by constant perfusion 
through the gallbladder of mono­
octanoin (glyceryl-1-monooctanoate) 
following cholecystostomy for a 
perforated gallbladder. The mono­
octanoin was given at a rate of 
7.5 m l/h  and monitored to ensure 
that delivery pressure did not rise 
above 20 cm H20. Perfusion was 
carried out for 60 hours, but could 
not be continued because of abdominal 
pain, nausea and vomiting. This 
was followed by progressive jaundice, 
anorexia and fever. The patient 
was treated with penicillin G 
and cefoxitin intravenously and 
metronidazole orally, but he died 
5 weeks after the perfusion.
Autopsy showed acute pancreatitis 
and cholangitis, and a biliary tree 
filled with pus and a black biliary cast. 
No calculi were present. The authors 
consider the possible causes for 
this patient's death.
Un homme de 72 ans atteint d'une 
choledocholithiase, mise en evidence 
a la radiographie, a ete traite par 
perfusion continue de la vesicule 
biliaire avec du mono-octanoi'ne 
(glyceryl-1-monooctanoate) apres une 
cholecystostomie pour une perforation 
de la vesicule. Le mono-octanoi'ne fut 
administre a la vitesse de 7.5 m l/h  
et surveille de fapon a s’assurer que 
la pression de perfusion ne depasse 
pas 20 cm H.,0. La perfusion s’etendit 
sur 60 heures, mais elle dut etre 
interrompue en raison de douleur 
abdominale, nausee et vomissement. 
Ceci fut suivi d’un ictere evolutif, 
d’anorexie et de fievre. Le patient 
recut de la penicilline G et de la 
cefoxitine par voie intraveineuse et 
du metronidazole par voie orale, mais 
il mourut 5 semaines apres la 
perfusion. L’autopsie revela une 
pancreatite aigue et une cholangite
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et montra des voies biliaires remplies 
de pus et d’un residu biliaire noir.
On ne releva pas la presence de 
calculs. Les auteurs commentent les 
causes possibles ayant pu entrainer 
le deces du patient.
Monooctanoin (predominantly glyce­
ryl-1-monooctanoate and glyceryl di- 
octanoate), a commercial emulsifying 
agent, has been used to dissolve bile- 
duct stones when a T-tube allows ac­
cess to the biliary tree.1 Perfusion of 
the bile ducts with monooctanoin in 
rhesus monkeys caused no obvious ab­
normality in contrast to other sub­
stances.* Furthermore, monooctanoin 
is a normal product of digestion of 
medium-chain triglyceride. In contrast 
to these studies, another group3 has 
reported the development of cholan­
gitis, papillitis, and possibly acute pan­
creatitis in anesthetized cats when the 
biliary tree was perfused with mono­
octanoin. We report here a case of 
necrotizing choledochomalacia after 
the use of monooctanoin.
Case Report
A 72-year-old white man suffered 
acute abdominal pain for 48 hours. At 
laparotomy there was biliary peritonitis 
secondary to gallbladder perforation. A 
Foley catheter was placed in the gall­
bladder after the evacuation of several 
small yellowish calculi. These calculi 
were not analysed. It was not possible 
to determine if pancreatitis was present, 
the liver appeared normal to inspection 
and no attempt was made to perform 
intraoperative cholangiography. Post­
operative pulmonary infection was treated 
with cloxacillin. He was discharged 38 
days after operation; a cholangiogram 
at that time demonstrated choledocholi- 
thiasis. On discharge his serum bilirubin 
level was 0.8 mg/dl (13.7 pmol/1) (nor­
mal less than 1.0 mg/dl [17.1 [j.mol/1]) 
and the alkaline phosphatase value was 
160 IU/1 (normal less than 85 IU/1). 
Over the next 5 months, the cholecys­
tostomy catheter was allowed to drain 
freely into a plastic drainage bag. Biliary 
volumes varied from 50 to 300 ml/24 h 
suggesting incomplete and intermittent 
obstruction of the distal duct. Because 
he seemed unwilling and unable to 
manage the biliary fistula by himself, 
the patient was readmitted for an 
attempt to dissolve the calculi by the 
use of monooctanoin.
A cholangiogram again demonstrated 
choledocholithiasis (Fig. 1). He was
afebrile, alert and on a normal diet. 
The serum bilirubin level was 0.6 mg/dl 
(10.3 u.mol/1), alkaline phosphatase 240 
IU/1 and serum glutamic oxaloacetic 
transaminase 102 IU/1 (normal less than 
200 IU/1).
Monooctanoin (Capmul 8210; Stokely- 
Van Camp, Capital City Products Co., 
Columbus, Ohio) was perfused by syringe 
pump through a sterile system containing 
a 0.45 n cellulose acetate filter and an 
open vertical venous pressure manometer, 
as suggested by Thistle and associates:1 
the perfusion was to be stopped if the 
pressure exceeded 20 cm H20 . Mono­
octanoin is supplied unsterile, but culture 
showed no growth by standard aerobic 
and anaerobic methods.
Perfusion at 7.5 m l/h caused anorexia 
after 24 hours and intermittent nausea. 
However, the perfusion was continued 
without interruption for a further 24 
hours as similar symptoms had been 
observed by Thistle and associates.1 The 
patient complained of right-sided abdo­
minal pain so the perfusion was stopped 
for 12 hours. The pump was then re­
started as his symptoms appeared to 
improve, but when his serum bilirubin 
level rose to 4.5 mg/dl (77 umol 1) the 
perfusion was discontinued.
Over the next 5 weeks, progressive 
jaundice and pyrexia developed, while 
the intermittent nausea and vomiting and 
anorexia continued. The cholecystostomy 
catheter was kept open throughout, but 
the volume of bile produced was only 
25 to 100 ml/24 h. Bile cultured on four 
occasions by needle aspiration of the 
lumen of the catheter was sterile. Initial 
blood cultures were sterile, but at 3 and 
again at 4 weeks after the perfusion was 
stopped, blood cultures grew, respective­
ly, Escherichia coli and Enterobacter
FIG. 1—Cholangiogram showing com­
mon duct calculus.
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cloacae. Liver scanning, computerized 
axial tomography and other radiologic 
studies were not helpful. Because of a 
clinical impression of liver abscess or 
ascending cholangitis, he was given 
metronidazole orally, and penicillin G 
and cefoxitin intravenously. His pyrexia 
showed slight improvement but the 
alkaline phosphatase value rose above 
1000 IU/1 and the serum bilirubin level 
to 22 mg/dl (376 pmol/1). The serum 
amylase level, determined on several 
occasions, was not elevated. A cholan-
FIG. 2—Cholangiogram 3 weeks after 
monooctanoin perfusion. Appearance is 
compatible with biliary cast (arrows): 
previously noted calculi are no longer 
present.
FIG. 3—Common hepatic duct con­
taining black biliary cast. Glass rod is 
in cystic duct.
giogram (Fig. 2) showed no calculi in 
the duct system, but was interpreted 
either as showing hemobilia or a biliary 
cast. The patient died from progressive 
renal failure and bronchopneumonia 
5 weeks after monooctanoin perfusion.
Autopsy was limited to examination 
of the abdomen. The peritoneal cavity 
contained 2 litres of clear orange fluid. 
The gallbladder was 4 cm long and its 
wall was thickened. The extra- and intra- 
hepatic bile ducts contained black biliary 
casts (Fig. 3) and there were focal 
abscess-like collections of turbid yellow 
fluid beside large bile ducts. No calculi 
were present. Histologically the large 
bile ducts were destroyed and their walls 
were replaced by casts of bile that re­
tained the central lumina. Bile appeared 
to have dissected into the duct wall 
because some connective tissue was 
found near the luminal surface. Bile had 
leaked focally into the portal tract to 
form small bile lakes or bile-containing 
abscesses. The casts contained clumps of 
gram-negative rods and were surrounded 
by a mixed neutrophil and macrophage 
response (Fig. 4). Ducts of less than 
500 u diameter were normal in appear­
ance as was their epithelium. The liver 
was green and histologically showed 
marked canalicular and liver cell choles­
tasis predominantly centrilobular in dis­
tribution. Copper stains were negative. 
The portal tracts showed mild lympho­
cytic and neutrophilic infiltration and 
edema. Neutrophils were not present in 
bile-duct lumina and there was no fur­
ther proliferation. There were multiple 
foci of fat necrosis throughout the lesser 
sac and pancreas; acute pancreatitis was 
present.
Discussion
Monooctanoin effectively dissolves
cholesterol gallstones when adminis­
tered directly into the human biliary 
system. Thistle and associates1 re­
ported that their 12 patients frequent­
ly had anorexia, nausea and emesis 
and abdominal discomfort during ad­
ministration of this substance, but that 
these side-effects were probably at­
tributable to increased pressure in the 
bile ducts and were relieved when the 
perfusion was stopped. For this reason 
we were not unduly disturbed when 
our patient had similar complaints.
The duration of therapy in the 
Mayo series varied from 4 to 21 days. 
Our patient had continuous perfusion 
for 48 hours and intermittent perfu­
sion for a further 12 hours. Admin­
istration of monooctanoin was then 
stopped because of a rising serum 
bilirubin level.
Despite the finding that monooc- 
lanoin did not cause any histologic 
changes in the bile ducts of rhesus 
monkeys,2 it has been reported to 
cause cholangitis and papillitis, and 
acute pancreatitis after perfusion of 
the biliary tree in anesthetized cats.3 
The histologic findings in our case 
were those of toxic epithelial necrosis 
in the bile ducts.
Thistle and associates1 perfused 
monooctanoin into the common bile 
duct of their patients by means of in­
dwelling T-tubes and interrupted the 
perfusion three times daily for periods 
of 1 to 2 hours. In our case, we at­
tempted to perfuse continuously for 
48 hours and only interrupted the per­
fusion when the abdominal pain de­
veloped as well as anorexia and nau­
sea. Furthermore, the monooctanoin
FIG. 4— Biliary cast replacing wall of major intrahepatic duct, with bile leakage 
into portal tract connective tissue. There was heavy mixed inflammatory cell response 
(hematoxylin and eosin, reduced by 31% from x  100).
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solution was perfused into the gall­
bladder by a cholecystostomy catheter 
rather than directly into the bile duct. 
We find it difficult to attribute the 
fatal result in this case to these dif­
ferences.
It is possible that perfusion of the 
duct system flushed a biliary calculus 
into the ampulla and simultaneously 
induced acute pancreatitis. The chol­
angitis observed would therefore rep­
resent a complication of distal biliary 
obstruction. Against this argument is 
the failure of decompression of the 
biliary tree to alter the clinical course 
and the repeated failure to culture any
organisms from bile samples. Perhaps 
the severe cholangitis represented an 
unusual response to one of the anti­
biotics administered after the initial 
jaundice was noted.
The clinical course and autopsy 
findings were consistent with a toxic 
choledochomalacia and pancreatitis 
induced by 60 hours of perfusion with 
monooctanoin solution, although we 
cannot exclude the coincidental devel­
opment of severe cholangitis. Any 
agent capable of making cholesterol 
crystals stable might also under some 
circumstances disrupt the lipid com­
ponent of cell membranes; this occurs
in cats3 and perhaps occasionally in 
man, as evidenced by this case.
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Immobilization Hypercalcemia
Lowell van Zuiden , md, frcs[c], K.A. Anquist, md, frcs[c], N. Schachar, md, frcs[c] and
N. Kastelen, md, frcs[c]
Three cases of immobilization 
hypercalcemia are presented and the 
incidence, clinical symptoms, laboratory 
investigation, pathophysiology and 
treatment of this metabolic abnormality 
are reviewed. Immobilization hyper­
calcemia is more common than has 
previously been suspected. Vague 
clinical symptoms may not suggest the 
diagnosis of hypercalcemia. Laboratory 
investigation of these clinical 
complaints in the immobilized patient 
should include determination of the 
serum calcium and total protein levels 
and the urinary calcium to creatinine 
ratio.
The pathophysiology of this entity 
is unknown. Treatment is directed 
towards lowering the serum calcium 
level using intravenous hydration, 
furosemide and salmon calcitonin. 
Definitive treatment consists of 
mobilizing the patient. Exercises in 
bed have not been effective in 
preventing or treating immobilization 
hypercalcemia.
Cet article decrit trois cas 
d’hypercalcemie d’immobilisation 
et passe en revue I’incidence, le 
tableau clinique, les examens de 
laboratoire, la pathophysiologie et le
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traitement de cette anomalie 
metabolique. L’hypercalcemie 
d’immobilisation est plus frequente 
qu'on ne I'a soupponne jusqu'a 
maintenant. La symptomatologie vague 
peut ne pas suggerer le diagnostic 
d'hypercalcemie. Les examens de 
laboratoire faits en rapport avec les 
plaintes du malade immobilise doivent 
inclure la determination des 
concentrations seriques du calcium 
total et des proteines totales ainsi 
que le rapport du calcium et de la 
creatinine urinaire.
La pathophysiologie de cette 
entite est inconnue. Le traitement 
cherche a abaisser la calcemie 
par I’administration de solutes 
intraveineux, de furosemide et de 
calcitonine de saumon. Le traitement 
definitif consiste a mobiliser le 
patient. Les exercices au lit ne se sont 
pas reveles efficaces pour prevenir 
ou traiter I'hypercalcemie 
d'immobilisation.
Osteoporosis that develops following 
partial or complete immobility of the 
human skeleton has been recognized 
for over a century.1,2 Hypercalcemia, 
only recently described in the immo­
bilized patient, is a metabolic com­
plication of immobilization. The cause 
of this type of hypercalcemia is un­
known.
Fuller Albright and associates3 pre­
sented the first complete description 
of this complication, illustrating the 
diagnostic and therapeutic problems
involved. Their patient, a 14-year-old 
boy with a fracture through a cyst in 
the neck of femur, was immobilized 
in a hip spica. Subsequent clinical and 
laboratory evidence of hypercalcemia 
suggested a diagnosis of hyperpara­
thyroidism. No abnormal parathyroid 
tissue was found following exploration 
of the neck and anterior mediastinum. 
It was assumed that the hypercalcemia 
resulted from a lack of stress on the 
skeleton. The patient was therefore 
mobilized and his symptoms resolved 
completely. The blood chemistry 
values returned to normal in t month.
Since the report of Albright and 
colleagues, this complication has been 
described in many clinical situations, 
including poliomyelitis,3,4 spinal cord 
injury,3 burns,6 acute renal failure7’8 
and postoperative immobilization.” 
The common factor in each of these 
clinical situations is immobility.
The present paper reports three 
cases of immobilization hypercalce­
mia, occurring at the Alberta Chil­
dren’s Provincial General Hospital, in 
Calgary, during a 3-month period. A 
review of the literature suggests that 
hypercalcemia is common in the im­
mobilized patient, but that it is fre­
quently missed. Further consideration 
of the clinical manifestations, as dem­
onstrated in the present study, em­
phasizes the subtle symptoms asso­
ciated with immobilization hypercal­
cemia. This may explain the frequent 
failure to recognize this complication. 
Both urine and serum biochemical 
studies may be helpful, but they are
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not diagnostic of immobilization hy­
percalcemia. Although the definitive 
method of measuring renal calcium 
excretion is by 24-hour urine collec­
tion, a more recent contribution by 
Rosen and associates10 suggests that 
the calcium to creatinine ratio is an 
easier and more effective indication 
of increased renal excretion of cal­
cium. However, no further reports 
using this test have appeared in the 
literature. Biochemical assessment of 
the serum total calcium, phosphate 
and total protein levels must be in­
cluded in the laboratory assessment of 
a patient with suspected hypercalce­
mia.
This paper also reviews the research 
into the pathophysiology of immobil­
ization hypercalcemia, discusses vari­
ous modes of treatment and concludes 
with a treatment plan for this meta­
bolic complication of immobility.
Case Reports
Case 1
A 14-year-old boy sustained a supra­
condylar fracture of the right femur. Bal­
anced skeletal traction with both tibial 
anu femoral condylar Steinman pins re­
sulted in adequate position.
Four weeks after the injury the boy 
was emotionally labile and had mild 
abdominal discomfort which slowly sub­
sided. The serum calcium level was not 
determined. At 7 weeks he had blood- 
tinged urine and severe flank pain. Uri­
nalysis revealed many red blood cells 
and a few calcium oxalate crystals. The 
total serum calcium level was 12.3 mg/dl 
(3.07 amol/1) (normal range, 8.5 to 10.5 
mg/dl [2.12 to 2.62 q.mol/1]). Serum 
phosphate, total protein and alkaline 
phosphatase levels were normal. Fluid 
intake was encouraged and acidification 
of the urine was accomplished using 
ascorbic acid. The patient was rapidly 
mobilized and his serum calcium level 
returned to, and remained, normal.
Case 2
This 7V5-year-old girl sustained a 
closed head injury, renal contusion and 
closed fracture of the left femur when 
she was struck by an automobile. The 
head injury and renal contusion resolved. 
The fractured femur was treated with 
balanced skeletal traction and immobi­
lization.
Four weeks after admission she ex­
perienced grumbling abdominal and right 
lower quadrant pain. Despite investiga­
tion, the diagnosis of hypercalcemia was 
not made until 5V4 weeks after admis­
sion. At this time her serum calcium level 
was 11.3 mg/dl (2.82 jj.mol/1). Urinalysis 
demonstrated calcium oxalate crystals 
and microscopic hematuria. A urinary 
calculus was passed 2 days after the diag­
nosis was made. The patient was treated 
with hydration and mobilization. Follow­
up laboratory studies showed that the 
condition had resolved.
Case 3
When she fell from a horse this ^V i- 
year-old girl sustained a mid-shaft frac­
ture of the left femur. The fracture was 
treated with balanced skeletal traction. 
Five weeks after injury she had mild 
abdominal discomfort, anorexia and 
slight emesis.
Laboratory examination revealed an 
elevated calcium level of 14.2 mg/dl 
(3.54 umol/I). Urinalysis and serum 
phosphate, total protein, alkaline phos­
phatase and parathyroid hormone estima­
tions gave normal results. Twenty-four- 
hour urine collections were used to meas­
ure calcium excretion throughout the 
course of the illness, but they were found 
to be unreliable. Salmon calcitonin 
(40 lU/d) given intramuscularly drama­
tically reduced the serum calcium to 
normal levels and eliminated the symp­
toms. Two and a half weeks after the 
diagnosis of hypercalcemia, mobilization 
with protected weight-bearing of the frac­
tured femur was permitted. Follow-up 
calcium levels were normal.
Literature Review
Clinical Assessment
The incidence of immobilization 
hvpercalcemia is controversial. Wolf 
and associates” and others12 have 
stated that this complication is rare 
in the immobilized trauma patient. 
Heath and associates13 compared the 
serum ionized calcium and urinary 
calcium levels of 4 healthy immobil­
ized adult volunteers with 10 adult 
patients immobilized for fracture man­
agement. He found elevated ionized 
calcium levels in all volunteers and in 
7 of the 10 patients. Such abnormal­
ities in immobilized children have 
been documented by Rosen and asso­
ciates.10 Further clinical confusion is 
added by Henke and colleagues,14 who 
stated that immobilization hypercal­
cemia occurs only in patients with an 
underlying disorder of calcium m eta­
bolism, such as Paget’s disease and 
hyperparathyroidism. The literature 
does not substantiate this premise.4,10,15 
Furthermore, the cases described here 
did not demonstrate any underlying 
abnormality.
We conclude that immobilization 
does cause an alteration in calcium 
dynamics, which may or may not be­
come clinically manifest. By careful 
consideration of the complaints of 
these immobilized patients we may un­
derstand why this phenomenon is not 
detected more frequently.
Hypercalcemia is a systemic ab­
normality, and its metabolic conse­
quences have diverse and often subtle 
clinical manifestations. As we ob­
served in our patients, symptoms be­
gin late in the period of immobiliza­
tion. Lethargy, slight alteration in 
mood, minor gastrointestinal distress, 
nausea or mild anorexia may be the 
only symptoms. These nonspecific 
complaints are unlikely to suggest a 
diagnosis of hypercalcemia. Their oc­
currence late in the period of immo­
bility may be dismissed as patient re­
action to confinement or a minor viral 
illness.
In children the period of immobil­
ization may be only 4 or 5 weeks. The 
onset of minimal symptoms may occur 
just before their mobilization and the 
diagnosis may be missed.
Urolithiasis is a late manifestation 
of hypercalcemia. It occurs after 
symptoms have been present for some 
time. This was evident in our second 
patient. It is our opinion that prompt 
clinical and laboratory investigation 
of these minor symptoms and treat­
ment of the hypercalcemia will pre­
vent the development of urinary cal­
culi.
Laboratory Assessment
Standard laboratory assessment is 
useful but not definitive in the diag­
nosis of immobilization hypercalce­
mia. The level of ionized calcium in 
the blood gives a physiologic repre­
sentation of altered calcium dynamics. 
However, this test is not available in 
most laboratories. Measurement of the 
serum total calcium is the most useful 
generally available test, but the total 
protein level must also be known. 
Total calcium may be normal in pa­
tients with elevated ionized calcium 
levels;13 therefore, the clinician may 
need to rely on the clinical manifesta­
tions and the urinary calcium excre­
tion.
Twenty-four-hour urine calcium ex­
cretion greater than 250 mg (6.24 
mmol) has been defined as abnormal. 
This test is awkward to perform and 
unreliable. In our third patient, the 
24-hour urinary calcium excretion was 
normal. Rosen and colleagues10 meas­
ured the urinary calcium clearance to 
creatinine clearance ratio and found a 
good correlation with serum ionized 
calcium. If this ratio is equal to or 
greater than 0.4:1, then hypercalcemia 
is likely.
Other determinations should include 
serum phosphate and alkaline phos­
phatase levels. In patients with 
immobilization hypercalcemia these 
values should be normal.3,10
There is no general agreement on 
parathyroid hormone levels to be ex­
pected in immobilization hypercalce­
mia. Parathormone levels in immo-
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bilization osteoporosis of animal 
models have been reviewed by Burk­
hart and Jowsey.18 Immobilization os­
teoporosis did not develop in para- 
thyroidectomized animals. In a further 
study of the effects of calcitonin on 
immobilized dogs, Chiroff and Jow­
sey17 postulated an elevation of para­
thormone to account for the minimal 
effects of calcitonin on the immobil­
ized bone. The role of parathyroid 
hormone in this syndrome remains 
unclear.
Lerman and associates18 measured 
the immunoreactive parathyroid hor­
mone level in two patients with im­
mobilization hypercalcemia and found 
it elevated. Others10'1214 have found a 
normal or low immunoreactive para­
thyroid hormone level in immobilized 
patients with hypercalcemia.
This problem may be resolved by 
recent studies on renal function in 
hypercalcemic patients.19 Altered glo­
merular filtration and loss of urine­
concentrating ability of the tubules 
has been shown to occur in hyper­
calcemia.7'8,10 Parathyroid hormone 
metabolism is dependent upon renal 
function.19 This may affect parathy­
roid hormone levels and account for 
the variability of reported levels in 
patients with immobilization hyper­
calcemia.
Hydroxyproline levels in the urine 
are known to be elevated in immobi­
lized patients, due to an increased 
breakdown of bone-derived colla­
gen.13’20 However, this does not appear 
to be helpful in the diagnosis and 
treatment of immobilization hypercal­
cemia.
Most other laboratory studies have 
been found useful in experimental 
metabolic studies but add little in the 
immobilized patient with hypercalce­
mia.
Pathophysiology
The pathophysiology of immobiliza­
tion hypercalcemia is unknown. A re­
lation between disuse osteoporosis and 
hypercalcemia has been postulated by 
many authors.4’6'7,11'13 Biochemical,21 
histologic,22 angiographic23 and radio- 
graphic24 investigations have revealed 
many complex mechanisms involved in 
the development of disuse osteopo­
rosis. Uhthoff and Jaworski,25 in a 
morphologic investigation of bone loss 
in dogs, described three distinct phases 
of bone loss (endosteal, Haversian and 
periosteal) with a bone envelope-spec­
ific response in each phase.
In humans, disuse osteoporosis has 
been the subject of recent interest be­
cause of space exploration.26 Investiga­
tion into calcium dynamics and
the effect of bed rest have been 
studied.410,13’24 Conclusions from these 
studies reveal a loss of mineral and a 
tendency to elevated ionized calcium 
levels in both the zero gravity and 
with bed rest.
In reviewing the literature, four 
possible pathophysiologic pathways 
emerge for the explanation of hyper­
calcemia in the immobilized patient:
1. Mechanical stress applied to 
bone has been shown to create a 
piezoelectric charge on the bone.27 A 
negative charge is established on the 
concave surface of bone, where bone 
deposition takes place. Bed rest de­
creases this stress, altering the charge 
in favour of bone resorption. Albright 
and associates3 proposed this theory 
for the development of immobilization 
hypercalcemia, and Becker27 stated 
that recent work on electrical prop­
erties of bone supports this theory.
2. The vascular response to immo­
bilization has been studied by Hardt,21 
who found an initial increase in bone 
blood flow associated with increased 
mineral deposition. A second response, 
after 15 days of immobilization, was 
a decrease in mineral deposition and 
bone blood flow. Geiser and Trueta23 
also studied immobilized bone and 
showed increased vascularity.
3. Metabolic factors have been im­
plicated as the cause of disuse osteo­
porosis and hypercalcemia. Altered 
metabolism of osteoblasts and osteo­
clasts has been proposed21’23 to explain 
the difference in pH and carbon di­
oxide tension noted in immobilized 
bone. The role of osteoblast-osteoclast 
coupling in immobilization hypercal­
cemia has not been established. Secre­
tion of parathyroid hormone in im­
mobilized volunteers and patients has 
been discussed. Other hormones (e.g., 
thyroid) may be involved directly16 or 
indirectly through parathyroid hor­
mone.28 The role of the metabolic re­
sponse to trauma in the development 
of disuse osteoporosis and hypercal­
cemia has not been studied.
4. Finally, a neurologic cause for 
disuse osteoporosis has been postu­
lated.22 The exact effect of denerva­
tion on the development of disuse os­
teoporosis and hypercalcemia has not 
been established. Loss of muscle func­
tion and its inherent mechanical load­
ing probably account for the osteopo­
rosis of denervation.
Hypercalcemia is thus a well-recog­
nized complication of disuse osteo­
porosis, but no unified pathogenetic 
mechanism has yet been described.
Treatment
The definitive treatment of immo­
bilization hypercalcemia is mobiliza­
tion of the patient. If the original 
problem precludes mobilization, med­
ical treatment can be effective in man­
aging this complication. Other causes 
of hypercalcemia must first be ruled 
out. Measurement of the total calcium 
level and urinary calcium to creatinine 
ratio can be used to follow the pa­
tient’s response to treatment.
Initially, the patient should be ade­
quately hydrated with saline. Renal 
perfusion must be maintained to allow 
adequate calcium excretion. Acidifica­
tion of the urine with ascorbic acid 
will diminish the risk of renal calcif­
ication.7 Furosemide enhances calcium 
excretion in the loop of Henle and 
is effective in lowering the serum 
calcium level.29 Complications of furo­
semide therapy such as volume deple­
tion, hypokalemia and hypomagnese­
mia must be avoided.
Diminution of calcium intake is 
generally not effective. It becomes im­
portant only in those patients already 
receiving supplemental calcium or vi­
tamin D. In these situations the sup­
plement should not be given.
Other therapeutic agents include 
phosphates, steroids, anabolic steroids 
and calcitonin.
Phosphate has been administered 
both orally and intravenously to lower 
serum calcium.30 Calcium levels are 
lowered without increasing the urinary 
excretion of calcium. Metastatic cal­
cification, hypotension, hypocalcemia 
and death have all been reported with 
its use.30
Steroids have been found effective 
in lowering serum calcium concentra­
tion in patients with hypercalcemia 
due to malignant tumours.8 Several 
cases of dramatic lowering of serum 
calcium in immobilized patients have 
also been reported.5,12 The systemic 
complications of steroids are well 
known. Anabolic steroids have also 
been used successfully to treat immo­
bilization hypercalcemia.31
Mithramycin has been used to 
lower calcium levels in patients with 
hypercalcemia due to malignant tu­
mours.32
Salmon calcitonin has been effec­
tive.10’20,33 Most authors agree that cal­
citonin exerts its effect by decreasing 
bone resorption. The response to cal­
citonin is biphasic; an initial decrease 
in osteoclast function accounts for the 
early rapid fall in calcium and later, 
with continued calcitonin administra­
tion, the number of osteoclasts is also 
decreased.20 Our third patient gives 
further support to the effective use of 
salmon calcitonin in the treatment of 
immobilization hypercalcemia. Idio-
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syncratic reactions to calcitonin have 
very rarely been described. Mild nau­
sea and gastrointestinal upset can oc­
cur. No adverse effect of calcitonin 
on fracture healing has been de­
scribed.20’33 We have found 40 IU of 
salmon calcitonin given intramuscu­
larly to be effective in the manage­
ment of our patients’ hypercalcemia. 
Others20 recommend up to 100 IU 
daily.
Physical methods have been used 
to treat immobilization hypercalcemia. 
Several investigations have shown that 
neither isometric nor isotonic exer­
cises in bed are helpful in lowering 
serum calcium levels in immobilized 
subjects.5’7,34 We agree that exercise in 
bed will not alter the pathophysiologic 
process of immobilization hypercalce­
mia. Intermittent longitudinal com­
pression of limbs does not alter the 
negative calcium balance in normal 
subjects confined to bed.34 Supple­
mental calcium, phosphate, calcitonin 
and longitudinal compression all to­
gether have been shown to prevent 
disuse osteoporosis.34
Definitive management of hypercal­
cemia in immobilized patients requires 
early diagnosis, rapid mobilization and 
medical intervention directed at lower­
ing the serum calcium. This is accom­
plished effectively by intravenous sa­
line, furosemide and salmon calcitonin 
given intramuscularly. Careful mon­
itoring of clinical symptoms, serum 
calcium levels, urinary calcium clear­
ance to creatinine clearance ratio and 
fluid balance will reflect the response 
to treatment.
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SESAP III Critique
ITEM 241
The combination of an area of pigmentation in the nail bed with pigmentation of the 
nail fold (Hutchinson’s sign) is diagnostic of subungual melanoma. This lesion occurs 
most frequently on the thumb and great toe. It spreads concentrically rather than in a 
vertical band. The lesion is in the nail bed, and therefore does not travel with nail 
growth. The most important differential diagnosis involves subungual hematoma. The 
pigmentation of subungual hematoma migrates distally with nail growth. Treatment 
requires amputation.
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Giant Hemangioma of the Liver
Greta Taitelbaum, md,* E. John H inchey, md, FRCs[c],f Milton J. H erba, md, FRCp[c]t and
John Lough, md, frcp[c]§
Six patients with hemangioma of the 
liver larger than 5 cm in diameter 
were treated at the Montreal General 
Hospital between 1968 and 1981.
Two patients were symptomatic, 
complaining of nonspecific right upper 
quadrant pain. One man presented 
in a dramatic fashion when he bled 
from a ruptured hemangioma after 
a fall. Arteriography in three of the 
patients revealed characteristic 
filling of the vascular spaces 
commencing in the arterial phase 
with persistent dense accumulation 
in the venous phase. A timed, 
infusion computerized axial tomogram 
in one case revealed prolonged 
opacification, occurring from the 
periphery of the lesion towards 
the centre over several minutes.
All six hemangiomas were benign; 
they consisted of large blood spaces 
separated by fine fibrous septae.
They appeared to expand by 
incorporating marginal liver sinusoids. 
Organizing thrombus was often 
seen; this could account for the 
right upper quadrant pain. The patients 
were treated by partial or total 
hepatic lobectomy to relieve symptoms 
and prevent hemorrhage due to 
trauma. On two occasions, nodules 
of hemangioma were left behind 
but none of the six patients showed 
evidence of recurrence on follow-up.
Six patients atteints d’un hemangiome 
hepatique dont le diametre etait 
superieur a 5 cm ont ete traites a 
I'Hopital General de Montreal entre 
1968 et 1981. Deux patients qui avaient 
des symptomes se plaignaient de 
douleurs non specifiques au quadrant 
superieur droit. Un homme presents 
un tableau dramatique alors qu'il se 
mit a saigner d’un hemangiome rompu 
a la suite d'une chute. Chez trois de 
ces patients, I’arteriographie revela 
un remplissage caracteristique qui 
debutait avec la phase arterielle et
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montrait une accumulation dense 
persistante durant la phase veineuse. 
Dans un cas, une tomographie 
transverse axiale sur ordinateur avec 
chronometrage et perfusion montra 
pendant plusieurs minutes une 
opacification prolongee apparaissant a 
la peripherie de la lesion et s’etendant 
vers le centre. Les six hemangiomes 
etaient benins; ils consistaient en de 
larges espaces sanguins separes par 
de fines parois fibreuses. Ils semblaient 
s'etendre aux depens des capillaires 
sinusoides marginaux du foie. Un 
thrombus en voie d’organisation etait 
souvent observe, ce qui peut expliquer 
la douleur au quadrant superieur 
droit. Le traitement a consiste a faire 
une lobectomie hepatique totale ou 
partielle destinee a soulager les 
symptomes et a prevenir les 
hemorragies pouvant resulter d'un 
traumatisme. En deux occasions, des 
nodules d'hemangiomes ont ete laisses 
en place mais aucun des six patients 
n'a montre de signes de recidive aux 
examens de controle.
Hemangioma is the most common be­
nign tumour of the liver.1 The inci­
dence, from various autopsy series, 
ranges from 0.4% to 7.3%.1-3 Because 
they usually do not produce symptoms 
hemangiomas are generally discovered 
incidentally at laparotomy or autop­
sy A3,4 Adam and associates5 found 
that tumours less than 4 cm in dia­
meter did not give rise to symptoms. 
Larger growths, which they called 
giant cavernous hemangiomas, pro­
duced symptoms due to their pressure 
on adjacent organs. Rarely, thrombosis 
occurs in the vascular spaces of the 
tumour and leads to severe abdominal
pain. Spontaneous rupture of the liver 
containing a hemangioma has been 
reported.
Advances in radiologic techniques 
now allow accurate diagnosis of he­
mangiomas of the liver. The proper 
management of these lesions is still 
not clear.
We have reviewed the experience 
with giant hemangiomas of the liver 
at the Montreal General Hospital, be­
tween 1968 and 1981.
Patients (Table I)
Our group consisted of six patients 
(four men. two women). Their ages 
ranged from 40 to 61 years. Two pa­
tients complained of right upper qua­
drant pain for which no other cause 
could be found. A large liver was 
found during the routine physical 
examination of one patient and fur­
ther investigations were carried out. 
In one man the presentation was dra­
matic; his hemangioma ruptured when 
he fell out of a third floor window. 
Two patients were found to have a 
hemangioma incidentally during lapa­
rotomy for gastric ulcer and gallblad­
der operations, respectively.
Three patients underwent extensive 
preoperative investigation. Prelimin­
ary diagnosis of the liver mass was 
metastatic carcinoma in one and 
echinococcal cyst in two, both of 
whom had a positive Casoni test. The 
true nature of the lesion was revealed 
by .arteriography in three and con­
firmed by computerized axial tomo­
graphy in two.
Radiologic Investigation
Three of the patients had preopera­
tive investigation for a mass in the
Table 1—Clinical Features
Patient
no. Sex Age, yr Presentation Size, cm Treatment
i M 44 Right upper 
quadrant pain
20 x 14 Left lobectomy
2 M 60 Post-traumatic
rupture
10 x 10 Partial right 
lobectomy
3 F 32 Incidental 
operative finding
7 x 7 Partial right 
lobectomy
4 F 40 Asymptomatic 10 x 8 Right lobectomy
5 M 58 Right upper 
quadrant pain
15 x 10 Left lobectomy
6 M 61 Incidental 
operative finding
14 x 10 Partial left 
lobectomy
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liver. Sulfur colloid liver scans showed 
the extent and location of the lesions. 
An angiogram showed a typical pic­
ture. In two patients the vascular 
spaces filled during the arterial phase 
and dense accumulation of contrast 
material persisted well into the venous 
phase. The lesions, characteristically, 
filled directly from normal-sized intra- 
hepatic arterial branches, as described 
in previous reports.6 In the third pa­
tient severe stenosis at the origin of 
the celiac axis prevented selective
FIG . 1— Patient 4. Arteriogram shows 
filling of vascular spaces during arterial 
phase. Left hepatic artery arises from 
left gastric artery. Area of hemangioma 
is indicated by arrows.
catheterization so the lesion could not 
be demonstrated. Arteriography car­
ried out before resection clearly out­
lined the arterial anatomy. In the case 
illustrated in Fig. 1 (patient 4 in Table
1) , the left hepatic artery originated 
from the left gastric artery. In the 
other patient subselective right and 
left hepatic arteriography showed the 
precise location and blood supply of 
the lesion in the left lobe.
The pattern of contrast accumula­
tion in the hemangioma is reflected 
by computerized axial tomography; 
with infusion, and sequential timed 
scans over several minutes, opacifica­
tion occurred initially in the periphery 
with a gradual increase in density 
towards the centre of the lesion (Fig.
2)  .
Pathologic Features
The six hemangiomas were similar 
in structure. They appeared irregularly 
loculated and dark red beneath the 
liver capsule and varied in greatest 
dimension from 7 to 20 cm. Multi­
focal, yellowish areas of organizing 
thrombus were sometimes seen on the 
sectioned surface. Microscopically, 
the hemangiomas had a sponge-like 
appearance with blood spaces sepa­
rated by fine fibrous septae lined by
FIG . 2— Patient 4. Computerized axial tomograms. (A) Preinfusion scan shows 
large hypodense lesion in right lobe. H =hcm angiom a. (B) Infusion, early scan, 
shows increased density at periphery. (C) Infusion, after several minutes, shows 
further filling of lesion from periphery towards centre of lesion. (D) A fter right 
hepatic lobectomy, bowel is located between abdominal wall and remainder of liver. 
Left lobe of liver has undergone considerable hypertrophy.
endothelium (Fig. 3). The tumours ex­
tended irregularly into the adjacent 
liver which did not show distortion 
by compression or pseudocapsule for­
mation. At the edge of the lesion, iso­
lated blood lakes were often seen in 
the hepatic parenchyma, sometimes 
communicating with ectatic sinusoids 
in association with atrophy of the 
liver cells (Fig. 4). Large arteries and 
veins were often present in adjacent 
liver. Old and recent thrombosis, with 
organization and fibrosis, was found 
in every case.
Operation
Hemangiomas of the liver may be 
resected by wedge excision, partial re­
section of the involved lobe or formal 
excision of a complete anatomical 
lobe. The operation required is de­
termined by the anatomical character­
istics of the individual lesion. Formal 
lobectomy should only be done for 
giant lesions replacing an entire lobe 
or for multiple lesions confined to one 
lobe. Three of our patients required 
formal lobectomy; the other three 
were treated by partial lobectomy. 
Two patients, who had left lobec­
tomies, also had single small heman­
giomas in the right lobe. Twelve-year 
follow-up by repeat liver scans in one 
of these two patients has shown no 
change in the size of the residual le­
sion.
Discussion
Cavernous hemangioma of the liver 
is discovered at autopsy in about 5% 
of cases1-3 and in about 10% of these 
there are multiple hemangiomas. They 
are considered to be vascular hamar­
tomas rather than true neoplasms.3 Al­
though it is uncertain whether these 
lesions are congenital or acquired, the 
structure, characterized by the pres­
ence of irregular blood lakes in ad­
jacent liver parenchyma and the ab­
sence of a capsule, suggests that giant 
hemangiomas slowly expand by incor­
porating and modifying liver sinu­
soids. As the slow enlargement occurs, 
there is often an associated central 
and subcapsular thrombosis followed 
by fibrosis of vascular channels.
Hemangiomas larger than 4 cm 
are said to be symptomatic,5 but only 
two of our patients complained of 
right upper quadrant pain. The pain 
may be caused by thrombosis affect­
ing the surface of the liver with asso­
ciated focal fibrinous serositis. Pain 
and hepatomegaly could also be ex­
plained by the gradual enlargement of 
the tumour with compression of ad­
jacent organs, such as the gallbladder 
and stomach. Liver function tests are
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not helpful in making the diagnosis. 
Other tests may be misleading; a false­
positive Casoni reaction incorrectly 
suggested an echinococcal cyst in two of our patients. The nonspecificity of 
this test has been described previous­
ly . 7-8 Plain roentgenograms were not helpful in our patients. Calcification 
in the region of the liver may be seen 
in some cases.4 Radionuclide scanning and ultrasonography cannot reliably 
distinguish giant hemangiomas from 
secondary carcinoma; this is especially 
so when the hemangioma is multifo­
cal. 2-910Arteriographic findings were char­
acteristic in three of our patients; ves­
sels of normal size were displaced by 
the lesion . 6-11-12 There were no arterio­
venous malformations, and prominent 
lakes containing contrast material per­
sisted into the venous phase.The infusion computerized axial to­
mogram showed early peripheral opa­
cification and late filling of the central 
area. This test may replace all invasive 
tests in the future as it is quite specific and is associated with minimal mor­
bidity. 13,14Laparoscopy was not carried out in 
any of our patients. It is diagnostic if 
the tumour is situated in the periphery 
of the liver. 14Liver biopsy should not be done 
because of the danger of hemorrhage 
from the tumour. 9
FIG. 3—Subcapsular hemangioma of liver. Vascular spaces are separated by fibrous septae (hematoxylin and eosin, reduced by 57% from x  1000).
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FIG. 4—Periphery of hemangioma. Liver parenchymal cells (P) show com­pression atrophy as enlarged sinusoids (S) appear to be incorporated into heman­gioma (hematoxylin and eosin, reduced by 57% from X975).
The need for therapy has not been 
clearly defined or objectively studied. 
Operation is advocated for large, re­
sectable lesions; 15,16 the danger of 
traumatic rupture and previously de­scribed cases of spontaneous rupture17 
lend support to this policy. The true 
risk of rupture must be low, however, since only a small number of cases 
have been reported in the literature.
Radiotherapy has been recom­
mended for lesions that are not re­
sectable and appears to have some 
value. 18
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available in boxes of 15 single-dose packets.
METAMUCIL Powder-contains dietary fiber (a natural, glu­
ten-free grain substance) derived from the refined husk of 
the psyllium  seed (Plantago ovata). Each rounded tea­
spoonful of buff-coloured powder (6.1 g of powder contain­
ing approximately 3.0g of psyllium hydrophilic mucilloid) 
contains 38% sucrose and 1 2% hydrous dextrose, has no 
added sodium and furnishes 12 ca lo ries. A va ilab le  in 
170g, 340g and 600 g containers. Single-dose packets are 
available to hospitals in boxes of 100.
Searle Pharmaceuticals, a Division of
G.D. Searle & Co. of Canada, Limited  “
400 Iroquois Shore Road P A A B
Oakville, Ontario r r p p
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A CASE
FOR METAMUCIL:
"THE POST-SURGICAL 
(CONVALESCING) PATIENT"
ETIOLOGY OF CONSTIPATION
• Lack of exercise -  reduced muscle tone
• Drug induced — narcotics, analgesics
• Disrupted bowel habits
• Voluntary avoidance of defecation —
(e.g. rectal surgery)
Leading to
IRREGULAR BOWEL FUNCTION
• Non-system ic action
• Does not interfere with normal digestive processes
(e.g. the absorption of essential nutrients, vitamins, 
or drugs) 4.
* • Does not encourage a "lazy bowel" or 
lead to laxative dependency -  can be 
used long term !
• Causes no "embarrassing*' urgency
• Provides natural source, 
water-absorbing fibre which produces 
bulk in the colon and
HELPS NORMALIZE 
BOWEL IRREGULARITY.
i§
Available in unflavoured Powder or effervescent, low-calorie 
Instant Mix (lemon-lime or orange flavour)
CA
SE 8
Acute Inflammation of Pancreatic Tissue 
in a Meckel’s Diverticulum
Robert H. T aylor, md, cm , frcs[c] and David A. Ow en, mb, b ch, mrc path, frcp[c]
The authors report what they believe 
is the first report in the English 
literature of acute inflammation of 
ectopic pancreatic tissue in a 
Meckel's diverticulum. A 29-year-old 
man presented with acute abdominal 
pain and a clinical diagnosis of 
acute appendicitis was made. 
Laparotomy revealed a normal 
appendix and a Meckel’s diverticulum 
with gross inflammation at the 
distal end. Microscopic examination 
showed acute inflammation limited 
to ectopic pancreatic tissue in the wall 
of the diverticulum. Fat necrosis 
was present. The possible patho­
physiologic mechanisms are discussed.
Les auteurs signalent ce qu'ils croient 
etre le premier rapport dans la 
litterature de langue anglaise d'une 
inflammation aigue de tissu 
pancreatique ectopique dans un 
diverticule de Meckel. Un homme de 
29 ans a ete vu souffrant de douleur 
abdominale aigue; un diagnostique 
clinique d’appendicite aigue fut pose.
A la laparotomie, I'appendice etait 
normal mais on observait un diverticule 
de Meckel avec inflammation marquee 
de la partie distale. L’examen 
microscopique revela une inflammation 
aigue limitee a du tissu pancreatique 
dans la paroi du diverticule. Une 
adiponecrose etait presente. Les 
mecanismes physiopathologiques 
possibles sont discutes.
Meckel’s diverticulum is reported to 
be present in about 2% of individ­
uals.1 The majority of these individuals 
are asymptomatic, but, occasionally, 
complications occur and make opera­
tion necessary. Such complications in­
clude hemorrhage, intussusception, di­
verticulitis, obstruction and perfora­
tion.2’3 The diverticulum can also be 
the site of a neoplasm or form a com­
ponent of a hernia.4,5
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Meckel’s diverticula are reported to 
contain ectopic pancreatic tissue in 
from 1% to 3% of cases studied.5,6 
Acute inflammation localized to the 
ectopic pancreatic tissue of such a 
diverticulum and giving rise to acute 
abdominal symptoms has not pre­
viously been reported in the English 
literature.
Case Report
A 29-year-old man presented with a 48-hour history of diffuse abdominal pain. Several hours before presenta­tion, the pain localized to the right lower abdomen and became more severe. He had anorexia, mild nausea and loose stools. There was no history of gastro­intestinal problems. He was a well-nour­ished young man. He was afebrile and his vital signs were normal. Abdominal examination revealed a slight increase in bowel sounds and marked rebound ten­derness in the lower abdomen, maximal just medial to McBurney’s point. Rectal examination gave negative results. His hemoglobin value was 15.9 g/dl and the leukocyte count 12.6 X 109/l with a slight shift to the left. Urine specific gravity was 1.027 and urinalysis showed trace ketones. Serum and urine amylase levels were not measured. A diagnosis of acute appendicitis was made.Laparotomy through a lower vertical incision revealed a normal appendix. On the antimesenteric border of the ileum, 60 cm proximal to the ileocecal junction, there was a diverticulum 4 cm long and with a narrow base. The apex of the diverticulum was swollen into an in­flamed, edematous, yellowish “knob”. The base of the diverticulum and adja­cent ileum were normal and there were no enlarged lymph nodes. The narrow base was crushed and ligated and the diverticulum excised; the stump was in- vaginated with a pursestring suture. The patient made a smooth recovery.
Microscopic Findings
The diverticulum was lined ex­
clusively by mucosa of small bowel 
type. No patches of gastric mucosa 
of either antral or acid-secreting type 
were noted and there was no evidence 
of mucosal inflammation or ulcera­
tion. The wall of the diverticulum 
showed a well-defined submucosa and 
two layers of muscularis propria. The 
overall structure was thus that of a 
congenital diverticulum (Meckel’s di­
verticulum).
Sections through the yellowish area 
at the tip showed acute inflammation
and fat necrosis external to the mus­
cularis propria (Figs. 1 and 2). This 
was associated with recognizable pan­
creatic tissue (Fig. 3). As is usual in 
acute pancreatitis the ductules and 
islands of Langerhans were more 
prominent than the acinic tissue, 
which was largely autodigested.
The microscopic appearances there­
fore were identical with those of acute 
pancreatitis seen in the normally situ­
ated pancreas. These changes were not 
secondary to luminal diverticular in­
flammation.
Discussion
Ectopic pancreatic tissue (pancrea­
tic heterotopia, aberrant pancreas, ac­
cessory pancreas) has been found in 
a variety of gastrointestinal organs: 
esophagus, stomach, duodenum, com­
mon bile duct, gallbladder, jejunum, 
ileum, Meckel’s diverticulum and 
within the mesentery.7’9 Such tissue 
contains all the elements and architec­
ture of the pancreas itself —  exocrine 
cells arranged into acini, ductules 
and ducts entering onto the mucosal 
surface of the organ and islands 
of Langerhans with measurable endo­
crine function.9’11 Why this displaced
FIG. 1— Apex of diverticulum. Nor­mal ileal mucosa (top). Acute inflamma­tory reaction in subserosal adipose tissue (bottom) (hematoxylin and eosin, re­duced by 46% from x 4 0 ).
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mation (including fat necrosis and 
foreign-body reaction) in an omphalo­
mesenteric cyst of the anterior abdom­
inal wall of a 22-year-old man.
Meckel’s diverticulitis is not rare. 
However, what makes our case unique 
is the fact that the ileal mucosa of 
the diverticulum was normal and not 
involved in the inflammatory process. 
The inflammation was limited to the 
ectopic pancreatic tissue and there 
was adjacent fat necrosis.
In considering the possible causes 
of the acute pancreatitis, there are 
only two reasonable explanations: ob­
struction and ischemia. Filling of the 
mouth of the diverticulum by a food 
mass could cause obstruction to the 
secretion of the pancreatic tissue and 
inspissation leading to inflammation. 
If this were the case, one might have 
expected the ileal mucosa also to be 
involved. An ischemic role in the 
pathophysiology is plausible, particu­
larly if there was an adhesion band 
that might cause torsion or kinking. 
However, no such band was present 
and the patient had never been oper­
ated on.
Whatever the cause of the pancrea­
titis in this unique case, it was clearly 
sufficiently severe to cause an acute 
abdominal condition necessitating 
emergency surgical intervention.
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tissue is found in these ectopic loca­
tions is not known but the two most 
commonly held theories are, first, that 
of lateral budding of the rudimentary 
pancreatic ducts as they penetrate the 
intestinal wall (tissue is separated, 
carried along the length of the gastro­
intestinal tract and subsequently 
grows) and, second, of de novo forma­
tion, since the embryonic digestive 
tube is pluripotential and capable of 
forming any of the accessory digestive 
organs. Neither theory, by itself, satis­
factorily explains the widespread and 
specific locations.
Such ectopic tissue has been found 
capable of undergoing all of the path­
ologic changes seen in the pancreas 
itself: benign and malignant neoplasms
of both exocrine and endocrine tissue 
have been reported, and acute and 
chronic inflammation including cyst 
formation has also been docu­
mented.911 Even cystic fibrosis has 
been found in aberrant pancreatic tis­
sue in a patient with this disease.10 All 
reported cases of inflammation in ec­
topic pancreas have occurred in struc­
tures adjacent to the pancreas itself — 
stomach, duodenum, common bile 
duct and transverse mesocolon. In 
some of these cases, the main gland it­
self was also involved. Pancreatitis has 
never been documented as occurring 
in ectopic pancreatic tissue of the jeju­
num or ileum, although, in 1946, Bar­
bosa and colleagues9 reported a case 
of pancreatic heterotopia with inflam­
FIG. 2—Edge of inflammatory mass shows fat necrosis (bottom right) (hema­
toxylin and eosin, reduced by 25% from x 40).
FIG. 3—Fat necrosis (left) associated with surviving pancreatic ductules (top) and 
island of Langerhans (right) (hematoxylin and eosin, reduced by 25% from x  100).
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Traumatic Diaphragmatic Hernias 
a Report of 19 Cases
F ernando  de  O liv eir a , m d , F ern ando  J. O liveira , m d  and
From an analysis of 19 patients 
with traumatic diaphragmatic hernias 
with respect to the type of injury, 
associated injuries, clinical and 
radiologic features, diagnosis, surgical 
management and causes of death 
and from a review of the literature, 
the authors draw a number of 
conclusions.
1. Careful clinical examination 
coupled with an accurate interpretation 
of the roentgenograms should detect 
most cases of traumatic rupture
of the diaphragm.
2. Impairment of respiratory 
function, possibility of strangulation 
and incarceration of the abdominal 
viscera demand early repair.
3. The choice of incision and 
approach depends on the stage at 
which the rupture is recognized 
(early or late), the site of rupture and 
the associated injuries.
4. Careful assessment of respiratory 
function should be made in order
to prevent postoperative complications; 
in some cases respiration must be 
assisted.
5. Although the mortality in 
patients with traumatic diaphragmatic 
rupture is still relatively high,
the deaths should not be related 
to the rupture per se, or to its 
repair, but rather to the associated 
injuries.
A partir de I'etude de 19 patients 
qui avaient une hernie diaphragmatique 
traumatique et qui ont ete analyses 
par rapport aux types de blessures, 
aux lesions associees, aux carac- 
teristiques cliniques et radiologiques, 
au diagnostic, au traitement chirurgical 
et aux causes de deces, ainsi que 
d'uno revue de la literature, les 
auteurs tirent plusieurs conclusions.
1. Un examen clinique minutieux 
associe a une interpretation precise 
des radiographies devraient
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permettre de deceler la plupart 
des cas de rupture traumatique 
du diaphragme.
2. Une atteinte de la fonction 
respiratoire et la possibility d’un 
etranglement des visceres abdominaux 
commandent une reparation immediate.
3. Le choix de I’incision et de 
I'abord chirurgical depend du stade 
atteint lors de la reconnaissance
de la rupture (precoce ou tardif), de la 
localisation de la rupture et des 
blessures associees.
4. L'evaluation minutieuse de la 
fonction respiratoire est de mise
si Ton veut prevenir les complications 
postoperatoires; dans certains cas, 
la respiration doit etre assistee.
5. Bien que la mortality chez les 
patients souffrant d’hernie 
diaphragmatique traumatique 
demeure relativement elevee, les 
deces ne devraient pas etre 
causes par rupture du diaphragme 
ou par sa reparation, mais plutot 
par les blessures associees.
Diaphragmatic hernias due to trauma 
have been seen much more frequently 
in the last two decades because the 
number of road and work accidents
Table l-Hern iated Viscera
Herniated organ No. of cases
Stomach 15
Spleen 8
Transverse colon 6
Liver 3
Jejunum and ileum 2
Greater omentum 2
Table I I - Associated Lesions
Associated lesion No. of cases
Spleen 9
Colon 4
Liver 2
Stomach 2
Mesentery 1
Pancreas 1
Ileum 1
Lung 3
Extremities 5
Ribs 5
Pelvis 2
Skull 2
A l b e r t o  Q u e ir o s , md
has increased. The purpose of this 
paper is to report our experience with 
traumatic diaphragmatic hernias, to 
discuss the most important diagnostic 
aspects and to consider the surgical 
management.
Patients and Findings
Nineteen patients with traumatic 
diaphragmatic hernias were treated at 
the University Hospital of Coimbra 
between Jan. 1, 1970 and Dec. 31, 
1979. There were 17 males and 2 
females. Their ages ranged from 5 to 
81 years.
In 17 patients the rupture was 
caused by road accidents, 1 patient 
had a fall from a great height and the 
last patient had an accident with a 
gun.
The diagnosis was made immediate­
ly following injury in 17, but in 2 
it was delayed 5 and 20 years respec­
tively.
The symptoms were abdominal in 
nine patients and thoracic in eight. In 
two others respiratory insufficiency 
was the most serious symptom.
In 11 patients paracentesis or peri­
toneal lavage, or both, showed a he- 
moperitoneum. Eight patients arrived 
at the hospital in a state of shock.
Plain films of the chest suggested 
traumatic diaphragmatic hernia in 13 
patients; in 12 of them there was a 
pattern of intestinal air or fluid in 
the chest, while in the other exagger­
ated elevation of the right hemidia- 
phragm was observed. Confirmation 
was obtained in five patients from 
contrast roentgenograms. In the re­
maining six patients the diaphragmatic 
rupture was found only at operation, 
because it was masked by other serious 
injuries.
There were no instances of bilateral 
rupture. Sixteen patients had a left­
sided tear while 3 had rupture of the 
right side. The size of the tears varied 
between 5 and 10 cm in 6 patients 
and was longer than 10 cm in 13.
The most frequently herniated or­
gans were the stomach (15 times) and 
the spleen (8 times) (Table I).
Associated injuries were frequent 
(Table II), occurring in 17 patients. In 
nine the injuries were limited to the 
abdomen (Table III).
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The interval between the accident 
and operation ranged from a few 
hours to 20 years. Of the 19 patients, 
14 were operated upon within the first 
24 hours; 3 were operated upon be­
tween 24 and 72 hours and in the 
other two the operation was per­
formed 5 and 20 years respectively 
after injury, when the diagnosis was 
made. The surgical approach in 12 
patients wqs by laparotomy; in 5 pa­
tients a thoracoabdominal approach 
was,necessary and in 2 a thoracotomy 
was performed.
Five patients (26.3%) in this series 
died (Table IV). The other 14 patients 
have been followed up regularly from 
1 to 10 years postoperatively; all are 
alive and have no symptoms.
Discussion
In the most recently reported 
series,1-4 as in ours, road accidents 
were the most frequent cause of trau­
matic rupture of the diaphragm. Indus­
trial accidents and sports were next in 
frequency.1"* In our series one rupture 
was caused by a bullet.
The side of the rupture is more 
commonly the left.1"3,5,6 because the 
right hemidiaphragm is protected by 
the liven It was also demonstrated by 
Bekassy and associates1 that the right 
hemidiaphragm is more resistant to 
pressure than the left.
Diagnosis
The diagnosis is difficult because
Table Ill-Associated Injury
Site of injury No. of cases
Abdomen alone 9
Abdomen + thorax 3
Abdomen + extremities 2
Abdomen + thorax + skull 
Abdomen + thorax
1
+ extremities 
Abdomen + extremities
2
+ pelvis
Abdomen + skull
1
+ extremities + pelvis 1
the patients generally have multiple 
associated injuries, masking the clin­
ical picture of diaphragmatic rupture. 
In our series only two patients had 
an isolated rupture.
The importance of early diagnosis 
as well as early repair has frequently 
been stressed.1-4'7 First, diaphragmatic 
rupture greatly impairs respiratory 
function;7 herniated viscera displace 
and compress the lung, leading to ate­
lectasis and hypoxia. Pneumonia, 
bronchietasis and lung abscesses may 
follow. Second, displacement of the 
mediastinum to the opposite side, par­
ticularly in patients with a consider­
able herniation of viscera, may inter­
fere with cardiac function. Finally, in­
carceration or strangulation of viscera 
may occur. Carter and Giuseffi8 re­
ported that 90% of strangulated dia­
phragmatic hernias are traumatic in 
origin.
When the possibility of a traumatic 
rupture of the diaphragm is high, we 
believe the diagnosis can be established 
preoperatively through careful clinical 
examination and radiologic study of 
the chest in frontal and lateral pro­
jections.
The characteristic symptoms of dia­
phragmatic injury, such as phrenic ex­
acerbation, hiccups and pain in the 
left shoulder, are seldom encountered. 
But, on initial examination, the fol­
lowing are suggestive: (a) the site of 
injury, (b) pain in the lower chest,
(c) abdominal paradoxical respiration,
(d) a percussion splash or bowel 
sounds in the chest and (e) dyspnea 
(polypneic type) with cyanosis.
On some chest roentgenograms 
clear signs of diaphragmatic rupture, 
especially those that show a large hy­
pertransparency, are found. However, 
the signs we find more frequent­
ly are those of atelectasis or hemo­
thorax. These signs, associated with 
the clinical picture, should make us 
suspicious and should lead to the diag­
nosis of traumatic diaphragmatic her­
nia. Confirmation of diagnosis is ob­
tained by roentgenographic study of 
the digestive tract.
In our series, the chest film was 
considered normal in 31.5% of the 
patients. This percentage is similar to 
that presented by Wise and associates9 
(37.5%) and by Freeman and Fischer5 
(33%) but it is rather greater than 
that found by MacCune and asso­
ciates3 (11%). More critical evaluation 
of the films may lower the margin of 
error and bring us closer to the values 
reported by MacCune and colleagues.
Treatment
The treatment of traumatic dia­
phragmatic hernia is exclusively sur­
gical. The patient should be operated 
upon as soon as possible; delay in 
making a diagnosis and undertaking 
treatment increases mortality. How­
ever, the controversial points are the 
choices of incision and approach. The 
types of incision and approach chosen 
vary with the stage at which the rup­
ture is recognized (early or late), the 
side of the rupture and with the asso­
ciated injuries (particularly abdom­
inal).
When the rupture is recognized 
early, when it is on the left side and 
intra-abdominal injuries are suspected, 
laparotomy should be used. It was 
our choice in 14 of the 17 patients. 
When intrathoracic injuries exist, thor­
acotomy associated with a laparotomy 
is the approach necessary. In three 
patients we had to use this combined 
approach. In this case we prefer to 
use separate incisions (laparotomy 
plus thoracotomy) rather than a con­
tinuous incision (thoracophrenolap- 
arotomy). For right-sided ruptures, 
right thoracotomy is preferable. For 
our three patients who had a right 
hemidiaphragmatic rupture we used a 
combined approach: laparotomy plus 
thoracotomy, in two patients because 
the rupture had not been diagnosed 
preoperatively, and in the other be­
cause the patient had associated intra­
abdominal injuries. When the ruptures 
are recognized late, as happened in 
two of our patients, thoracotomy is 
the approach we prefer. In these cases,
Table IV Causes of Death (Five Patients)
Age, yr
Interval between 
trauma and operation, h
Site of
associated injury
Time of death 
after operation, d Cause
45 4 Skull + lungs 1 Brain damage
80 6 Spleen + extremities
+ pelvis + skull 1 Brain damage
24 3 Spleen + colon + lungs 1 Cardiorespiratory
insufficiency
50 72 Liver + extremities 4 Cardiorespiratory
insufficiency
33 6 Mesentery + ileum + colon 14 Pulmonary embolism
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Sternectomie partielle pour tumeur metastatique avec 
reconstruction par plaque de methylmethacrylate
Y. GLOCK, MD,* J. HERREROS, MD,t V. EcHAVE, MD, FRCS[c]t ET F.J. T eijeira , m d §
Les auteurs rapportent un cas de 
sternectomie partielle pour carcinome 
thyroi'dien metastatique. L’exerese 
en monobloc a ete suivie d’une 
reconstruction par plaque moulee de 
methylmethacrylate.
Les tumeurs sternales sont rares 
et I'operation a visees curatives 
des metastases ne se justifie que si 
I’etat general du patient le permet, 
et qu’il s'agit d’une metastase unique 
dont le cancer primaire a subi une 
cure consideree comme radicale.
La chirurgie d'exerese large et en 
monobloc repose sur une exploration 
preoperatoire oil la tomographie axiale 
sur ordinateur a une place 
importante pour apprecier I'etendue 
de la tumeur, et sur un contrdle 
extemporane des marges de section.
La reconstruction par methyl­
methacrylate presente I’interet d'un 
montage rigide, par une substance 
modelable extemporanement, 
semi-transparente aux rayons X, 
inerte et bien toleree par I'organisme.
En position sternale haute, le 
moulage de methylmethacrylate 
contribue a stabiliser la ceinture 
scapulaire et assure une protection des 
plans mediastinaux sous-jacents avec, 
accessoirement, un effet esthetique 
acceptable.
A case of partial sternectomy for 
metastatic thyroid carcinoma is 
reported. En bloc excision was 
followed by reconstruction using a 
molded plate of methylmethacrylate.
Sternal tumours are rare and 
operations for cure of metastases 
are justified only if the general 
condition of the patient permits and
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in the patient with a single metastasis 
whose primary cancer operation 
was a radical one.
Extensive en bloc excision is based 
on preoperative investigation in which 
computerized axial tomography 
has an important place in delineating 
the extent of the tumour and providing 
accurate knowledge of the margins 
of the section.
Reconstruction with methyl­
methacrylate allows a rigid setting 
with a material that can be molded, 
is radiolucent, inert and well tolerated. 
In the upper sternum it contributes 
to the stability of the shoulder girdle 
and protects the underlying mediastinal 
structures in a cosmetically 
acceptable way.
Si les tumeurs localisees au thorax 
osseux sont rares, cedes a topographie 
sternales sont exceptionnelles.1'8 Toute 
tumeur sternale doit etre consideree 
comme maligne jusqu’a preuve du 
contraire.1,4'8'10 Apres cure radicale du 
cancer primaire, la metastase, si elle 
est unique, se traite chirurgicale- 
ment.11"14 Le bilan d’extension tumoral 
s’est enrichi recemment de l’examen 
par tomographie axiale sur ordinateur, 
qui permet d’evaluer la profondeur 
d'envahissement. Le diagnostic patho- 
logique doit etre fait chirurgicalement 
lors de 1’exerese qui est toujours large 
et en monobloc.5'11,1419 Des lors, se 
pose le probleme de la reconstruction 
parietale. Dans les sternectomies par- 
tielles, la rigidite thoracique n’est pas 
compromise;4,5,8’9’11,12’19 toutefois, le 
comblement de la perte de substance 
nous apparait justifie tant pour recons- 
tituer un plan profond rigide capable 
de proteger le mediastin18 que pour 
stabiliser la ceinture scapulaire. L ’effet 
esthetique est obtenu accessoirement. 
A cette fin, le methylmethacrylate est 
un materiel adequat.15,19,20 Nous decri- 
vons un cas de sternectomie partielle 
pour une lesion metastatique unique 
d’un carcinome thyroi’dien, suivie 
d’une reconstruction par plaque mo- 
delee de methylmethacrylate.
Observation
Une femme, agee de 64 ans, est 
porteuse d’une neoplasie thyro'idienne 
folliculopapillaire, decouverte a la
suite de Installation d’une paralysie 
recidivante avec dysphonie. II s’agit 
d’une masse thyro'idienne dominant a 
gauche, multinodulaire, fixee, et lege- 
rement douloureuse. Le bilan biolo- 
gique revele une glande euthyro'i- 
dienne et la scintigraphie montre une 
heterogeneite de fixation avec des 
zones froides au niveau du lobe gau­
che. La recherche d’anticorps antithy- 
roidiens est negative. Le diagnostic 
pathologique ayant montre la nature 
folliculopapillaire du carcinome et de- 
vant un envahissement important au 
niveau des cartilages larynges, on rea­
lise une laryngectomie totale avec evi- 
demment jugulo-carotidien et thyro'i- 
dectomie totale. Les suites sont sim­
ples. On decouvre, au decours du bilan 
d’extension, une tumeur situee au ni­
veau du manubrium sternal. C ’est pour 
l’ablation de cette tumeur que la ma- 
lade est confiee au departement de 
chirurgie cardiovasculaire et thora­
cique.
A l’entree, la malade presente une 
cicatrice arciforme cervicale en rap­
port avec la laryngectomie et la thy- 
roi'dectomie. L ’orifice de tracheosto- 
mie permanente est situe un travers 
de doigt au dessus du manubrium ster­
nal. La cicatrice est nette. Clinique- 
ment, la malade est en bon etat gene­
ral. L ’examen met en evidence une 
masse d’environ 8 cm de diametre 
proeminente d’environ 2 cm sous la 
peau (fig. la). Cette masse est molle, 
pulsatile, sensible a la palpation, sans 
thrill, ni souffle. La peau en regard 
est rouge et un peu inflammatoire. II 
n’y a pas d’adenopathie sus-clavicu- 
laire. La masse est situee surtout du 
cote gauche du manubrium. Le reste 
de l’examen est negatif, l’auscultation 
cardiopulmonaire est normale, l’aus- 
cultation de la masse n’objective pas 
de souffle. Une scintigraphie thyro’i- 
dienne a l’iode-131, montre qu’il n’y 
a pas de captation d’iode au niveau 
de la masse manubriale. Par contre, 
la scintigraphie au technetium-99m 
montre une hyperfixation au niveau 
de la portion superieure du sternum. 
Les coupes tomographiques standards 
du sternum (fig. 2) revelent une large 
lesion osteolytique soufflant l’os, af- 
fectant essentiellement la moitie su­
perieure et laterale gauche du manu­
brium et s’etendant jusqu’au niveau du
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cartilage sternocostal de la premiere 
cote gauche. L’extremite proximale de 
la clavicule est respectee. La tomogra- 
phie axiale du mediastin superieur et 
du cou confirme la presence de cette 
large lesion metastatique osteolytique 
du manubrium sternal (fig. 3). Elle 
permet de constater qu’il existe un bris 
de la corticale anterieure et poste- 
rieure. II y a peu de masse tumorale 
dans le mediastin anterieur en relation 
avec 1 os sternal. Devant la chirurgie 
radicale realisee au niveau cervical, il 
est decide, en l’absence d’autres me- 
tastases, de realiser une resection de 
la masse tumorale sternale avec re­
construction.
La patiente est placee en decubitus 
dorsal sous intubation par sonde 
armee au niveau de la tracheostomie, 
laquelle est separee du reste du champ 
operatoire par un Op-Site sterile. Le 
champ operatoire est large de fagon 
a englober les deux seins de la malade 
et a laisser toute la poitrine pour faire 
face au probleme de recouvrement 
cutane par d’eventuels lambeaux. L’in- 
cision est realisee de fagon a emporter 
en monobloc la peau et les tissus re- 
couvrant la tumeur. II s’agit d’une in­
cision arciforme, concave en haut, 
passant au pole superieur de la tumeur 
et allant jusqu’au tiers moyen des cla- 
vicules droite et gauche. Branche sur 
cette premiere incision, on realise une 
incision concave vers le haut faisant 
le tour de la masse tumorale et em- 
portant une surface de 8 cm2 de peau. 
A la partie inferieure de cette incision, 
est branchee une incision verticale me- 
diane. On decolle deux lambeaux late- 
raux emportant la peau, le tissu sous- 
cutane, l’aponevrose et le muscle 
pectoral. Ces lambeaux sont sains bien 
vascularises; ils sont chacun reclines 
vers la droite et vers la gauche. Le 
plastron sternal apparait; un lambeau 
superieur est decline vers le haut, em­
portant la peau, le tissu sous-cutane, 
et les chefs d’insertion claviculaires et 
sternaux des muscles sternaux cleido- 
mastoi'diens droit et gauche. On fait 
un deperiostage de la clavicule au 
tiers moyen ainsi que de l’extremite 
de la premiere cote a droite et a 
gauche. Celles-ci sont sectionnees a la 
scie de Gigli. Le pole inferieur de la 
tumeur se situe 3 cm au dessus du 
bord superieur de la deuxieme cote 
et il est decide de la laisser en place. 
On disseque le deuxieme espace inter­
costal et une scie de Gigli est glissee 
sous le sternum de fagon a sectionner 
celui-ci transversalement. On controle 
les vaisseaux mammaires internes 
droits et gauches qui sont lies sous 
la zone de resection claviculaire. Le 
plan profond est libre de tout enva-
hissement mediastinal bien que la cor­
ticale posterieure soit effondree. Le 
fragment manubrial sternal emportant 
la premiere cote et le tiers interne de 
clavicule est enleve en monobloc. On 
constate que toutes les berges de la 
zone resequee sont libres d’envahisse- 
ment neoplasique. On se trouve alors 
en presence d’une perte de substance 
de la paroi thoracique mediane manu- 
brio-sternale de 18 X 20 cm a com- 
bler. A l’aide d’un fil d’acier, on rea­
lise d’abord l’osteosynthese de la cla­
vicule avec la premiere cote. On fait 
ensuite un moulage de methacrylate 
qui est modele de fagon a donner le 
relief d’une fourchette sternale cor- 
recte. Les berges de cette plaque ster­
nale synthetique sont modelees de 
fagon a s’arrimer sur la face externe 
de la clavicule, de la premiere cote, 
de la deuxieme cote et sur la table 
externe du corps sternal restant. La 
plaque de methacrylate est perforee 
d’une serie d’orifices destines a passer 
les fils d’acier qui sont successivement 
fixes au niveau de la clavicule, de la 
premiere cote, de la deuxieme cote 
et du corps sternal. Le montage realise
Fig. Ib
FIG. 1— (a) Preoperatoire: tumeur
sternale vue a jour frisant. (b) Postopera­
tive: cicatrice en Y avec bonne trophi- 
cite des lambeaux.
est solide (fig. 4). La plan de couver- 
ture est fait grace a la suture sur la 
ligne mediane, apres decollement des 
masses musculaires et aponevrotiques 
des grands pectoraux qui realisent un 
plan consistant et bien vascularise. Des 
points de rapprochement sont faits 
dans le tissu sous-cutane et un surjet 
sous-cuticulaire ferme l’incision cuta- 
nee sans tension. II est laisse en place 
un Hemovac retrosternal et presternal
FIG. 2— Incidences manubrio-sterna- 
les: metastase osteolytique.
FIG. 3— Coupe sternale et mediasti- 
nale a la tomographie axiale sur ordina- 
teur: envahissement sternal avec effon- 
drement des corticales anterieure et pos­
terieure. Le sternum est indique par la 
fleche.
FIG. 4— Radiographic postoperatoire: 
seuls se voient les fils d’acier fixant la 
plaque semi-transparente aux rayons X, 
aux berges osseuses.
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et on recouvre d’un pansement com- 
pressif. Au plan histologique, la masse 
tumorale est un carcinome folliculo- 
papillaire. Les suites operatoires sont 
simples. La malade est sur pied le 
lendemain de 1’intervention. Les drains 
sont enleves en 24 heures. La peau 
cicatrise sans probleme (fig. lb). La 
malade sort au lOe jour avec une re­
paration satisfaisante tant au plan de 
la stability sternale qu’au point de vue 
esthetique, sans depression liee a la 
perte de substance et avec un relief 
manubrial correct.
Discussion
Les tumeurs du thorax osseux sont 
rares. Elies represented moins de 1% 
de toutes les tumeurs malignes,13 et de 
7% a 8% des tumeurs osseuses.6'8 Les 
tumeurs sternales, quant a elles, comp- 
tent pour 3.7% a 15% des tumeurs 
thoraciques osseuses,2,6'8'21 mais pour 
seulement 0.6% a 0.9% de toutes les 
tumeurs osseuses.6,8 Les tumeurs meta- 
statiques du sternum dominent en fre­
quence1'13 et represented 39.8% des 
cas recenses par Kinsella et collabora- 
teurs5 (67 cas sur 168). L’origine thy- 
roi'dienne de la metastase sternale est 
retrouvee dans 34% des cas de Kin­
sella et collaborateurs5 (23 sur 67 cas). 
Le premier rapport est celui d’Olli- 
vier22 en 1868 qui soulignait le carac- 
tere pseudo-anevrismal de cette tu- 
meur.23 La premiere resection revient 
a von Eiselsberg en 1893.24
La symptomatologie associe de fa- 
$on constante le binome “tumeur, dou- 
leur”. Une croissance rapide plaide en 
faveur de la malignite.1,9 La douleur 
peut preceder de plusieurs mois la le­
sion osseuse decelable a la radiogra- 
phie.13 Ces signes peuvent neanmoins 
faire defaut.16 La caracteristique des 
metastases osseuses de la thyroide et 
des hypernephromes du rein est la 
pulsatilite.4’9,12,22,23 Au niveau sternal, 
la topographie de ces metastases est 
surtout manubriale5 bien que le cas 
de Baue11 necessita une resection ster­
nale totale du fait d’un envahissement 
du corps et du manubrium sternaux. 
La masse tumorale est molle et la 
pulsatilite ne s’accompagne pas de 
thrill ni de souffle. En plus du bilan 
radiologique standard et des tomogra­
phies sternales precisant l’importance 
de la lyse osseuse, certains auteurs 
preconisent l’angiographie globale et 
selective des arteres thyro’idiennes, 
mammaires internes et intercostales 
afin d’exclure un anevrisme aortique 
et d’apprecier l’origine de la vascula- 
risation en cas de tumeur vasculaire, 
et pour en preciser l’abord chirurgi- 
cal.10,25 La tomographie axiale sur
ordinateur nous est apparue tres utile 
pour apprecier l’envahissement des 
plans profonds. Son caractere non in- 
vasif et la fiabilite des images en font 
un examen de choix dans le bilan des 
tumeurs sternales.
Comme le note Campbell,14 l’indica- 
tion operatoire en matiere de meta­
stase repose, sur une bonne condition 
generate du patient, l’unicite de la 
metastase et la cure radicale du can­
cer primaire, et la possibility de rese- 
quer sans mortality prohibitive. Ces 
conditions etaient reunies chez notre 
patiente.
L’intervention comporte toujours 
deux temps operatoires: la resection 
suivie de la reconstruction.12,16 En 
ce qui a trait a la resection, l’unanimi- 
te est faite sur la necessity d’une exe- 
rese large, en monobloc, emportant 
tous les plans concernes par le proces­
sus tumoral. En cas de biopsie ou 
d’envahissement, la peau est excisee et 
les lambeaux conserves doivent etre 
viables. La presence d’un pathologiste 
s’impose afin de preciser l’integrite 
de la marge de resection en cours 
d’operation.5,6,9,10,12,14,16,25 Au niveau 
sternal, les cartilages costaux adja- 
cents sont a resequer ainsi que les tiers 
internes des clavicules en cas de tu­
meur manubriale.16
Le jugement du chirurgien ne doit 
pas etre defavorablement influence 
par la crainte de la perte de substance 
creee26 car une excision partielle n’est 
pas mieux que l’abstention.1
En matiere de sternectomie par­
tielle, la reconstruction ne s’impose 
pas, du fait de l’absence de trouble 
ventilatoire par instability, et une sim­
ple couverture musculo-cutanee peut 
suffire.5,8,9,22 Nous pensons toutefois 
que la creation d’un plan resistant 
de protection mediastinal16 et a visee 
esthetique est justifiee. Si la perte du 
support claviculaire est minimise par 
les insertions musculaires,11 il est sur 
que la reconstitution d’un “arc-bou­
tant anterieur” a la ceinture scapulaire 
evitera les genes fonctionnelles et les 
risques de lesions plexulaires.
Le materiel autogene a ete large- 
ment employe avec succes,2,5,12 mais 
les caracteristiques actuelles des mate- 
riaux prothetiques en font d’excellents 
substituts. En matiere de plastie ma­
nubriale, le choix d’un materiel rigide 
s’impose car, du fait de l’absence de 
mouvement sterno-costal au niveau de 
la premiere cote,14 on ne se heurte pas 
a l’inconvenient d’un materiel rigide 
fixe a une cote mobile, comme c’est 
le cas a l’etage du corps sternal. Le 
materiel de choix nous a paru etre le 
methylmethacrylate utilise par les neu- 
rochirurgiens pour les cranioplasties et
adopte par certains chirurgiens thora­
ciques.15,19,20 Facilement modelable en 
extemporane, a la mesure et a la 
forme de la perte de substance, ce 
materiel est inerte et offre une excel- 
lente tolerance biologique. Sa semi­
transparence aux rayons X n’hypothe- 
que pas les possibilites de surveillance 
radiologique des plans sous-jacents. 
Sa mise en place avec fixation par fils 
d’acier est facile.
Conclusions
Bien que la chirurgie des metastases 
sternales soit souvent palliative, elle 
peut neanmoins faire esperer des sur- 
vies de plusieurs annees.14 Une repara­
tion la plus anatomique possible s’im­
pose alors. L’observation rapportee il- 
lustre les possibilites d’exerese et de 
plastie des metastases uniques chez 
des malades en bon etat general qui 
ont subi une cure radicale de la tu­
meur primaire.
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Femoropopliteal Bypass:
Saphenous Vein and Expanded Polytetrafluoroethylene
Grafts
D.L. Wooster, md, frcs[c1,* J.L. Provan, md, frcs, frcs[c1, FACS,f S.G. Sojka , b sc* and
P.N. M adras, md, frcs[c]§
The patency of 181 saphenous vein 
and expanded polytetrafluoroethylene 
(PTFE) femoropopliteal bypass grafts 
was assessed during a follow-up that 
ranged from 1 to 53 months after 
operation. Significantly better patency 
(P <  0.05) was noted with saphenous 
vein (70%) than with PTFE (56%). 
Life-table analysis at 30 months 
demonstrated a cumulative patency of 
50% for saphenous vein grafts versus 
39% for PTFE, while at 53 months the 
rates were 4P% and 33% respectively. 
The PTFE gra . -nded to occlude 
earlier than sap 'ous vein grafts 
but after the initial year, both types 
of graft failed at a rate of about 
5% a year. Patency was similar in 
both groups when operation was 
performed for claudication, but for 
limb salvage operations saphenous
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vein patency was superior to PTFE. 
Although the groups were similar in 
constitution, a higher percentage of 
patients in the PTFE group had 
undergone previous vascular 
operations.
La permeabilite de 181 pontages 
femoro-poplites par greffe de veine 
saphene ou par greffon de poly­
tetrafluoroethylene expanse (PTFE) 
a ete evaluee au cours d’examens de 
surveillance qui se sont etales de 
1 a 53 mois apres I’operation. Une 
permeabilite significativement meilleure 
(P <  0.05) a ete observee avec les 
greffes de veines saphenes (70%) 
comparativement au PTFE (56%). 
L’analyse apres 30 mois a I’aide de 
tables actuarielles a demontre un taux 
cumulatif de permeabilite de 50% 
pour les greffes de saphenes contre 
39% pour le PTFE; apres 53 mois, 
les taux etaient de 46% et de 33% 
respectivement. Les greffons de PTFE 
avaient tendance a s'obstruer plus 
tot que les greffes de saphenes mais, 
apres la premiere annee, les deux 
types de greffons avait un meme taux 
d'echec d'environ 5% par annee. Dans 
les operations pour claudication, la 
permeabilite etait similaire pour les 
deux groupes, mais dans les 
interventions visant a sauver un 
membre, les greffes de veines 
saphenes etaient superieures au 
PTFE. Bien que les caracteristiques 
des deux groupes aient ete semblables, 
un plus fort pourcentage des patients 
du groupe PTFE avaient deja subi 
dans le passe des operations 
vasculaires.
Femoropopliteal bypass is frequently 
performed to relieve claudication, rest 
pain and threatened limb loss. The 
reversed saphenous vein is the stand­
ard against which newer graft mate­
rials are tested and remains the 
most satisfactory conduit. Grafts 
of expanded polytetrafluoroethylene 
(PTFE) (GORE-TEX; W.L. Gore & 
Associates, Flagstaff, Ariz.) have been 
advocated as the most satisfactory by­
pass if the saphenous vein is absent 
or inadequate for a femoropopliteal 
bypass.1'3
The following retrospective review 
o f our experience over a 3-year period 
compares the patency of the saph­
enous vein graft with PTFE and dem­
onstrates that PTFE is less than ideal 
for below-knee femoropopliteal by­
pass.
Patients
We reviewed the records o f 170 
patients who underwent femoropopli­
teal bypass during a 30-month period 
(January 1977 to July 1979) and were 
followed up between January 1977 
and December 1979. The results of 
bypass in 204 limbs were considered. 
However, 23 limbs in which composite 
grafts or grafts other than saphenous 
vein or PTFE were used were ex­
cluded. The results on the remaining 
181 limbs were analysed. The same 
181 grafts were also reassessed in May 
1981.
The groups were compared with re­
spect to age, indications for the pro­
cedure, previous vascular operations, 
inflow and outflow (run-off) status.
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patency and subsequent amputation 
up to December 1979. A random sub­
group defined the incidence of ciga­
rette smoking. Diabetes, coronary ar­
tery disease and cerebrovascular dis­
ease were not correlated in this study.
The indications for bypass were 
grouped as “claudication alone” or 
“limb salvage”, which included rest 
pain and gangrene. Bypass patency 
was determined by clinical and Dop­
pler assessment and in some cases 
defined by angiography regardless of 
the presence or absence of symptoms 
at follow-up. If a technical error was 
recognized and remedied within hours 
of the initial procedure and resulted 
in a viable graft, the graft was con­
sidered patent. Later occlusion treated 
by thrombectomy or graft revision, re­
gardless of outcome, was considered 
as a graft failure. If a patent graft 
resulted it was followed up as a new 
graft.
Inflow was assessed from the angio­
grams and was classified as “good’ 
if normal anatomy or minimal changes 
were identified or “poor” if marked 
stenosis or occlusion was noted. Run­
off was defined as “good” if two or 
three vessels were patent or “poor” 
if one small or no moderate-sized ves­
sels were identified on angiography.
Statistical analysis of the results 
was carried out using the unpaired 
Student’s t-test.
FIG. 1— Cumulative patency by life- 
table method to 48 months for long 
saphenous vein (solid line) and poiytetra- 
fluorocthylene grafts (broken line).
R esults
Four subgroups were identified on 
the basis of patency or occlusion of 
saphenous vein or PTFE femoropop- 
liteal bypass graft (Table I). These 
populations proved to be comparable. 
The mean age of the patients was 65 
years. Of a random subset of patients 
78% were smokers. Grafts had been 
placed previously in 38 (21%) of the 
181 limbs (Table I). Follow-up ranged 
from 1 to 53 months in both groups. 
Amputations resulted from 35 of the 
68 occluded bypasses (51.5%) with 
no significant difference noted be­
tween saphenous vein and PTFE 
grafts. No difference with respect to 
level of amputation was identified. 
One graft infection occurred in the 
PTFE group and two patients suf­
fered fatal arrhythmias in the peri­
operative period.
Significantly better (P < 0.05) pa­
tency was noted in the saphenous 
vein group for all bypasses as well 
as for distal (tibial) procedures (Table 
II). Overall patency for saphenous 
veins was 70% compared with 56% 
for the PTFE grafts. Life-table anal­
ysis demonstrated 50% cumulative pa­
tency for saphenous veins versus 39% 
for PTFE at 30 months. Results were 
somewhat better if analysed after ex­
clusion of those grafts that failed with­
in the first month (54% versus 45%). 
The saphenous vein bypass still was 
slightly superior. Follow-up to 53 
months demonstr i  a life-table cu­
mulative patenc; rate of 46.4% for 
saphenous vein grafts and 33.3% for
Table I I - Overall Patency Rates
Type of graft
All grafts, 
no. (%)*
Distal (tibial) 
grafts, no.
(%)*
Saphenous vein
Patent 59 (70) 6 (55)
Occluded 25 (30) 5 (45)
PTFE
Patent 54(56) 1 (14)
Occluded 43 (44) 6 (86)
'Saphenous vein vs PTFE = P <  0.05.
Table l-Saphenous Vein and Polytetrafluoroethylene (PTFE) Groups.
Relation of Patient Age, Previous Grafts, Indication for Operation and Run Off Status
Type of graft
Patient 
age, yr
No. of 
limbs 
previously 
grafted
Indication
Run-off
status
Mean Range Claudication Rest pain Good Poor
Saphenous vein
Patent (n =  59) 65 32-81 9 32 27 38 21
Occluded (n =  25) 65 49-86 2 10 15 18 7
PTFE
Patent (n =  54) 64 40-88 13 36 18 42 12
Occluded (n =  43) 65 44-84 14 16 27 22 21
PTFE (Fig. 1 shows the follow-up to 
48 months). Both saphenous vein 
and PTFE grafts showed occlusions 
throughout the study period. Polyte- 
trafluoroethylene grafts occluded ear­
lier than saphenous vein (52% versus 
72% patency at 6 months). After the 
initial year both grafts failed at a 
rate of 3% to 5% per year. Aggres­
sive attempts to maintain patency of 
PTFE grafts with thrombectomy in 
patients with good run-off and better 
prospects for rehabilitation resulted 
in 47 thrombectomies in 27 patients. 
Twelve patent grafts resulted after one 
to four thrombectomies, whereas 15 
remained occluded after 27 attempts 
at salvage (range 1 to 4). Occluded 
saphenous vein bypasses were gener­
ally not treated further unless limb loss 
threatened. In such cases a technically 
inadequate anastomosis was revised or 
a new graft of prosthetic material was 
used.
Although no difference in results 
with the two conduits was apparent 
when claudication was the indication 
for surgery, patients operated on to 
save the limb did better when saph­
enous vein was used (Table I). The 
run-off status did not affect patency 
in those who had a saphenous vein 
graft but those in the PTFE group 
with good run-off did better than 
those with poor run-off. Overall, the 
run-off status was comparable in the 
two groups. Inflow was comparable 
and did not determine patency in 
either group. Poor inflow was cor­
rected by aortofemoral bypass when 
necessary before the femoropopliteal 
bypass was carried out.
D iscussion
In general, an extended period of 
observation involving hundreds of 
cases is necessary to report on the 
merits of a particular prosthetic graft 
material. Various graft materials have 
shown promising results at 2 years 
only to fail later;2 therefore, we 
believe that at least 5 years are nec­
essary to assess a new graft accurate­
ly.3'4 Despite this, many reports have 
recently appeared describing patency 
rates of 58% to 88% with PTFE 
over short periods1'5 with minimal late 
failures. In a few reports610 the re­
sults were not as good, with 29% to 
52% patency and continued late fail­
ure. The data presented in our study 
shows rather poor patency (39% at 
30 months) for PTFE with ongoing 
late failures at a rate of 3% annually. 
Evans and associates11 found that most 
failures with PTFE occurred in the 
first 6 months and late failures at 
1% per month.
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Polytetrafluoroethylene has certain 
unique characteristics related to the 
arrangement of nodules and fibrils of 
Teflon. The graft is relatively resistant 
to thrombosis and develops a thin 
adherent neointima. It is resistant to 
kinking and compression.12 Apart 
from the material of the graft itself, 
at least three other major variables 
affect any interpretation of reports 
regarding the efficacy and reliability 
of the graft: (a) patient, (b) procedure 
and (c) reporting of the results.
•  Patient selection is an important 
determinant of overall results, since 
aggressive attempts to salvage limbs 
with severe advanced disease will re­
sult in poorer patency for any graft 
or technique. Associated conditions 
such as diabetes or smoking may sub­
stantially affect the outcome. Gener­
ally, severe signs and symptoms of 
advanced ischemia are associated with 
poorer patency rates13 and poor out­
flow status correlates with occlu­
sion,4’14 although not all reports sup­
port these findings.615 In this study 
patients with claudication did better 
than those whose limbs were threat­
ened, regardless of the type of graft 
used. In the latter setting the patency 
of saphenous veins was superior to
PTFE. Run-off status had a greater 
effect on patency in the PTFE than 
in the saphenous vein group. Doppler 
studies may help delineate those in 
whom graft patency could be ex­
pected. Without full documentation 
to allow comparison of patients, inter­
pretation of graft patency and com­
parison of various conduits will re­
main inexact.
•  Variation in technique of femo- 
ropopliteal bypass may have an im­
pact on overall success; however, for 
carefully performed operations the 
most important factor is how far dis- 
tally the anastomosis is carried out. 
Below-knee anastomoses do less well 
than above-knee7 and still more distal 
anastomoses are even less reliable.2 
In this study, 65% of distal grafts be­
came occluded. In the PTFE group, 
86% of the distal bypasses throm­
bosed. This is similar to the 79% fail­
ure rate reported by Suy and asso­
ciates.16 A second aspect of technique 
relates to aggressive thrombectomy or 
revision in failed bypasses. The results 
of this study may have been improved 
by more aggressive revision of failed 
bypasses as suggested by Veith and 
associates.17
•  The reporting of results varies
widely in different studies. Patency is 
often defined by palpable pulses, Dop­
pler studies or angiographic findings; 
however, some reports base patency 
on lack of symptoms or merely avoid­
ance of amputation.1 This wide range 
of criteria for patency certainly con­
founds efforts to compare studies; in­
deed, in this study not all patients with 
failed grafts showed symptoms and 
only 43% of those with occluded 
grafts underwent amputation. More­
over, some studies include as patent 
those grafts that were patent after 
thrombectomy for occlusion.3'8 In this 
study any occlusion that occurred 
after the first few hours constituted 
graft failure and a subsequently pa­
tent graft after thrombectomy was 
considered as a new graft for follow­
up. Such variations in definition may 
be more important to the overall re­
sults than the graft material itself.
Certain aspects of the timing of 
graft occlusion have been presented 
to support the relative value of a pros­
thesis. Those grafts that become oc­
cluded immediately after placement or 
within 3 months of operation may re­
flect technical errors2 whereas late oc­
clusions (after more than 24 months) 
may reflect distal progression of athe-
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rosclerosis.8 It has been suggested, 
therefore, that occlusions in the inter­
mediate range of follow-up more 
clearly relate to thrombogenicity and 
neointimal proliferation, with subse­
quent stasis resulting from the char­
acteristics of the graft itself.2’8 Those 
studies showing few or no occlusions 
after 6 months2,3 suggest that the flow 
characteristics of PTFE make for 
long-term patency. Other studies;*’6,8 
including our own, show occlusion 
even after 6 months; this may portend 
less than optimal patency for PTFE. 
However, on extended follow-up to 
53 months the patency of PTFE 
grafts parallels that obtained with 
saphenous vein.
In general, no report has been able 
to support the exclusive use of PTFE 
and, in view of the short duration of 
follow-up and multiplicity of factors 
mentioned, this material cannot be 
advanced as the conduit of choice if 
saphenous vein is available. Vein is 
much preferred for extended distal 
bypasses; PTFE should not be used 
electively in patients with claudication. 
Polytetrafluoroethylene may be used 
for limb salvage if a suitable vein is 
not available, even though there is 
potential for high occlusion rates in 
the long term. Limb salvage may well
be successful with PTFE grafting be­
cause not all failed grafts lead to am­
putation and aggressive thrombectomy 
of occluded grafts may clear some of 
them. No increased incidence of graft 
infection has been noted. The role of 
PTFE in an above-knee segment in 
patients with claudication or in ill 
patients when a short operation is 
desired remains to be assessed.
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Surgical Management of Left Ventricular 
Pseudoaneurysms
R. Landymore, md, frcs[c]
Cardiac rupture usually results in 
hemopericardium, tamponade and 
death, but occasionally the rupture 
is contained by the pericardium, 
permitting the formation of a left 
ventricular pseudoaneurysm. This 
report describes a patient who 
underwent successful removal of a 
false aneurysm of the left ventricle 
and discusses the surgical management 
of left ventricular pseudoaneurysms.
Les consequences d'une rupture 
cardiaque sont habituellement un 
hemopericarde, une tamponnade et la 
mort. Occasionnellement, la rupture 
se limite au pericarde, ce qui entraine 
la formation d'un pseudo-anevrisme 
ventriculaire gauche. Cette 
communication decrit le cas d'un 
patient qui subit avec succes la 
resection d'un faux anevrisme du 
ventricule gauche. Le traitement 
chirurgical des pseudo-anevrismes 
ventriculaires gauches est discute.
The admission chest roentgenogram 
(Fig. 1) showed marked cardiac enlarge­
ment compared with previous films. 
Cardiac catheterization demonstrated 
total occlusion of the left anterior des­
cending coronary artery with an asso­
ciated left ventricular pseudoaneurysm. 
The transient ischemic attacks were 
thought to be related to embolization 
from the pseudoaneurysm because of the 
temporal relation to the onset of the 
attacks and the lack of clinical evidence 
of carotid disease.
At operation the sternum was split 
and the pericardium opened. A large 
pseudoaneurysm extended from the re­
gion of the interventricular septum to 
the anterior chest wall (Fig. 2). No 
attempt was made to manipulate the 
pseudoaneurysm before initiating cardiac 
bypass, to avoid dislodgement of ventri­
cular thrombus into the systemic circula­
tion. After cardiac bypass was established 
with systemic hypothermia to 25°C, the 
aorta was cross-clamped and the heart 
arrested with a crystalloid cardioplegic
Cardiac rupture following train nura 
myocardial infarction usually r ult 
in hemopericardium, tam ponade i< 
death. However, a small percen 
of patients will survive acute rupty 
of the left ventricle with the form 
tion of a left ventricular pseudoaneu 
rysm. This report describes a patien 
who successfully underwent left ven 
tricular pseudoaneurysmectomy an< 
discusses the surgical management o 
left ventricular pseudoaneurysms.
Case Report
FIG. 1— Marked left ventricular en­largement.
agent (potassium 20 meq/1) and topical 
hypothermia. The pseudoaneurysm was 
then mobilized. The sac of the false 
aneurysm extended laterally towards the 
left chest and was covered by a thin 
layer of pericardium. It contained large 
amounts of thrombus. After the dissection 
was completed the false aneurysm was 
removed and the ventricular cavity care­
fully inspected for thrombus that might 
have been dislodged during the manipula­
tion (Fig. 3). A standard aneurysm repair 
was then carried out using multiple 
mattress sutures of 0-Prolene buttressed 
with Teflon felt. A small transverse 
aortotomy was created in the ascending 
aorta to inspect the lumen for debris 
that could have fallen through the aortic 
valve during the procedure. After re­
moval of air and rewarming, the patient 
was weaned from cardiopulmonary by­
pass without difficulty. The postoperative 
course was smooth; histologic examina­
tion confirmed the diagnosis of left 
ventricular pseudoaneurysm.
Comment
Left ventricular rupture is the cause 
of death in 4%  to 8% of patients 
after an acute myocardial infarction.1’3 
Although cardiac rupture has been re­
ported following ventriculotomy,4 
traum a5 and endocarditis,6 it is usually 
secondary to a transm ural myocardial 
infarction. Any portion of the ventri­
cle may be involved but rupture most 
commonly occurs through the anterior 
free wall3,7 with 90% taking place 
within 2 weeks of the acute infarc­
tion.3-8
Cardiac rupture usually results in 
the form ation of a hemopericardium
A 61-year-old man made a smooth 
recovery from an acute anterior trans­
mural myocardial infarction and was 
discharged from hospital after 2 weeks. 
One week later he suffered transient 
ischemic attacks and was readmitted.
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FIG. 2— Large pseudoaneurysm ex­tending anteriorly towards chest wall. Clamp holds pericardium.
FIG. 3— Open left ventricular cavity and margins of left ventricular pseudo- aneurysm.
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with the rapid onset of tamponade 
and death. Occasionally, however, 
pericardial adhesions, resulting from 
postinfarction pericarditis, contain the 
rupture, allowing the patient to sur­
vive. A false aneurysm is then formed; 
the walls consist of organized throm­
bus and pericardium.3A,°
The formation of a left ventricular 
pseudoaneurysm usually causes mild 
left ventricular failure; the diagnosis 
should be suspected when there is a 
sudden increase in cardiac size. Other 
patients may present with arrhyth­
mias, emboli or rupture.11 The indica­
tions for surgical intervention are si­
milar for true and false aneurysms of 
the left ventricle.12 In contrast to true 
aneurysms, however, pseudoaneu­
rysms will frequently enlarge and rup­
ture resulting in death in 45% of 
patients, suggesting that the diagnosis 
is an indication for emergency opera­
tion.2’13
Although the surgical repair is simi­
lar for true and false aneurysms of 
the left ventricle, particular care must 
be exercised during the initial stages 
of operation for left ventricular pseu­
doaneurysms. The ventricular cavity 
of a true aneurysm may contain or­
ganized or fresh thrombus in some 
cases.14,15 By contrast, virtually all 
pseudoaneurysms contain thrombus 
since the wall of the pseudoaneurysm 
consists of thrombus and pericardi­
um.3’9,10 The material removed from 
the cavity of a pseudoaneurysm is not 
unlike the layered thrombus found in 
the wall of an abdominal aortic aneu­
rysm and any attempt to dissect or 
manipulate the false aneurysm before 
establishing bypass and clamping the 
aorta may result in embolization into 
the systemic circulation, with resulting 
neurologic injury. After completing 
the dissection and opening the left 
ventricle, the cavity should be care­
fully inspected and any debris re­
moved. It is also wise to open the 
ascending aorta through a small trans­
verse aortotomy to inspect the lumen 
directly for thrombus that may inad­
vertently have fallen through the aor­
tic valve during manipulation of the 
false aneurysm. The small aortotomy 
may subsequently be used to remove 
air from the heart. With these guide­
lines the repair of left ventricular 
pseudoaneurysms should be accom­
plished without complication.
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Correction
The paper entitled “Hirschsprung’s 
disease: long-term follow-up of 65 
cases” that appeared in the July 1982 
issue of the Journal (page 435) in the 
section “Voluntary Contributions” 
was, in fact, solicited by the coeditors. 
The following footnote should have 
appeared on the title page: “Presented 
at the 13th annual meeting of the 
Canadian Association of Pediatric 
Surgeons, Toronto, Ont., Sept. 15, 
1981.” We apologize to Dr. Cram 
for this error.
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Dynamic Peroneus Tendon Transfer 
for Repair of the Unstable Ankle
The author considers the anatomic 
basis and indications for a dynamic 
peroneus brevis tendon transfer 
to treat ankle instability and pain 
caused by rupture of the lateral fibular 
ligaments. He describes the surgical 
technique. The peroneus brevis 
tendon is passed through a tunnel 
in the distal fibula and cuboid bone, 
proximally and deep to the belly 
of the short toe extensor muscle and 
is looped back and sutured to itself. 
Thirty-two patients with ankle 
instability and pain of 10 years' 
duration or acute ligamentous rupture 
underwent dynamic peroneus brevis 
tendon transfer in a prospective 
study between Nov. 1, 1976 and 
Oct. 31, 1981. Twenty-five of the 
32 patients were available for 
follow-up, which ranged from 15 to 
57 months. The operation resulted 
in improved activity in 80% and relief 
of pain in 76%. There were three 
complications: causalgia, infection 
and numbness in one patient each. 
The author believes this procedure 
is worthwhile in active individuals 
who have long-standing ankle pain and 
weakness due to rupture of the 
lateral ankle ligaments.
L'auteur se penche sur les fondements 
anatomiques et les indications du 
transfert dynamique du tendon 
du court peronier lateral pour traiter 
I’instabilite de la cheville et la 
douleur causee par la rupture des 
ligaments peroniers lateraux.
II decrit la technique chirurgicale.
Le tendon du court peronier lateral est 
passe a travers un canal dans le peronier 
distal et le cuboi'de, proximal et en 
profondeur par rapport au ventre du 
muscle extenseur du petit orteil, 
puis retourne pour former une boucle 
et suture sur lui-meme. Dans une etude 
prospective qui s’est deroulee du 1er
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novembre 1976 au 31 octobre 1981,
32 patients qui souffraient depuis 10 ans 
d'instabilite et de douleur de la 
cheville ou qui ont eu une rupture 
subite d'un ligament ont subi 
un transfert dynamique du tendon 
du court peronier lateral. Vingt-cinq 
des 32 patients ont ete revus 
aux examens de contrdle qui se sont 
etendus de 15 a 57 mois. L’operation 
a ameliore I’activite dans 80% 
des cas et soulage la douleur dans 
76%. Trois complications ont ete 
enregistrees: causalgie, infection et 
engourdissement chez un patient 
chacun. L'auteur croit cette intervention 
tres valable pour les personnes 
actives qui souffrent depuis longtemps 
de douleur et de faiblesse de la 
cheville dues a la rupture de ligaments 
peroniers lateraux.
Slight ankle instability in sports or 
daily activities may be accepted by 
some patients. Many, however, seek 
ways to have their ankle disability cor­
rected so that they can perform their 
regular job properly or fully enjoy 
sporting activities that require a stable, 
pain-free, dependable ankle joint. Re­
current trauma may weaken or rup­
ture especially the anterior talofibular 
ligament.1"3 In spite of supportive tap­
ing or elastic bandages, further dam­
age to this ligament may occur,4 re­
sulting in a discrepancy between the 
symptoms and the clinical stability of 
the ankle joint.5 Severe anterolateral 
tenderness, giving way in plantar 
flexion and inversion without a severe 
talar tilt are encountered.
The standard roentgenograms usu­
ally give a normal appearance. Stress 
films may show a talar tilt but the 
findings are often normal.6 A slight 
talar tilt at the talotibiofibular joint 
may, however, be demonstrated more 
easily by an arthrogram.7*8 In some 
patients, tilting on stress even with 
contrast medium in the ankle joint is 
not shown. The anterior drawer sign 
of the ankle can only be demonstrated 
on roentgenograms if standard tech­
niques are followed.9 If the ankle is 
painful a local anesthetic can be used.
Anatomic Considerations
The anatomy of the lateral joint 
ligaments has been well described by
Robichon and colleagues.10 Percy and 
coworkers11 graded the lesions and 
pointed out techniques for demon­
strating the integrity of the ligaments. 
Arthrography was used by Brostrom 
and associates7 and stress tenograms 
by Evans and Frenyo.12 Elmslie,13 
Watson-Iones14 and Evans15 described 
techniques for stabilizing the ankle 
joint by creating a tenodesis. Sta­
bility is provided only for a severe 
talar tilt due to a rupture of the cal- 
caneofibular ligament. They used the 
peroneus brevis tendon, severing it 
at the point of its main blood supply 
at the musculotendinous junction. Pea­
cock16 concluded that the blood ves­
sels enter from the muscular origin 
and are able to nourish the proximal 
third of the tendon. Permanent dis­
ruption of the central blood vessels 
causes cellular death and eventually 
disintegration of collagen bundles. 
Therefore, the proximal blood supply 
to the tendon must be preserved to 
ensure restoration of tendon function 
with minimal loss of collagen fibres. 
Furthermore, elasticity is preserved 
when the muscle remains attached to 
the tendon. If a tendon transfer is to 
be successful, these elements must be 
left intact. Detachment of the tendon 
should be carried out at its insertion 
rather than at the site of its blood 
supply at the musculotendinous junc­
tion.
Indications for Dynamic 
Peroneus Tendon Transfer
A surgical repair is indicated only 
in patients with a history of continu­
ous, intolerable instability and per­
sistent pain. This instability must be 
demonstrable on a plain roentgeno­
gram or arthrogram. A talar tilt may 
be present in both ankles, but when 
there is also a history of injury, swell­
ing, pain and giving way, then a mor­
bid condition exists. The patient must 
be unable to perform his job or con­
tinue athletic activities after at least 
6 months of conservative manage­
ment.
An arthrogram may be contraindi­
cated when there is a possible allergy 
to the local anesthetic or the contrast 
medium used. In these cases, a stress 
test is done under direct vision at 
operation. If the test result is positive
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and if the anterior talofibular ligament 
cannot be adequately repaired, a dy­
namic peroneus tendon transfer is 
added.
No tendon transfer should be done 
on patients who can perform satis­
factorily with ankle support. A dyna­
mic peroneus tendon transfer per­
formed in a patient with arthritis of 
the ankle or subtalar joint usually re­
sults in an excessively stiff and pain­
ful ankle, so the procedure is contra­
indicated in such patients.
Surgical Technique and 
Postoperative Care
An anterolateral incision is made 
from the base of the fifth metatarsal 
in a proximal direction anterior to 
the lateral malleolus and curving pos­
teriorly just proximal to the lateral 
malleolus. The lateral cutaneous pe­
roneal nerve should be located and 
protected. The peroneus brevis tendon 
is detached from the base of the fifth 
metatarsal. Proximal and posterior to 
the lateral malleolus, the peroneus 
brevis tendon is identified and, with 
care not to jeopardize its musculo­
tendinous blood supply, is gently 
pulled proximally out of its bed (Fig. 
1). The musculotendinous portion is 
protected while an oblique drill hole 
is made, large enough to allow free 
movement of the tendon, in the distal 
fibula from the anterior distal side to 
posterior proximal, close to the proxi­
mal attachment of the talofibular liga­
ment (Fig. 2). The edges are smoothed 
by curette. A second drill hole is made 
through the cuboid bone, initially 
from a dorsal to plantar direction, 
close to the insertion of the talofibular 
ligament, then from the lateral aspect 
to make a hole that will allow the 
peroneus brevis tendon to be reat­
tached in a loop to itself (Fig. 3). The 
peroneus brevis tendon is now gently 
pulled forward through the fibular 
hole in a posterior to anterior direc­
tion (Fig. 4) and then through the 
cuboid tunnel from dorsal to plantar 
and laterally through the side hole 
(Fig. 5). The tendon is turned prox­
imal and deep to the belly of the short 
toe extensor muscle. It is long enough 
to be looped back and sutured to 
itself (Figs. 3 and 6). A plaster cast 
is applied with the foot in a neutral
position. The cast is split anteriorly 
to allow for swelling. Two weeks later 
a walking cast is applied for another 
month. Exercises are then started and 
full activity is allowed 4 to 6 weeks 
after removal of the cast.
Method of Analysis
After we had developed the prin­
ciples of the procedure, we undertook 
a prospective clinical study of patients 
with chronic ankle problems (up to 
10 years’ duration) and those with 
acute athletic or work-related injuries. 
All patients were reviewed by per-
FIG. 3— Diagram shows routing of 
peroneus tendon.
/
PERONEUS
TENDON
FIG. 1—Incision anterior to lateral malleolus and removal 
of peroneus tendon.
FIG. 4— Hole drilled through cuboid bone indicated by 
tendon passer showing proximity of distal attachment of talo­
fibular ligament. Peroneus brevis tendon has been pulled 
through fibular hole.
FIG. 2—Cadaver ankle shows hole drilled through fibula. 
Hemostat is under intact anterior talofibular ligament, which 
is either ruptured in acute or absent in chronic ankle lesions.
FIG. 5— Peroneus tendon passed through hole in cuboid 
bone exits laterally.
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sonal examination, questionnaire or 
telephone. Between Nov. 1, 1976 and 
Oct. 31, 1981, 32 patients (16 male, 
16 female), who ranged in age from 
13 to 53 years, underwent dynamic 
peroneus tendon transfer. The patients 
were taken at random. There were 
three main groups: (a) 20 patients 
with chronic instability; (b) 3 patients 
with chronic instability and an acute
F IG .  6—Peroneus brevis tendon is 
looped back and attached to itself with 
Vicryl suture.
episode of severe sprain or rupture; 
(c) 9 patients with recent acute liga­
mentous rupture without previous in­
jury or handicap. These patients had 
profuse hemorrhage and needed im­
mediate repair.
All patients with chronic problems 
were fully investigated; arthrograms 
and stress studies were included. In 
six patients no arthrogram could be 
done so a stress test was performed 
under direct vision at operation. Six­
teen patients had a positive talar tilt 
sign (5° or more) indicating lateral 
laxity.17 Of the 32 patients, 25 were 
available for follow-up which ranged 
from 15 to 57 months.
Findings
Nineteen patients (76%) were able 
to increase their activity as a result of 
the operation, in 3 activity was the 
same and 3 were less active (Table I). 
Twenty patients (80%) had complete 
relief of pain, 1 was unchanged and 
4 had residual pain. Twenty-one pa­
tients had stronger ankles and 3 felt 
their ankle was weaker. Seventeen pa­
tients said they would consider a simi­
lar operation on the other ankle and 
8 would not. Overall, 20 patients 
thought the operated ankle was better, 
2 that it was the same and 3 that it 
was worse.
There were three complications: 
causalgia in one patient, infection in 
one and numbness of the fourth and 
fifth toes in one. This last patient was 
not handicapped. The patient with 
causalgia also had moderate arthritis 
of his ankle. The patients with causal­
gia and infection and patient no. 22 
(Table I) with stiffness were the only 
three who had to reduce some activi­
ties to avoid irritating their ankle.
Five of six patients with normal 
arthrographic findings were operated 
upon on the basis of their symptoms; 
they were able to increase their ac­
tivities.
Discussion
The principal pathologic features in 
most of our cases appear to be a 
rupture of the anterior talofibular lig­
ament, in some a rupture of the an­
terior talofibular and calcaneofibular 
ligaments and, in one, a complete dis­
ruption of all the lateral fibular lig­
aments. The procedures for tenodesis 
of the ankle joint, described by Wat- 
son-Jones14 and Evans15 have been suc­
cessful in our hands only in obvious 
cases with severe talar tilting; even 
then, there were often complaints 
of residual weakness. Watson-Jones’ 
technique is aimed at repair of both
Table 1-Results of Peroneus Brevis Tendon Transfer
Patient
no. Sex
Age,
Yf Occupation
Talar tilt 
on arthrogram*
Ankle
stronger
Postoperative results 
Pain Motion Activity
Overall
assessment
Patient would 
consider operation 
on other ankle
i M 22 Fireman + Yes Relief Better More Better Yes
2 M 25 Labourer + Yes Relief Better More Better Yes
3 F 18 Student + No Worse Stiff Less Same No
4 M 35 Electrician - Yes Same Better but
stiff More Better Yes
5 F 13 Figure skater Normal Yes Relief Better More Better Yes
6 F 20 Clerk - Yes Relief Stiff More Same Yes
7 M 33 Labourer + + Yes Relief Stiff More Better Yes
8 F 36 Housewife Severe Yes Relief Same More Better Yes
9 M 45 Labourer Severe Yes Relief Stiff More Better No
10 M 28 Labourer Severe No Worse Stiff Less Worse No
11 F 13 Figure skater - Yes Relief More Better Yes
12 M 29 Labourer Severe Yes Relief Better More Better Yes
13 M 22 Labourer + + Yes Relief Better More Better Yes
14 M 26 Labourer + + Yes Relief Stiff Same Better No
15 F 27 Teacher + Yes Relief Same More Better Yes
16 M 53 Physician - No Worse Stiff Same Worse No
17 F 17 Student + Yes Relief Better More Better Yes
18 F 20 Student + Yes Relief Better More Better Yes
19 F 15 Student + Yes Relief Stiff Same Better No
20 F 15 Figure skater Normal Yes Relief Better More Better Yes
21 M 33 Teacher Severe Yes Relief Stiff More Better Yes
22 F 17 Student + Yes Worse Stiff Less Worse No
23 F 31 Clerk - Yes Relief Better More Better Yes
24 F 14 Student + Yes Relief Better More Better Yes
25 F 16 Student + Yes Relief Stiff More Better No
*+ = tilt of 5°, ++ = tilt of more than 5”.
— = arthrogram not done due to allergic reactions.
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ligaments, the anterior talofibular and 
the calcaneofibular ligaments, and this 
is a rather difficult procedure to per­
form. The tendon often is not long 
enough. Evans’ technique fails to pro­
tect or replace the anterior talofibular 
ligament, but when there is obvious 
tilting of the ankle joint due to com­
plete disruption, some benefit will be 
derived from such a tenodesis. The 
dynamic peroneus transfer, in con­
trast, has been a very satisfying pro­
cedure in patients with less severe in­
stability. This is due to the continued 
activity of the peroneus brevis tendon.
Since it is possible for a transferred 
tendon to function properly through 
a pulley as described for the thumb 
by Lipscomb and associates18 there is 
no reason why a transferred tendon 
should not function properly when a 
tunnel is created through a bone such 
as the fibula. The peroneus brevis 
muscle remains functional by sliding 
through the fibular tunnel and stabil­
izes the ankle during activity, such as 
running and skating, when a load is 
put on the ankle joint.
The patency of the fibular tunnel 
is demonstrated by a cortical border 
seen on the roentgenogram (Fig. 7). 
Inversion of the operated ankle is only 
a few degrees less than that of the 
other ankle.
Occasionally, adhesions are formed 
in the bony tunnel; tenodesis is the 
result of these. The adhesions were 
removed by tenolysis in two instances. 
Because of excessive stiffness in three 
of our cases, the cast is now worn for 
only 4 weeks; this resulted in earlier 
walking and no undue stiffness.
The statement of Ruth:19 “If the 
physician decides against operative
FIG. 7—Fifty-seven months after 
operation. Cortical margins delineate 
fibular tunnel.
treatment or immobilization in plaster, 
he should first have proof that the 
ligaments are intact and that the ankle 
is stable”, covers a wide field of ankle 
injuries and appears to be slightly 
idealistic. Many patients do not want 
a cast or an operation because they 
feel that their ankle is “just sprained”. 
Those patients first must have a dis­
ability before they will seek help and 
immobilization with a cast is by then 
no longer effective.
Before repair, residual disability is 
present in at least 33% of patients 
and abnormalities of the ankle can be 
found in 60% of patients with pre­
vious ankle injuries.20 According to 
Freeman,21 cast immobilization for a 
minimum of 6 weeks is satisfactory in 
most cases.
Repair of a ruptured ligament19 or 
reinforcement, or both, by the tech­
niques described by Elmslie,13 Watson- 
Jones,14 Evans,15 Chrisman and Snook22 
and Gillespie and Boucher23 have been 
used. Some are simple, others com­
plicated. All are designed as a teno­
desis.
The advantages of the dynamic pe­
roneus tendon transfer can be sum­
marized as follows:
•  The new route of the peroneus 
brevis tendon runs in the same direc­
tion as that of the anterior talofibular 
ligament.
•  During the healing period, as 
with any muscle at rest, the peroneus 
brevis contracts to its shortest posi­
tion; therefore, the tendon transferred 
will obtain its shortest possible length 
due to its active elasticity during this 
healing period.
•  Ankle mobility in plantar and 
dorsiflexion is not impaired.
•  The stability of the subtalar joint 
is greatly improved and provides a 
marked increase in the patient’s re­
liance on the ankle joint in plantar 
flexion.
•  Eventually a capsule is formed 
around the distal part of the tendon 
which becomes a natural reinforce­
ment of the ankle capsule.
•  The musculotendinous blood 
supply is intact allowing for rapid 
healing and return of function.
The dynamic peroneus tendon 
transfer is a worthwhile procedure for 
active individuals to improve long­
standing ankle pain and weakness due 
to rupture of the anterior talofibular 
ligament and to prevent these prob­
lems in recent injuries.
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Factors Affecting Rehabilitation following 
Aortocoronary Bypass Procedures
J. Dornan, mb, ch
Two hundred and ten men were referred 
consecutively to a rehabilitation 
program following aortocoronary 
bypass surgery. The program involved 
exercise tolerance testing 8 and 20 
weeks postoperatively, with an 
intervening 12-week exercise program. 
A retrospective analysis of data showed 
50% of these patients to be on no 
medication throughout their 
rehabilitation and the others on 
medications likely to affect cardiac 
performance. Factors likely to 
influence exercise tolerance such 
as age, medication and extent of 
revascularization were subjected to 
multivariate analysis in these two 
cohorts of patients. Age (up to 
60 years) and the extent of 
revascularization did not appear to 
influence exercise tolerance.
Following the 12-week exercise 
program, patients in both groups had 
improved significantly (P <  0.01), but 
the initial and final performance of the 
cohort of patients requiring cardiac 
drugs was significantly poorer than 
those on no medication (P <  0.01).
Deux cent dix hommes ont ete diriges 
consecutivement vers un programme 
de readaptation apres pontage 
aorto-coronarien. Le programme 
impliquait une epreuve d'effort aux 
8e et 20e semaines apres I'operation 
avec, dans I'intervalle, un programme 
d'exercice de 12 semaines. Une analyse
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retrospective des donnees a revele 
que 50% de ces patients ne prenaient 
aucun medicament durant le 
programme de readaptation aiors que 
les autres recevaient une medication 
susceptible de modifier leur 
performance cardiaque. Pour ces deux 
cohortes, les divers facteurs capables 
d'influencer I’epreuve d'effort tels 
que I’age, la medication et I'etendue 
de la revascularisation ont ete soumis 
a une analyse de covariance. L'age 
(jusqu'a 60 ans) et I'etendue de la 
revascularisation n'ont pas semble 
affecter I’epreuve d'effort. Apres 12 
semaines du programme d'exercice, 
les patients des deux groupes s'etaient 
ameliores significativement (P <  0.01) 
mais les performances initiate et 
finale du groupe necessitate des 
medicaments cardiotropes etaient 
significativement plus faibles que 
celles des patients qui n'avaient pas 
de medication.
The saving and restoring to health 
members of society, whose labours 
are indispensable in a State, may well 
be ranked among the more important 
services done to the community.
The History of the Royal Infirmary, 
Edinburgh, 1788
The factors that affect the outcome 
of rehabilitation following cardiac sur­
gery include those that are physical, 
psychosocial and associated with the 
health care system, and the patient’s 
perception of health and level of phy­
sical fitness.1’3
Of patients who undergo aortocoro­
nary bypass surgery, 80% to 90% 
experience a prompt improvement in 
their symptoms and approximately 
70% are rendered free of pain.4’7 
However, many who are physiologic­
ally capable of returning to work, do 
not, for a variety of reasons. Studies 
dealing with the effects of revascular­
ization upon work status report a rate 
of return to work ranging from 83% 
to less than 50%.712 Recently, Dan- 
chin and associates13 analysed the 
working status of 1217 men after 
aortocoronary bypass surgery. They 
noted that 24% had never returned 
to work, 56% were working at 6 
months after the operation and 66% 
at 2 years. Thereafter the proportion 
declined progressively to 56% and
53% at 4 and 5 years respectively. 
Whether a structured rehabilitation 
program and demonstration of physi­
cal improvement to aortocoronary by­
pass patients through exercise toler­
ance testing, regular supervised exer­
cise sessions and education is likely to 
influence return to work has not, as 
yet, been addressed.
Description of Postoperative 
Rehabilitation Program
The cardiovascular rehabilitation 
program at the Toronto General Hos­
pital is continuous from the time of 
operation until the patient returns to 
an optimum level of vocational and 
avocational activity. It extends over 
a period of 20 weeks and is arbitrarily 
divided into four stages.
Immediately after Operation
This stage includes the usual post­
operative physiotherapy chest routine. 
When the patient is allowed out of 
bed he is taught to take his own pulse 
rate and is incorporated into a daily 
calisthenics and walking program. At 
the time of discharge he is given an 
exercise routine compatible with car­
diovascular status and level of fitness. 
It includes some simple calisthenics 
and walking.
Early Postoperative Rehabilitation
During this phase the patient is en­
couraged to exercise daily to the pre­
scription provided before discharge 
and is asked to record pre-exercise, 
postexercise pulse rates and any un­
toward symptoms experienced. At 4 
weeks after discharge, the program 
may be expanded.
Intermediate
Six to 8 weeks after operation a 
multistage, steady state, exercise tol­
erance test (T-l) is carried out using 
a treadmill and a modification of the 
protocol described by Balke and 
Ware.14 Exercise testing is to 85% 
of the age-adjusted maximum or is 
symptom-limited. A 12-lead electro­
cardiogram monitors cardiac status 
throughout the test and in the post­
exercise recovery period. With this 
test, an assessment of work capacity 
and limiting factors is made and an 
extrapolation of the maximum at-
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tained oxygen uptake at peak work­
load is recorded. Based upon the re­
sults a conditioning heart rate (85% 
of that achieved on the test) is pre­
scribed for each patient. All patients 
attend a supervised exercise program 
lasting 12 weeks followed by a second 
exercise tolerance test (T-2) using the 
same protocol and recording methods. 
During this phase a six-subject educa­
tional program and a program for 
spouses are conducted.
Late Rehabilitation
Upon completion of the 12-week 
exercise and education program pa­
tients may continue to attend the 
physician-supervised exercise sessions 
or may continue to exercise to a pre­
scribed heart rate in a program of 
their choosing.
Subject Selection
Of those who have undergone aor­
tocoronary bypass surgery 210 men 
have been referred consecutively into 
this rehabilitation program and con­
stitute the patient population of the 
study. No patient who was referred 
has been excluded. The age range, 
mean age, age distribution and extent 
of revascularization are shown in Figs.
1 and 2. We recognize that in a pro­
portion of instances, not yet deter­
mined, complete revascularization of 
all vessels might not have been pos­
sible for technical or other reasons.
Results
A comparison of parameters that 
indicate an improvement in the level 
of physical fitness (resting heart rate, 
resting blood pressure and estimated 
attained oxygen uptake at peak work­
load) are shown in Tables I and II. 
The mean resting heart rate dimin­
ished significantly (P <  0.001, two- 
tailed Student’s r-test) over the 12- 
week intermediate phase. Since each 
test was terminated at 85% of an age- 
adjusted maximum (or was symptom- 
limited) the heart rate at peak work­
load between the two tests is not sta­
tistically significant. Similarly, as 
might be expected, the mean systolic 
blood pressure at peak workload did 
not alter significantly. Over the 12- 
week period between the two tests 
the improvement in the mean exercise 
tolerance for all patients was highly 
significant (P <  0.001). When this 
improvement in aerobic capacity is 
considered against age, regression 
analysis demonstrates a clear negative
linear correlation with increasing age 
at T-l and T-2. The younger the pa­
tient the greater the potential im­
provement in aerobic capacity in the 
age range studied (30 to 70 years). A 
significant (P <  0.025) age by test 
interaction is present, that is, the rela­
tion between attained oxygen uptake 
at peak workload depends upon which 
tolerance test is considered. For each 
year of increment at T-l there is a 
decrement in exercise tolerance of 
0.302%. At T-2, although there is an 
overall improvement in performance, 
this decrement increased to 0.456%/yr 
causing a tendency for the “best 
straight” lines to converge. It should 
be recognized that age is merely a 
single factor amongst many to be con­
sidered in the assessment of exercise 
tolerance following aortocoronary by­
pass surgery (Fig. 3).
When aerobic capacity between T-l 
and T-2 is compared against the ex­
tent of revascularization it can be 
seen that a numerical improvement 
in all categories occurs (Table III). A 
patient who had six lesions bypassed 
early in 1978 is one of the highest 
achievers in the program, leads an ex-
FIG. 1— Age distribution of 210 men 
who underwent coronary artery bypass 
surgery. Age ranged from 30 to 69 years 
(mean 52.4 years).
FIG. 2— Extent of revascularization.
Table 1 -M e a n  H eart R ate (beats/m in)
H eart ra te First tes t Second test P value
Resting 77.1 72.3 < 0 .0 0 1
M ax im u m  (a t peak 
w orkload) 139.8 140.6 NS
N S  =  not significant.
Table I I—Blood Pressure (mm Hg)
Blood pressure f irs t  test Second test P value
Resting systolic 125.3 121.2 < 0 .0 0 1
R esting diastolic 
M ax im u m  systolic (at
80.0 76 .9 < 0 .0 0 1
peak workload) 
M ax im u m  diastolic (a t
165.3 167.7 NS
peak w orkload) 82.4 79 .6 < 0 .0 1
Table I l l - M e a n  O xygen U ptake (ml/kg - min) 
(A ttained) by N um ber of Bypass Grafts in 210  M en
N o. of 
grafts
N o. of 
patients
First
test
Second
te s t P value
1 35 21.9 25 .3 N S
2 68 20.3 25.1 0.0001
3 81 22.1 27 .0 0.0001
4 22 20.9 24 .5 N S
5 3 23.8 24.7 —
6 1 46.0 49 .5 -
22.1 26 .2 < 0 .0 0 1
/  .
I
A
i
*
r
4
i
i
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s< -
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tremely active avocational life and is 
capable of exercising at high levels for 
prolonged periods. This particular pa­
tient has been followed at intervals 
since 1978, has continued to exercise 
assiduously, has been exercise toler­
ance tested on six separate occasions 
and has improved upon his initial high 
performance.
Correlation of Exercise Tolerance 
with Medication
Analysis of data showed that the 
population fell into two cohorts of 
comparable size: Patients (group 1) 
who throughout their rehabilitation 
were taking no medication likely to 
influence cardiac performance and pa­
tients (group 2) taking medications 
likely to influence cardiac action.
FIG. 3—Age and exercise tolerance. 
TI =  first tolerance test, decrement is 
0.302 %/yr, T2 =  second tolerance test, 
decrement is 0.456%/yr.
FIG. 4—Exercise tolerance and med­
ication over 12-week period. Group 1 
(103 patients [49%]) =  taking no med­
ication influencing cardiac performance. 
Group 2 (107 patients [51%]) =  (a) 
taking same cardiac medication through­
out, (b) taking different cardiac medica­
tion at end of program, (c) taking no 
medication at beginning but taking car­
diac medication before end of program.
Within group 2 there were three sub­
categories: (a) patients who started 
the program taking a cardiac medica­
tion and who finished using the same 
medication (Fig. 4a), (b) those who 
started with a medication that was 
changed before the rehabilitation pro­
gram was complete (Fig. 4b) and (c) 
those who started with no medication 
but who were given a cardiac drug 
before the completion of the 12-week 
program (Fig. 4c). When the mean 
oxygen uptake of groups 1 and 2 is 
compared at the time of the initial ex­
ercise tolerance test it can be seen that 
the group requiring no medication 
started off at a higher level of physical 
fitness than those who were deemed 
to require medication (mean oxygen 
uptake group 1, 22.9 ml/kg-min vs. 
group 2, 19.9 ml/kg-min). This dif­
ference is statistically highly signif­
icant (P <  0.001). After 12 weeks of 
prescribed exercise both groups im­
proved by a statistically significant 
margin although the discrepancy be­
tween them was maintained at the 
time of T-2 (mean oxygen uptake 
group 1, 28.2 ml/kg -min vs. group 2, 
23.6 ml/kg*min). All four groups 
were subjected to two-way analysis of 
variance. Group 1 differed significant­
ly from the three other subgroups 
(P <  0.001). The differences between 
the three subcategories (Fig. 4) were 
not statistically significant. Group by 
test interaction did not demonstrate 
any significant difference in the rate 
of improvement.
It could be hypothesized that the 
superior performance of those on no 
medication might have resulted from 
a preponderance of younger patients 
in group 1. However, the distribution 
of the two groups by decades is com­
parable (Table IV).
Return to Work
When 147 patients had completed 
the program we decided to survey 
employment patterns following sur­
gery and a questionnaire was distrib­
uted. Twenty-three patients were lost 
to follow-up and 4 had died (one pa­
tient had been killed in a car acci­
dent). Ninety-three patients responded 
to the questionnaire (78% compli­
ance); 80 (86%) had returned to 
work. The time frame within which 
these patients resumed work is shown 
in Table V; 68% had returned to 
work within 12 weeks and 39.8% 
had returned to work within 4 weeks 
of surgery. The majority (92.5%) had 
returned to their preoperative occupa­
tion. Of the 13 patients (14%) who 
did not return to gainful employment, 
8 gave reasons for leaving their job, 
4 of them citing age as the deciding 
factor for early retirement, the other 
4 citing fear of returning to work, 
excessive physical demands of the oc­
cupation, medical advice and angina 
as their reasons for not returning.
Discussion
We realize that our study has a 
number of imperfections. The cohort 
of male patients being reported rep­
resents a biased population in that 
they are patients who possess the 
motivation to become involved in a 
rehabilitation program and there is 
no control group for comparison. It 
might also be argued that the im­
provement in aerobic capacity seen 
over the 12-week rehabilitation pe­
riod in the various subgroups (Fig. 4) 
might represent an improvement that 
could have occurred without a re­
habilitation program. Such argument 
can only be refuted by a carefully
Table IV -A ge versus Medication*
Age group, yr
Patients 30-40 41-50 51-60 61-70
No medications, 
n = 103 (49%) 16 (7.6) 26 (12.4) 48 (22.9) 13 (6.2)
Medications, 
n = 107 (51%) 4 (1.9) 31 (14.8) 53 (25.2) 19(9)
'Figures in brackets are percentages.
Table V-Retum to Employment : Time Frame, 
Range 1 to 150 Weeks
Time, wk
1-4 4-12 12-52 >52
No. of patients 37 27 12 17
% 40 28 13 19
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conducted prospective study and by 
making comparison of an active treat­
ment group with a control group, 
carefully matched for habitus, social 
status, educational level, type of oc­
cupation, severity of disease and car­
diovascular function. These arguments 
notwithstanding, the study provides an 
insight into the rate of improvement 
in exercise tolerance that can be ex­
pected in patients who undergo aorto­
coronary bypass surgery and some of 
the factors that might affect it.
That those patients requiring car­
diac drugs started their rehabilitation 
at a much lower level of exercise tol­
erance than those who were consid­
ered not to require such drugs is not 
surprising. It might be speculated that 
the second group represents patients 
whose cardiovascular function is poor­
er and who require cardiac medication 
as a consequence. The medication it­
self could play a part in altering a 
patient’s exercise tolerance and capa­
city although often such drugs are 
prescribed in the hope of improving 
performance, recognizing that some 
(eg.. /2-blockers) interfere with the 
heart-rate response to exercise. How­
ever, the poorest group (group 2c) 
started the rehabilitation program with 
no medication and so the influence of 
chemical interference on response in 
this group cannot be incriminated. In 
this group there was a “training effect’’ 
comparable to all other groups, albeit 
at a lower level.
In contrast to the findings of 
Barnes and associates,7 of the factors 
likely to influence eventual outcome 
in terms of aerobic capacity, the ex­
tent of revascularization did not ap­
pear to be an important factor, al­
though, in the group of 35 patients 
who had a single-vessel bypass, statis­
tical analysis did not reveal a signif­
icant difference between the results of 
T-l and of T-2.
Despite potential criticisms of the 
study, we believe that a structured re­
habilitation program for patients who 
have undergone aortocoronary bypass 
surgery, with serial exercise tolerance 
testing, an intervening exercise regi­
men prescribed by a knowledgeable 
physician and an education program 
for both patients and their spouses is 
important if these patients are to 
achieve maximum recovery at an op­
timum rate following surgery, taking 
into consideration such factors as vo­
cational and avocational exercise re­
quirements, cardiovascular status and 
the medical management of cardio­
vascular impairment. It is probable 
that a rehabilitation program such as 
we have described improves the con­
fidence of patients in their ability to 
work and in their work capacity by 
reducing apprehension and by dem­
onstrating a work capacity beyond 
their occupational requirement. Such 
an approach facilitates advice con­
cerning return to work at an optimal 
time to patients more prepared and 
receptive to such advice.
Conclusions
Maximum aerobic power can be in­
creased by a structured exercise pro­
gram for patients who have undergone 
aortocoronary bypass surgery. Im­
provement in aerobic power is accom­
panied by a decrease in the resting 
heart rate and blood pressure. Educa­
tional and psychological support pro­
grams for both patients and spouses 
are valuable adjuncts to an exercise 
program following aortocoronary by­
pass surgery. This investigation has 
provided a step in the attempts to 
clarify the many factors involved in 
rehabilitation of patients after aorto­
coronary bypass procedures. This 
study might be considered a pilot one, 
providing direction for further re­
search in this area.
The authors would like to record their 
indebtedness to Dr. W.G. Bigelow, with­
out whose foresight and support this 
rehabilitation program would not have 
come into existence and Mr. Henzel 
Jupiter and Mr. Hau Lei for their as­
sistance in analysing the data.
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NOTICES
Trauma Care ’83
The second national symposium on 
the comprehensive management of 
the critically injured patient, spon­
sored by the John C. Lincoln Hospital 
& Health Center, Phoenix, Arizona, 
will be held Jan. 9-13, 1983, at the 
Scottsdale Hilton Hotel in Scottsdale, 
Arizona.
Trauma Care ’83 will be a forum 
for exploring a variety of trauma 
management techniques, including 
management of pregnant, pediatric 
and geriatric patients. Other topics 
will include management of hepatic, 
vena caval, splenic and pancreatic in­
juries as well as discussions on anti­
biotics and anesthesia.
Dr. Jeffrey A. Singer, program 
chairman for the symposium, said that 
“the major goal of the symposium is 
to provide an exchange of knowledge 
and techniques for broad-based and 
selective management of the critically 
injured patient”. Original papers are 
currently being sought for presenta­
tion. with particular interest in those 
concerning new approaches to trauma 
care.
Featured speakers at the symposium 
will be noted physicians and surgeons 
in the field of trauma, including Dr. 
Alasdair Conn, director of field pro­
grams, Maryland Institute for Emer­
gency Medical Systems; Dr. Howard 
Champion, director of surgical critical 
care services, Washington Medical 
Center; and Dr. John Stafford, direc­
tor of emergency medical services, 
Arizona Department of Health Ser­
vices. Also featured will be members 
of the Lincoln Hospital, such as Dr. 
Michael Krentz, director of emergen­
cy services; Dr. Rosalie Deckert, as­
sociate director of critical care med­
icine; Dr. Nelson Faux, director of 
prehospital systems; and Dr. David 
Elliott, critical care specialist.
continued on page 694
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Annular Pancreas with Coexistent Ampullary 
Carcinoma in an Elderly Woman
E nsor T ransveldt, m d ,* R oger G. Keith , md , frcs , frcs[c], facs,* James F onger , m d* and
M urray M. F isher , md, f r c p [c] |
The authors report the first known 
case of annular pancreas with 
coexistent ampullary carcinoma. 
Obstructive jaundice occurring 
in an 80-year-old woman was caused 
by the neoplasm rather than the 
congenital anomaly. Although the 
annular pancreas did not obstruct 
the duodenum, it did account for 
an unusual appearance of the neoplasm 
on air contrast roentgenography 
of the upper gastrointestinal tract.
The two lesions were successfully 
treated by radical pancreaticoduodenec­
tomy. The woman has been 
disease-free for more than 24 months.
Les auteurs decrivent le premier cas 
connu de pancreas annulaire avec 
carcinome ampullaire coexistant. Chez 
une femme de 80 ans est apparu 
un ictere par obstruction cause par la 
neoplasie plutot que par la malformation 
congenitale. Bien que le pancreas 
annulaire n’ait pas obstrue le duodenum, 
il etait responsable de I’aspect 
inhabituel de la radiographie a 
contraste gazeux des voies 
gastro-intestinales superieures.
Les deux lesions furent traitees 
avec succes par pancreatico- 
duodenectomie. Cette femme est 
exempte de maladie depuis plus 
de 24 mois.
Annular pancreas is a rare congenital 
anomaly that presents in adults as fre­
quently as in children. Most often the 
lesion causes duodenal obstruction, al­
though associated peptic ulcer, pan­
creatitis and jaundice have been de­
scribed.1’3 The oldest patient ever to 
present with an annular pancreas is 
reported here. The coexistence of am­
pullary carcinoma has not been re­
corded before.
Case Report
An active 80-year-old woman had
From the departments of *surgery and 
tmedicine, University of Toronto, Toronto, Ont.
Accepted for publication Mar. I, 1982
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painless jaundice, had lost 10 kg in weight and experienced intermittent stea­torrhea. Hepatomegaly was noted on abdominal examination. Results of hematologic investigations were normal. Biochemical evaluation showed abnormal serum levels as follows: total bilirubin was 124.8 iimol/l. conjugated bilirubin 97.5 umol/l, alkaline phosphatase 309 lU/dl, total protein 7.7 g/dl and albumin 3.4 g/dl. All other liver enzyme, serum amylase and glucose levels and pro­thrombin and partial thromboplastin times were normal.Ultrasonography showed dilated intra- hepatic biliary radicles and gallbladder, without calculi. A scan of the liver using technetium-99m was normal. At endos-
FIG. 1—Stenosis of supra-ampullary second portion of duodenum and large filling defect at junction of second and third parts of duodenum.
FIG. 2—Second part of duodenum. Annular pancreas encircling supra-am­pullary region.
copic examination stenosis of the duo­denal lumen was noted 10 cm beyond the pylorus. A biopsy specimen taken from this site showed normal duodenal mucosa. No other lesion could be iden­tified beyond the stenosis because the duodenoscope could not be passed into the distal duodenum. Therefore, endos­copic retrograde cholangiopancreatogra­phy was not feasible.Upper gastrointestinal air contrast roentgenography revealed a large intra­luminal filling defect at the junction of the second and third parts of the duo­denum. In addition, consistent narrow­ing was noted at the middle of the second part of the duodenum (Fig. 1).The patient refused to undergo percu­taneous transhepatic cholangiography but agreed to operation. An annular pancreas was found to be completely encircling the midportion of the second part of the duodenum (Fig. 2). The duo­denum was patent through the anomaly but the luminal diameter was less than 2 cm. A large intraluminal tumour was palpated beyond the annular pancreas, at the junction of the second and third parts of the duodenum. Duodenotomy identified a large carcinoma arising from the ampulla of Vater, displaced distally by the annular pancreas (Fig. 3). The tumour and the annular pancreas were resected en bloc by a radical pan­creaticoduodenectomy.Histologic examination showed that the tumour was a moderately differen­tiated adenocarcinoma of the ampulla of Vater. Peripancreatic lymph nodes were not involved. The annular pancreas was histologically normal. The patient re­mains well and free from recurrent malignant tumour 24 months after her operation.
FIG. 3—Duodenum with ampullary carcinoma distal to annular pancreas.
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Discussion
There have been 250 reported cases 
of annular pancreas. The majority of 
these have been in adults.4 Although 
the condition is congenital, symptoms 
of duodenal obstruction may be de­
layed as long as the duodenal lumen 
is not encroached upon by pancreatic 
inflammation within the encircling 
anomaly and is not compromised by 
peptic ulceration of the proximal duo­
denum. Prior to our case, the oldest 
patient reported with symptoms refer- 
rable to an annular pancreas was 75 
years old.5
The presentation of annular pan­
creas and jaundice has been reviewed 
by Morrell and Keynes.6 They found 
15 cases; of these 1 had liver disease 
due to alcoholism, 4 had common bile 
duct stones and 10 had pancreatitis. 
The association of an? ular pancreas 
and carcinoma of the ampulla of 
Vater has not previously been re­
corded.
In our case the presenting sign of 
intermittent jaundice suggested a peri­
ampullary neoplasm rather than bili­
ary obstruction by the congenital 
anomaly. Ultrasonographic examina­
tion demonstrated acalculous dilata­
tion of the biliary tract without defin­
ing the level of obstruction. The ste- 
nosing anulus precluded definitive en­
doscopic evaluation and biopsy of the 
tumour. Unfortunately, percutaneous 
transhepatic cholangiography was un­
acceptable to the patient. The level of 
the biliary obstruction was confirmed 
only by examining the surgical speci­
men which showed dilatation of the 
intrapancreatic portion of the bile 
duct, with stenosis only at the level 
of the ampullary carcinoma.
The radiographic appearance of the 
upper gastrointestinal tract with air 
contrast examination was unusual in 
that the polypoid tumour presented in 
the third part rather than the more 
typical site in the second part of the 
duodenum (Fig. 1). This position was 
created through displacement of the
large periampullary lesion by the con­
stricting annular pancreas.
Surgical treatment in this case con­
sisted of radical pancreaticoduodenec­
tomy in spite of the patient’s advanced 
age. The results have been gratifying. 
In such a case with metastatic spread, 
we advise biliary bypass by cholecys- 
tojejunostomy or choledochojejunos- 
tomy and gastric decompression by 
gastrojejunostomy.
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BOOK REVIEW
ESSENTIALS OF ANORECTAL SUR­
GERY. Stanley M. Goldberg, Philip 
H. Gordon and Santhat Nivatvongs. 
389 pp. Illust. J.B. Lippincott Com­
pany of Canada, Toronto, 1980. 
Price not stated. ISBN 0-397-50417-9.
Management of minor disorders of anus 
and rectum has long been overlooked 
in most training programs in general 
surgery. The knowledge provided in these 
areas in the popular textbooks is gen­
erally scanty and often the postoperative 
management of anorectal problems is 
learned by following the regimen pre­
scribed by the surgeon. Goldberg and 
Nivatvongs from the University of Min­
nesota and Gordon from McGill Univer­
sity have performed a commendable task 
in covering these neglected areas. Their 
text is augmented by 300 illustrations, 
including a large number of neatly 
drawn figures by Martin E. Finch.
The text comprises 30 chapters, cover­
ing every conceivable anorectal problem 
from prolapse of rectum to perianal en- 
dometrioma. It is preceded by a fore­
word which describes the history of 
anorectal surgery both in Europe and 
North America. In it, William C. Bern­
stein highlights the landmarks and de­
velopment of anorectal surgery from an­
cient Egypt to modern times with the 
formation of the American Board of 
Colon and Rectal Surgery. The topics
and the chapters are arranged in a meth­
odical manner. After describing the ana­
tomy and physiology of rectum and anal 
canal, the authors follow with diagnosis, 
postoperative management of anorectal 
wounds and principles of anesthesia in 
anorectal surgery. The following chapters 
are devoted to a discussion of common 
anorectal problems and end with compli­
cated rectal problems including benign 
and malignant tumours of the rectum, 
rectal prolapse, anal incontinence and 
rectovaginal fistula.
Throughout the text the authors have 
concentrated on developing a scientific 
basis for understanding and managing 
anorectal problems. The pathogenesis of 
anorectal prolapse and fistulas is de­
scribed clearly with the help of original 
diagrams taken from Parks’ classic 
paper. The chapter on anorectal physiol­
ogy describes in great detail mechanisms 
of anal continence, with reference to re­
cent studies, and provides an exhaustive 
list of references to support the con­
cepts outlined. Similarly, in dealing with 
hemorrhoids, a good description of path­
ogenesis is followed by a rational scheme 
of practical management. In the chapter 
on rectal cancer the correlation between 
pathology and prognosis is described in 
detail to provide a basis for an appro­
priate selection of operation.
Throughout the book the authors have 
emphasized the benefits of a jack-knife
or prone position both for endoscopic 
examination of rectum and for thera­
peutic procedures. In fact, in all the 
illustrations of the perineum the patient 
is in the prone position. It takes a 
conventional surgeon some time to re­
verse his anatomical concepts. In their 
enthusiasm for the prone position the 
authors recommend it for perineal exci­
sion of the rectum in an abdominoperi­
neal operation. This approach obviously 
precludes a synchronous abdominoperi­
neal excision of rectum which the au­
thors have chosen not to include in the 
options. In postoperative management 
the authors recommend dehydrating the 
patient to avoid the need for catheteriza­
tion. I do not think the rationale for 
this approach would be acceptable to 
most practising surgeons.
This is an excellent book that should 
be read by all general surgeons and 
trainees in general surgery and proctol­
ogy. It will also be a very useful refer­
ence book for medical students. The 
authors are to be congratulated for pro­
viding an excellent collection of rather 
neglected but much needed information.
T.A. K h a n , m  s c , m d , f r c s , f r c s [c ]
Department of surgery,
University of Manitoba,
Health Sciences Centre,
Winnipeg, Man.
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Tuberculous Dactylitis: a Rare Entity
E.P. Urovitz, md, frcs[c]
Tuberculous dactylitis is a rare 
musculoskeletal infection, but as 
emigration from developing countries 
increases it is likely to be seen 
more frequently. The author reports 
the case of a 23-year-old man with 
this condition. The radiologic features 
of tuberculous dactylitis include 
soft tissue swelling, periostitis with 
bone expansion and cortical 
destruction, diffuse uniform infiltration 
and localized osteitis.
The major role of surgery is to 
provide tissue for diagnosis and 
to allow for the removal of caseous 
avascular tissue to promote 
distribution of drugs into surrounding 
tissues. An important aspect in 
the rehabilitation of these patients 
is early motion to prevent joint 
contracture and subsequent ankylosis.
La dactylite tuberculeuse est une 
infection musculo-squelettique rare; 
toutefois, avec I'emigration croissante 
des pays en voie de developpement, 
elle est susceptible d'etre rencontree 
plus frequemment. L'auteur decrit 
un cas de cette maladie chez un 
homme de 23 ans. Les caracteristiques 
radiologiques de la dactylite 
tuberculeuse associent inflammation 
des tissus mous, periostite avec 
expansion osseuse et destruction 
corticale, infiltration uniforme diffuse 
et osteite localisee.
Le role principal de la chirurgie 
consiste a aller prelever du tissu 
pour le diagnostic et a permettre 
I’enlevement du tissu caseeux 
avasculaire dans le but de favoriser 
la distribution des medicaments 
dans les tissus adjacents. Un aspect 
important de la readaptation de ces 
patients est leur mobilisation precoce 
afin de prevenir la contracture des 
articulations et I'ankylose subsequente.
The increasing number of people 
emigrating to Canada from developing 
third world countries has resulted in 
a continuing rise in the incidence of 
musculoskeletal tuberculosis despite
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effective chemotherapy.1 Nevertheless, 
tuberculosis of the hand remains an 
uncommon manifestation and tuber­
culous dactylitis (affecting only the 
phalanges) is rare.2 The following re­
port of a case of reactivated tuber­
culous dactylitis serves to illustrate 
the clinical, radiologic and therapeutic 
principles involved.
Case Report
In November 1980, a 23-year-old man 
was seen, complaining of a 1-year history 
of progressive swelling of and drainage 
from the left index finger. In 1976, 
while in India, he had experienced pain 
and swelling of the proximal interphal- 
angeal joint of the left index finger and 
a diagnosis of tuberculosis had been 
made. Subsequently, he underwent a 
proximal interphalangeal joint arthro­
desis. In October 1979, he had injured 
his finger playing football and a roent­
genogram was interpreted as showing a 
fracture near the fused joint. He was 
treated with a splint but continued to 
complain of pain and swelling. He emi­
grated to Canada in April 1980. Approx­
imately 6 weeks before this presentation 
he had noted the development of a sinus 
over the radial aspect of the middle 
phalanx. He also complained that he had 
lost 1 to 2 kg in weight but denied any 
history of pyrexia, nocturnal sweats, 
cough, sputum or pleuritic chest pain.
The hand had a tender, fusiform 
swelling involving the middle phalanx 
and the distal interphalangeal joint of 
the index finger. A small sinus over the 
radial aspect of the middle phalanx 
drained a minute quantity of seropu- 
rulent fluid. The proximal interphalan­
geal joint was fused and painless. The 
range of motion of the distal inter­
phalangeal joint was from 45° to 10° of 
flexion.
A roentgenogram (Fig. 1) revealed a 
decreased cartilage space at the proximal 
interphalangeal joint, diffuse soft tissue 
swelling and multiple radiolucencies and 
cortical thinning involving the middle 
phalanx. The cartilage space of the distal 
interphalangeal joint was maintained.
Routine blood tests gave normal results 
and the biochemical profile was normal. 
Drainage fluid was sterile on routine, 
fungal and tuberculous culture. A chest 
roentgenogram revealed no evidence of 
tuberculosis.
To make a definitive diagnosis, an 
open biopsy of the middle phalanx was 
performed through a dorsolateral inci­
sion; the sinus was erased. At operation 
the dorsal cortex of the middle phalanx 
was found to be replaced by grey­
ish-brown gelatinous granulation tissue 
which surrounded the extensor mech­
anism. A few small sequestra lay in this 
tissue, and these and the tissue itself 
were curetted to normal bone. The distal 
interphalangeal joint appeared to be free 
of disease, so arthrotomy of this joint 
was not performed. The proximal inter­
phalangeal joint was solidly fused.
The histopathologic findings (Fig. 2) 
were consistent with tuberculosis and 
the diagnosis of tuberculous dactylitis was 
confirmed when Mycobacterium tuber­
culosis grew on tissue culture. Post- 
operatively, the patient was given a 
combination of isoniazid (150 mg/d), 
ethambutol (15 mg/kg daily) and rifam­
pin (600 mg/d). Active motion of the
FIG. 1— Index finger showing loss of 
cartilage space at proximal interphalan­
geal joint and multiple radiolucencies in 
middle phalanx with cortical thinning.
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distal interphalangeal and metacarpopha­
langeal joints was started 10 days after 
the biopsy and debridement.
Six months after operation the swell­
ing was much reduced and there was no 
drainage. Range of motion of the distal 
interphalangeal joint was the same as 
before operation.
Discussion
Tuberculosis of the hand is uncom­
mon; only 159 cases have been re­
ported in the five largest series.2'6 The 
majority of these were tuberculous 
tenosynovitis. According to Leung’s6
definition of true dactylitis, however, 
cases of tuberculous dactylitis number 
only 22.
Several features of our case are 
worth emphasizing as they illustrate 
several clinical and radiographic as­
pects mentioned in past reviews. Frost7 
stated that a history of trauma was 
common in tuberculous dactylitis al­
though Mason4 disagreed.
In our patient, the football injury 
probably contributed to the activation 
of a tuberculous synovitis of the prox­
imal interphalangeal joint.
There is often no associated pul­
monary lesion; this has been noted by 
both Robins5 and Feldman and asso­
ciates2 and in our case. Feldman and 
colleagues2 noted that the commonest 
radiologic features of tuberculous dac­
tylitis were soft tissue swelling, perio­
stitis with bone expansion and cortical 
destruction, diffuse uniform infiltra­
tion (honeycombing) and localized 
osteitis. Unlike pyogenic sepsis, tuber­
culosis rarely incites much sclerosis 
or new bone formation. It should be 
emphasized that these are general 
characteristics and departures from 
them are quite frequent. Sequestra 
and pathologic fractures may also oc­
cur. Many of the features stressed by 
Feldman were present in our case and 
were possibly overlooked at the initial 
presentation following injury.
The treatment of tuberculous dac­
tylitis involves a combined medical 
and surgical approach. The poor re­
sponse to conservative therapy alone 
has been mentioned by Bickel and col­
leagues,3 Kanavel8 and Mason,4 al­
though these reports represent experi­
ence in an era before the advent of 
the newer antituberculous chemother­
apy. The major surgical procedures 
include: (a) open biopsy to obtain suf­
ficient pathologic tissue for diagnosis 
and (b) removal of avascular tissue to 
promote the distribution of drugs into 
surrounding tissues.
Prolonged immobilization has ad­
verse effects upon joint capsule and 
ligaments leading to stiffness; early 
motion is now recognized as superior 
to lengthy immobilization for this dis­
order.6
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Permanent Subcutaneous Vascular Access:
the Chemo Shunt
A technique is described for providing 
permanent painless vascular access 
in patients receiving chemotherapy 
for malignant disorders. In 55 patients 
with no suitable vascular access, a 
permanent subcutaneous vascular 
access site was created in the upper 
anterior chest wall utilizing a Silastic 
dome and attached tubing. The drugs 
to be given are injected into the 
dome, the solution passes through the 
tubing and empties into the superior
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vena cava. When not being used 
the system is filled with heparin 
solution. There have been no instances 
of infection either primarily or in 
the long term. In some patients the 
access site has been used for 2 V2 
years and the technique has met with 
enthusiastic patient response. The 
author has termed this technique 
the chemo shunt.
On decrit une technique permettant 
d’etablir une voie d’acces vasculaire 
indolore et permanente chez les 
patients qui recoivent une 
chimiotherapie anti-cancereuse. Chez 
55 patients qui n’avaient pas de voie 
d’acces vasculaire adequate, un acces 
vasculaire sous-cutane permanent
a ete cree dans la partie anterieure 
et superieure de la cage thoracique, 
a I’aide d’un reservoir a coupole de 
Silastic attache a une tubulure. Les 
solutions de medicaments sont 
injectees sous la coupole, passent 
dans le tubulure et sont evacuees 
dans la veine cave superieure. Pendant 
qu’il est au repos, le systeme est 
rempli d’une solution d’heparine. On 
n’a enregistre aucune infection ni 
en debut d’utilisation, ni a long terme. 
Chez certains patients, cette voie 
d’acces est utilisee depuis 2 V2 ans 
et la technique a regu un accueil 
enthousiaste de la part des patients. 
L’auteur a nomme cette technique le 
"chemo shunt” (derivation pour 
chimiotherapie).
FIG . 2— Granulation tissue of middle 
phalanx demonstrating inflammatory 
infiltrate and Langhans giant cells (hema­
toxylin and eosin reduced by 54%  from 
X 250).
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Many patients with cancer receive 
chemotherapy either as primary or as 
adjunctive treatment with operation 
or radiotherapy, or both. Of the many 
chemotherapy regimens, most are in­
termittent and long term, lasting over 
a number of months or years. Unfor­
tunately, most of the drugs used ir­
ritate the veins into which they are 
injected. As a result, phlebitis and 
sclerosis develop at the vascular ac­
cess site. Administration then becomes 
difficult, and painful and frightening 
to the patient who is already anticip­
ating the unpleasant side-effects of 
the therapy.
This paper outlines a technique for 
providing permanent vascular access 
without pain. It was carried out on 
55 patients over a 3-year period.
Patients
From Jan. 1, 1979 to Dec. 31, 1981 
at Metropolitan General Hospital in 
Windsor, Ontario, in conjunction with 
the regional unit of the Ontario Can­
cer Foundation, chemotherapy divi­
sion, 55 patients (19 men, 31 women, 
5 children) had implanted into the sub­
cutaneous layer of the upper anterior 
thoracic wall an apparatus that pro­
vides permanent vascular access. All 
patients had cancer and were receiv­
ing chemotherapy, most on a long­
term basis. In each patient peripheral 
venous access was no longer available. 
The ages of the patients ranged from 
the teens to the 80s. Cancers included 
lymphoma, leukemia and those of
FIG. I— Original dome and tubing 
used.
FIG. 2—Cutaneous landmarks drawn 
on skin before insertion.
breast, bowel and lung. There were 
no contraindications to the use of 
this apparatus because of age or type 
of cancer.
Technique
The materials used for this appara­
tus include: Heyer-Schulte tubing (cat. 
no. 850-1225; A.H.S. Medical Special­
ties, Mississauga, Ont.) (Raimondi 
peritoneal catheter). This is a spring- 
reinforced silicone catheter with a 
distal slit valve (Fig. 1), which pre­
vents blood reflux and clotting. The 
spring reduces the possibility of kink­
ing or folding and makes the entire 
catheter visible on the roentgenogram. 
It is provided with a straight threaded 
connector, to join to a Heyer-Schulte 
injection dome (cat. no. 350-9000). 
The dome is approximately 1.5 cm 
in diameter, with a mesh embedded in 
its base to prevent needle puncture. A 
standard protocol for use of this sys­
tem has been made for cancer clinic 
staff and the “IV team”.
Preoperative assessment included a 
hemogram and coagulation profile. 
All procedures were done on an out­
patient basis under local anesthesia. 
Valium may be given intravenously 
as a sedative. Children are usually ad­
mitted to hospital and the procedure 
is done under general anesthesia.
The patient is placed in a semisit­
ting position with the arm at the side. 
Two incisions are used. The first, 2 
cm long, is placed below the medial 
end of the third rib. A subcutaneous
FIG. 3— Dome and tubing in position.
pocket is created above this incision; 
some denervation of the skin is 
achieved for future needle puncture 
(Fig. 2).
A second incision, 3 to 4 cm long, 
is made below the clavicle, overlying 
the deltopectoral groove. The cephalic 
vein or a branch is isolated and pro­
vides access to the central venous sys­
tem, via the subclavian vein. The in­
jection dome is placed in the pocket 
created in the medial incision. A fine 
Silastic tube, attached to the dome, is 
run through a tunnel created between 
the two incisions. This tube is intro­
duced through the cephalic and sub­
clavian veins into the superior vena 
cava, just proximal to the heart. If 
the vein in the deltopectoral groove 
is not readily available, an introducer 
in the subclavian vein will allow the 
tube to be placed in the superior vena 
cava. All attachments of the apparatus 
are secured with cotton ties. The com­
plete system is checked for patency 
and function at the end of the pro­
cedure via a percutaneous puncture 
into the dome. It is then filled with 
heparin solution (1:1000), as it is 
after each use. Antibiotics are not 
given routinely, either locally or sys- 
temically.
The material to be injected goes 
into the dome through a 25-gauge 
needle and thus to the superior vena 
cava. A chest roentgenogram is not 
routinely obtained to confirm that the 
catheter is correctly placed but may 
be used to confirm the position of 
the Silastic tubing in the superior vena 
cava (Fig. 3).
D iscussion
All equipment inserted into the pa­
tient is made of Silastic. The tubing 
used in our first six patients did not 
contain a finely coiled wire and in 
some was placed over the clavicle. As 
a result, three of these tubes cracked 
and leaked within 3 months of inser­
tion. However, there has been no 
trouble since we started to use tubing 
with coiled wire inserted below the 
clavicle. There have been no infec­
tions, either primarily or in the long­
term, following multiple uses of this 
system for chemotherapy. The follow­
up of these patients is carried out by 
the cancer clinic staff.
Patients generally are not operated 
upon until they have a leukocyte 
count greater than 1 X 10V1 and a 
platelet count greater than 25 X 109/1.
Four domes have been replaced, 
two because of leakage from the in­
jection area and two because of over- 
lying ulceration. All had been used 
for more than 10 months.
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Is Aminoglutethimide an Alternative to Adrenalectomy 
for Metastatic Carcinoma of the Breast?
E r n e s t  E . St e r n s , m d , f r c s [c], fa c s , C h a r les  E . B ir d , m d , f r c p [c ], fa c p  and  
K e n n e t h  W . M a c k ie , m d , d m r d , f r c p [c ]
Aminoglutethimide inhibits steroid 
synthesis by the adrenal gland and 
the peripheral conversion of androgens 
to estrogens. As such it has been 
recommended in the place of 
adrenalectomy for the treatment of 
advanced breast cancer. Amino­
glutethimide with hydrocortisone was 
given to 19 women with metastatic 
cancer of the breast whose disease 
was progressive, who would otherwise 
have undergone adrenalectomy 
and whose potential for response 
was good. Four patients could not 
tolerate the drug and seven failed 
to respond. Eight women had an 
objective response, complete in two 
and partial in four. In two patients 
the disease stabilized. The period 
of treatment ranged from 11 to 
26 months but three patients are still 
on treatment after 26 months. The 
authors conclude that aminoglute­
thimide has a place in the management 
of women with advanced breast 
cancer who satisfy the criteria for 
hormone manipulation.
[.’aminoglutethimide inhibe la 
synthese des steroides par les glandes 
surrenales, ainsi que la conversion 
peripherique des androgenes en 
oestrogenes. Telle quelle, on I'a 
recommandee en remplacement de la 
surrenalectomie dans le traitement 
du cancer du sein au stade avance. 
L'aminoglutethimide associee a 
I'hydrocortisone fut administree a 
19 femmes porteuses d’un cancer 
metastatique du sein en evolution qui 
auraient autrement subi une 
surrenalectomie et dont les possibilites 
de reponse etaient bonnes. Ouatre
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patientes n’ont pu supporter le 
medicament et il y eut sept echecs 
therapeutiques. Huit femmes eurent 
une reponse objective, complete 
dans deux cas et partielle dans quatre. 
Chez deux patientes, la maladie 
se stabilisa. La periode de traitement 
variait de 11 a 26 mois mais 
trois patientes sont toujours sous 
traitement apres 26 mois. Les 
auteurs concluent que I’aminoglute- 
thimide a une place dans le 
traitement du cancer du sein au stade 
avance chez les femmes qui 
rencontrent les criteres etablis 
pour la manipulation hormonale.
At least one third of all patients with 
metastatic carcinoma of the breast 
will demonstrate an objective response 
when subjected to adrenalectomy. 
This number is increased in women 
with a previous response to hormone 
manipulation or who have estrogen 
receptor-positive tumours, or both.1 
However, many patients are denied 
this form of management for very 
valid reasons. The operation is asso­
ciated with a mortality of between 
2% and 7% and with serious com­
plications.2 At best the response rate 
is 50%. Finally, after adrenalectomy 
the patient is permanently dependent 
on exogenous steroids and this often 
complicates chemotherapy when there 
is a relapse.
An alternative to adrenalectomy is 
the biochemical suppression of adre­
nal steroid production. Aminoglute­
thimide was first marketed as an anti­
convulsant but was withdrawn because 
it inhibited steroid production. This 
inhibiting activity was subsequently 
applied to the management of patients 
with carcinoma of the breast.3 The 
advantage of “medical adrenalectomy” 
is obvious. The morbidity and mortal­
ity of surgery are avoided, the inhibi­
tion of steroid production is reversible 
following the relapse of disease and 
complications of the use of this drug 
are relatively minor and usually self­
limited. The patient with a limited life 
expectancy who might well refuse ma­
jor surgery is more inclined to accept 
a drug treatment program.
Although aminoglutethimide is not 
available for the routine treatment of
patients with metastatic carcinoma of 
the breast, the investigational use to 
date indicates that the response to the 
drug at least equals that of adrenalec­
tomy4 and hypophysectomy.5 Amino­
glutethimide must be combined with 
steroid replacement and most inves­
tigators have used dexamethasone to 
this end. Unfortunately, aminoglute­
thimide accelerates the metabolism of 
dexamethasone and some of the man­
agement problems of this combination 
may be ascribed to this interaction. 
To avoid this problem, hydrocortisone 
has been advocated as a form of 
steroid replacement.6
Patients and Methods
We used aminoglutethimide and hy­
drocortisone in 19 women (age range 
32 to 71 years, mean 48 years) with 
advanced breast cancer who had un­
dergone a previous oophorectomy or 
who were postmenopausal. All had 
previously undergone hormonother­
apy. The interval between the time of 
diagnosis and the identification of sec­
ondary disease (disease-free interval) 
ranged from 0 to 132 months. These 
women would have been considered 
for surgical adrenalectomy and were 
selected for aminoglutethimide ther­
apy because they had the greatest po­
tential for response — a previous re­
mission after hormone manipulation, 
a disease-free interval longer than 24 
months or, in those tested, an estrogen 
receptor-positive tumour. In selecting 
these 19 women, we chose those with 
secondary tumours in soft tissue and 
bone preferentially; patients with lym­
phatic pulmonary involvement, exten­
sive hepatic metastases or central 
nervous system disease were excluded.
Before aminoglutethimide and hy­
drocortisone treatment was begun, the 
extent of the disease was documented. 
All surface tumours were photo­
graphed and measured. Hematologic 
and biochemical profiles were estab­
lished, including a complete blood 
count and measurement of serum al­
kaline phosphatase, lactic dehydro­
genase and calcium levels. Chest and 
skeletal roentgenograms as well as 
radionuclide scans of the bones and 
liver were also obtained. Whenever
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secondary hepatic lesions were sus­
pected, ultrasonography was per­
formed. Measurable metastases were 
evaluated at 3-month intervals and 
general assessments were carried out 
every 6 months or as determined by 
the course of the disease.
Aminoglutethimide was adminis­
tered in doses of 250 mg four times 
daily, and hydrocortisone in 20-mg 
doses morning and evening. When 
aminoglutethimide was discontinued, 
hydrocortisone was administered for 
48 hours longer. There were no cases 
of hypothalamic-pituitary-adrenal un­
responsiveness when hydrocortisone 
was withdrawn.
Assessment of Response
Patients were considered to have a 
complete response to treatment when 
clinical, radiologic or biochemical de­
terminations confirmed the disappear­
ance of all evaluable metastases and 
skeletal films demonstrated the pres­
ence of sclerosis or reossification. A 
partial response was defined as a de­
crease by at least 50% of all measur­
able lesions and a failure of new sec­
ondaries to appear. The patient was 
considered to have stable disease 
when no demonstrable change in any 
of the detectable metastases occurred 
and the patient remained subjectively 
well during the course of treatment. 
Since the patients were entered into 
the study only when they had docu­
mented progressive disease, the failure 
of the disease to progress for a period 
of more than 3 months was considered 
to be an effective form of palliation. 
Progression of disease was present 
when any of the metastatic deposits 
failed to regress or stabilize and there 
was deterioration in the general con­
dition of the patient.
Results
Treatment had to be discontinued 
in 4 of the 19 women because of in­
tractable side-effects. Fifteen patients 
were therefore available for assess­
ment. Treatment has been terminated 
in 12 patients and 3 continue to re­
ceive aminoglutethimide and hydro­
cortisone.
Eight patients responded and seven 
did not. The mean age, disease-free 
interval and survival time from diag­
nosis to death between responders and 
non-responders is given in Table I. 
The disease-free interval and total sur­
vival was longer in responders. The 
site of metastatic disease is given in 
Table II. There was no difference be­
tween the two groups.
All 15 patients had received hor­
monotherapy previously. Seven of the 
eight responders had demonstrated an 
objective response while only four of 
the seven non-responders had had a 
remission.
Failure to respond to aminoglute­
thimide and hydrocortisone was evi­
dent within 6 weeks. Only one patient 
was maintained on treatment for more 
than 24 weeks. This woman had a 
slowly progressive tumour and while 
she was subjectively improved for 9 
months she had no objective evidence 
to indicate a response to the drug.
Of the eight responders (Table III) 
two had complete remission, which 
continues after 26 months. Four had 
a partial response, the longest for 26 
months and that patient continues in 
remission. In two patients the disease 
stabilized, one of these women had 
complete disappearance of her chest 
wall disease but radiographs demon­
strated no change in her osseous me­
tastases.
Side-Effects
Only 5 of the 19 patients reported
no side-effects of treatment. The most 
common complaints were drowsiness 
in nine patients, nausea and vomiting 
in five and skin rash in four. The 
other symptoms reported were non­
specific and may not have been re­
lated to use of the drug. Most of the 
effects were self-limited and disap­
peared spontaneously without treat­
ment. Of the five patients who com­
plained of nausea and vomiting, four 
had intractable symptoms. Change in 
the dosages of both aminoglutethimide 
and hydrocortisone was ineffective. 
The condition was controlled only by 
discontinuing therapy.
Discussion
Although the management of meta­
static breast cancer is an important 
entity in breast cancer treatment and 
hormone manipulation is paramount, 
aminoglutethimide has not been 
strongly promoted and the drug is 
available only for investigational use. 
Although its use in this condition was 
first reported in 1973, there have been 
few reported studies. Most of the ear­
lier investigators used dexamethasone
Table 1-Results of Aminoglutethimide Therapy in 15 Patients
Disease-free
Age, yr interval, mo*
Group No. Mean Range Mean Range survival, mot
Responders 8 49 34-62 37 0-102 85*
Non-responders 7 45 32-66 26 0-57 61 §
*Time from diagnosis to demonstration of secondary disease. 
tTime from diagnosis to death.
+Four patients still alive at 38 to 142 mo.
§Two patients still alive at 79 and 97 mo.
Table II—Site of Metastatic Disease
Chest
Group No. Osseous Visceral Nodal wall
Responders 8 6 6 2 2
Non-responders 7 7 6 2 2
Table Ill-Responders
Nature of Age, Disease-free Duration of Total
response Vf interval, mo treatment, mo survival, mo
Complete 52 0 26* 38t
Complete 41 21 26* 98t
Partial 34 26 11 83t
Partial 62 24 12 89
Partial 38 102 26* 142+
Partial 59 54 25 112
Stable 45 42 12 54
Stable 58 29 16 68
'Continues in remission on aminoglutethimide and hydrocortisone. 
tStill alive.
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for steroid replacement so the results 
may not be comparable to those in 
studies in which hydrocortisone was 
used.
Santen and Wells8 recently reviewed 
the mechanism of action of aminoglu- 
tethimide and reported the largest 
series to date. Of 52 patients, 4 had 
complete remission lasting for an 
average of 25 months and 11 had a 
partial response for a mean duration 
of 10 months. Ten patients had stable 
disease for 8 months.7 From their 
findings and our results it appears that 
the more complete the response the 
longer is its duration. The responses 
are also more predictable in patients 
who have estrogen receptor-positive 
tumours. It is obviously impossible to 
do a comparative study on medical 
and surgical adrenalectomy but the 
evidence to date suggests that the re­
sults of aminoglutethimide therapy are 
as good or better than those of adre­
nalectomy or hypophysectomy. The 
advantages of the drug are important 
since surgical morbidity and mortality 
are eliminated. It is of interest that 
two of four patients reported by San­
ten and Wells who had an objective 
response to adrenalectomy had further 
partial remission when aminoglute­
thimide was administered after re­
lapse.4 It has also been reported8 that 
a 12-week trial of aminoglutethimide 
will accurately identify those patients 
who will subsequently respond to sur­
gical adrenalectomy.
There are several complications of 
aminoglutethimide therapy. Drowsi­
ness and skin rash in other studies, 
though not in ours, prompted the ter­
mination of treatment in an appreci­
able percentage of patients.4 Pancyto­
penia and hypothyroidism have also 
been reported. Four of our patients 
experienced nausea and vomiting of 
such severity that drug had to be dis­
continued. This has not been previous­
ly reported as an important side- 
effect. Complications generally occur 
in three quarters of the patients but 
treatment has to be terminated in less 
than 20%.
The results of our small series agree 
with those of previously reported 
studies indicating that aminoglute­
thimide is effective in women with 
metastatic cancer of the breast. In 
those who tolerate the drug it appears 
to be an effective substitute for adre­
nalectomy with longer remissions in 
those with complete response.
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Editorial comment.—The paper by 
Sterns and colleagues discusses their 
experience with aminoglutethimide as 
a substitute for adrenalectomy in the 
treatment of 19 patients with meta­
static cancer of the breast. This form 
of therapy is certainly at the fore­
front of current management efforts 
and may have something to offer. 
Four of the 19 women (21%) were 
unable to tolerate the drugs, 8 (42%) 
responded to the drug and 7 (37%) 
did not. This simple descriptive re­
sult cannot and should not be com­
pared with results that would be 
achieved by adrenalectomy, hypophy­
sectomy or any other endocrine rou­
tine proposed for the management of 
advanced breast cancer patients. The 
data presented in this study do not 
support a conclusion that aminoglute­
thimide therapy should or could be 
used as an alternative to surgical adre­
nalectomy, despite the intuitive feeling 
that such therapy would be desirable 
when contrasted with the fairly serious 
nature and unpredictable results of 
adrenalectomy. The only way by which 
adrenalectomy and aminoglutethimide 
therapy can be compared is by a ran­
domized clinical trial; without it, a 
valid comparison would be exceeding­
ly difficult.
The observation that responders 
were women whose “disease-free in­
terval” was longer than that of the 
non-responders is in keeping with ob­
servations made with almost any man­
agement routine instituted for breast 
cancer patients. Similar information 
has been generated ever since the early 
years of chemotherapy and somehow 
indicates that those women whose dis­
ease is slow in manifesting itself are 
also those in whom improvement by 
any manipulative therapeutic regimen 
is better than those whose disease is 
more aggressive. Thus, the comparison 
of responders with non-responders 
gives little or no useful information. 
Such comparisons probably should be 
discouraged and eliminated from the 
surgical literature.
Aminoglutethimide therapy may be 
promising but its role in the treatment 
of advanced breast cancer awaits fur­
ther observations.
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Melanoma: the Management of Local Recurrence 
and In-transit Metastasis
Following the primary treatment of 
melanoma, subsequent appearance 
of local recurrence and in-transit 
metastasis remains one of the most 
difficult problems faced by surgeons.
In managing the disease at this 
stage, it is important to realize that, 
because of a favourable immune 
reaction in some patients, the disease 
may remain localized for many 
months or years. Consequently, local 
control should be attempted in the 
best possible manner when the disease 
is confined to a specific region and 
there are no signs of dissemination.
Methods of local control include 
local surgical procedures, local and 
systemic chemotherapy, immuno­
therapy, radiotherapy, amputation and 
isolation-perfusion. After reviewing the 
literature and based upon personal 
experience, the author found that 
hyperthermic isolation-perfusion can be 
effective in the management of 
local recurrences of melanomas and 
in-transit metastasis.
Le traitement des recidives locales 
du melanome et des metastases 
en transit qui accompagnent souvent 
cette maladie demeure un des 
problemes les plus difficiles en 
chirurgie.
Dans I’etablissement d'un plan 
de traitement, on doit tenir compte 
du fait que, chez certains patients, 
a cause d'une reaction immunitaire 
favorable, la maladie peut demeurer 
localisee pendant plusieurs mois 
ou annees. En consequence, un 
traitement local approprie doit etre 
propose lorsque la maladie demeure 
localisee et s'il n’y a pas de signes 
decelables de metastases.
Les diverses modalites therapeutiques 
comprennent le traitement chirurgical 
fait localement, la chimiotherapie 
locale et systemique, I’immunotherapie, 
la radiotherapie, I’amputation, et 
la perfusion regionale. Apres avoir 
revu la litterature sur ce sujet
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et suite a une certaine experience 
personnelle, I'auteur est d’avis 
que la perfusion regionale realisee 
sous hyperthermie est efficace dans 
le traitement des recidives locales 
et des metastases en transit du 
melanome.
The surgical management of mela­
noma has always been a challenge. 
Although results of surgical treatment 
have improved, many problems re­
main unsolved, one of them being the 
management of stages II and IIIA 
melanomas (classification of the M.D. 
Anderson Hospital and Tumor Insti­
tute). In stage II, local recurrence 
occurs within or adjacent to the scar 
of a primary lesion; stage IIIA is de­
fined as regional in-transit disease or 
“satellitosis” without clinical or mi­
croscopic evidence of metastasis in 
the regional lymph nodes.
In this paper, I review some of the 
factors in the natural behaviour of 
melanomas that are important in the 
management of local and regional dis­
ease and I describe the various meth­
ods of treatment that can be used at 
these stages.
Natural Behaviour of Local and 
Regional Melanomas
For the surgeon, the occurrence of 
stages II and IIIA disease comes as a 
surprise; often, the primary tumour, 
sometimes rather small, has been ex­
cised widely and prognosis has been 
considered good. Then local recur­
rences develop quite rapidly, frequent­
ly within 6 months of the primary 
operation, to the distress of the sur­
geon, the patient and family. In most 
instances, such a poor outcome could 
not have been predicted. Following 
the classical works of Clark and asso­
ciates1 and Breslow2,3 it was hoped 
that the level of invasion and the tu­
mour thickness might be helpful in 
predicting not only the patient’s sur­
vival but also the percentage of local 
recurrences or in-transit metastases. 
Recent papers on the subject4-6 have 
established the good prognostic value 
of this method as far as survival is 
concerned but have failed to predict 
with enough accuracy the percentage 
of patients-in whom stages II and IIIA 
disease will develop.
It must be realized that many pa­
tients with local and regional disease 
are also suffering from metastatic dis­
ease, and, consequently, cannot bene­
fit from local or regional treatment. 
Fortunately, there are more favour­
able situations, however distressing, in 
which patients are afflicted with very 
extensive local and regional disease 
that remains localized for a long time. 
Therefore, effective control of the dis­
ease at this stage is of the utmost im­
portance as this can bring about a 
cure in some patients. This period of 
localization is specific to melanomas; 
it has been postulated that an immune 
reaction is present in some cases. Ac­
cording to Lewis7,8 and others,9 some 
patients are in a temporary phase of 
resistance which is due to a host- 
tumour reaction. Tumour antibodies 
have been identified, which, in the 
opinion of these authors, protect the 
organism from systemic disease. It 
has also been demonstrated that, once 
the antibodies disappear from the cir­
culation, there is a breakdown of the 
immune reaction and the patients de­
velop systemic disease quite rapidly.
It is then obvious that, in a number 
of patients, local and regional control 
should be attempted when the immune 
reaction, if present, keeps the disease 
confined to a specific region and there 
are no signs of dissemination.
Treatment of Stages II and 
IIIA Disease
Several methods have been pro­
posed in the treatment of melanomas 
at these stages.
Surgical treatment of recurrences 
varies from local excision to wide, ra­
dical excision of local disease and in­
transit lesions. Although only a small 
number of patients will survive 5 years 
following aggressive local treatment, 
most will enjoy a longer survival than 
patients treated by more conservative 
local surgery. Of 35 patients reported 
by Karakousis and associates,10 there 
were 10 long-term survivors following 
radical local treatment; the survival 
time among those who died from the 
disease following aggressive local 
treatment was 28 months compared 
with 13.5 months for patients treated 
by conservative means.
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In a group of 170 patients reported 
by Conrad,11 17% achieved 5-year dis­
ease-free survival following local ex­
cision of recurrences. Similar results 
were reported by Mehnert and Heard12 
and Jones and associates,13 in whose 
studies the 5-year survival was less 
than 25%.
Chemotherapy administered by lo­
cal intratumoral injection or system- 
ically occasionally gives temporary 
improvement. Some partial regressions 
have been observed with alkylating 
agents but there is usually no lasting 
benefit. The use of DTIC (dimethyl- 
triazeno-imidazole carboxamide) and 
BCNU (bischloroethyl nitrosourea) 
has given a response rate of 20% to 
25%, but the effects are temporary.14 
Evidently, systemic or local chemo­
therapy does not yield a high rate of 
success in local and regional disease.
Immunotherapy has been used ex­
tensively following the report of Mor­
ton and colleagues15 that 90% of pa­
tients receiving bacille Calmette- 
Guerin intratumorally showed regres­
sion of the lesions; the regression rate 
in noninjected lesions was 17% and 
25% of patients remained free of dis­
ease for 1 to 6 years. However, 
most10,16 claim that only a third of the 
injected nodules will regress.
Jewell and associates16 reported 
24% tumour regression in 244 pa­
tients with stages II and IIIA mela­
nomas treated with a crude acellular 
homogenate of allogeneic melanoma 
cells. Isolated reports have claimed 
prolonged survival after local or sys­
temic immunotherapy, but there are 
no figures that show a meaningful in-
FIG . 1— Recurrent melanoma and 
satellite nodules in 62-year-old woman 
operated on 6 months before for primary 
tum our in right calf (Clark’s level III1).
crease in the 5-year survival in pa­
tients with local and regional disease.
Irradiation has been considered in­
effective in the treatment of melano­
mas in general. Occasionally, good 
results are reported, but they are usu­
ally temporary and do not affect long­
term survival in patients with stages 
II and IIIA melanoma.
Amputation was thought to be the 
treatment that would give the best re­
sults in cases of local and regional 
disease, but the results have been dis­
couraging.17"20 Since less than one third 
of patients with melanoma have long­
term survival, surgeons generally have 
been reluctant to recommend amputa­
tion for the management of a disease 
with a high probability of metastatic 
spread. It still is being done occasion­
ally but the results do not justify 
the very radical amputation that is 
sometimes required.
Isolation-perfusion, suggested by 
Creech and associates21 in 1958, has 
been used extensively by some investi­
gators in the treatment of melanomas. 
It is designed to deliver a high dose 
of the chemotherapeutic agent, in this 
case melphalan, to a tumour-bearing 
region in an extremity previously iso­
lated from the systemic circulation. 
This is achieved by cannulating the 
artery and vein, and establishing a 
temporary extracorporeal circuit using 
a pump oxygenator containing a heat
FIG . 2— Lower leg following hyper­
thermic isolation-perfusion performed 
8 days previously. There is extensive 
edema and marked regression of some 
malignant nodules.
exchanger. The isolation is almost 
complete with the addition of a tour­
niquet above the occluded vessels, so 
that systemic toxicity is avoided.
Results to date have demonstrated 
clearly the value of isolation-perfusion 
in treating melanomas at stages II and 
IIIA and its superiority over other 
methods at these stages of the disease. 
Local control can be achieved in more 
than 50% of cases.22"26 Moreover, the 
5-year survival has been greatly im­
proved with this treatment in a way 
that was totally unexpected. When in­
terpreting the reported results, one has 
to take into account the addition of 
heat to the technique in later years. 
According to Stehlin and associates,23 
the improvement in local control and 
5-year survival are due largely to hy­
perthermic perfusion; in 73 patients 
with stages II and IIIA disease, the 
5-year survival was 22% with normo- 
thermic perfusion, but increased to 
more than 50% in 30 patients who 
underwent hyperthermic perfusion. 
Other groups using hyperthermic per­
fusion have not achieved as high a 
5-year survival rate, but local control 
has been just as good.22'25,26
The increase in the 5-year survival 
with isolation-perfusion cannot be ex­
plained only by a local effect, other­
wise one would expect the same re­
sults following amputation, which 
eliminates tumour completely, as with 
regional perfusion in patients with 
stages II and IIIA disease. Therefore, 
there must be some systemic effect, 
which, according to Stehlin, can be 
explained by the immune response re­
sulting from destruction of distal dis­
ease and increase of the cytotoxic ac­
tivity of plasma and lymphocytes 
against the patient’s own melanoma 
cells.
Our experience with 13 patients 
who had stage H or IIIA disease has 
been similar; complete or partial re­
gression of tumour occurred in 50% 
of the cases and, as a consequence, 
amputation was not indicated in any 
case. The only three living patients 
belong to a group of six patients sub­
jected to hyperthermic perfusion. Figs. 
1, 2 and 3 show the results in one of 
these cases.
Most complications are minor and 
are associated with some local tissue 
reaction and edema; major complica­
tions can occur in 1% to 2% of the 
cases and manifest themselves by 
some tissue necrosis, which can be 
extensive and may lead to amputation. 
Fortunately, such a procedure was re­
quired only three times in Stehlin’s 
series of 185 hyperthermic perfu­
sions.23 Mortality is what would be
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expected in any major surgical pro­
cedure and has been reported to be 
about 1% to 2 %.  Systemic toxicity 
is rare, because isolation of an ex­
tremity is usually quite satisfactory 
and leakage of the drug is minimal.
Discussion
Of the modalities proposed for 
treatment of stages II and IIIA mela­
nomas, isolation-perfusion is the treat­
ment of choice. Depending on local 
conditions, other methods may be em­
ployed if available. The place of im­
munotherapy is yet to be determined. 
However, because of the immune re­
sponse to some melanomas there is 
promise that further research will 
make it possible to obtain better re­
sults with local or systemic immuno­
therapy.
For many surgeons, local excision is 
the most popular form of treatment. 
The success rate is not high but if it 
is done early and radically it can be 
almost as good as that of radical am­
putation; for this reason there are few 
indications, if any, for radical amputa-
FIG. 3—Three months following treat­
ment, melanoma and edema have dis­
appeared almost completely. Local sur­
gical treatment and skin graft were 
carried out at this time. Patient is well 
without recurrence 18 months after 
treatment.
tion in melanomas of stages II and 
IIIA.
Isolation-perfusion is not used in 
most centres, partly because of the 
technical problems involved and be­
cause it is not universally accepted. 
Although initial results of treatment 
of stage I melanomas of the extrem­
ities by regional perfusion were good 
and in many instances superior to the 
conventional surgical treatment,22'24,56 
skepticism remains, mainly because of 
the lack of randomized series compar­
ing both treatments. For this reason, 
the results of treatment of stage I 
melanomas by isolation-perfusion have 
been questioned, at least as far as 
5-year survival is concerned. However, 
most investigators agree that isolation- 
perfusion as an adjuvant to surgical 
treatment carries a much lower recur­
rence rate than surgical treatment 
alone. In our institution, there were 
five local recurrences in 20 stage I 
melanomas (level III or higher) treated 
by wide excision of the primary tu­
mour with or without node dissection, 
but only one recurrence in 15 mela­
nomas at a comparable stage when 
isolation-perfusion was added.
Consequently, if isolation-perfusion 
has any value in preventing local re- 
curences, it should be of value in the 
treatment of stages II and IIIA mela­
nomas. I believe our results and 
those reported in the literature, espe­
cially since the addition of hyperther­
mia, demonstrate the superiority of 
this modality over other methods pres­
ently available.
Summary
Local recurrences and in-transit me- 
tastases, as seen in stages II and IIIA 
melanomas, are the most important 
problems faced by surgeons in the 
treatment of this disease. Of the mo­
dalities available for treatment of 
melanomas at these stages, hyperther­
mic isolation-perfusion, either alone 
or as an adjunct to surgical treatment, 
is recommended.
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Use of Vitallium Prosthesis to Relieve Jaundice 
in Patients with Obstruction at the Bifurcation
of the Hepatic Duct
P aul H . N il o ff , m d , frc s[c] and  E. John  H inch ey , m d , fr c s[c1
Fourteen patients with hepatic duct 
obstruction were treated by inserting 
a Vitallium prosthesis through the 
strictured area. Eleven had proven 
cholangiocarcinoma; in 3 a definitive 
diagnosis was not obtained. Jaundice 
was relieved and patients were 
afforded good palliation. Obstruction 
of the prosthesis has not been a 
problem and the absence of external 
drainage tubes has been a factor 
in improving the quality of life of 
these patients. The simplicity of the 
operation is emphasized.
Ouatorze patients souffrant d'une 
obstruction des canaux hepatiques ont 
ete traites par I'insertion d'une 
prothese Vitallium dans la partie 
retrecie. Onze de ces malades avaient 
un cholangiocarcinome demontre; 
chez les 3 autres, un diagnostic 
definitif n’a pu etre etabli. L'ictere 
fut soulage et les patients 
beneficierent d'un bon traitement 
palliatif. II n'y eut pas de probleme 
d'obstruction de la prothese et 
I'absence de tubes de drainage externe 
a contribue a ameliorer la qualite de 
vie des patients. Les auteurs 
soulignent la simplicity de cette 
operation.
Since cholangiocarcinomas are usually 
slow-growing tumours, long survival 
as well as effective palliation can be 
achieved by adequate surgical decom­
pression.1-5 To this end a Vitallium 
prosthesis (Fig. 1) has been designed 
to relieve obstruction in tumours of 
the proximal hepatic ducts that cannot 
be resected.
Patients
During the past 14 years, 14 pa­
tients with biliary obstruction at the 
hepatic duct bifurcation have been
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treated by the insertion of a Vitallium 
prosthesis. In 11 patients (6 men, 5 
women) the stricture was due to chol­
angiocarcinoma. These patients ranged 
in age from 49 to 87 years (mean 65 
years). Tumour could not be proven 
by biopsy of the bile ducts in three 
patients; one patient proved to have 
a Candida infection of the duct and 
two patients are presumed to have had 
sclerosing cholangitis. Three of the 
patients with cholangiocarcinoma had 
associated gallstones.
Surgical Technique
The common bile duct is opened 
distal to the tumour. A Bake’s dilator 
is used to create a passage through 
the tumour and proximal obstructed 
intrahepatic ducts and the prosthesis 
is inserted to maintain decompression 
of the biliary tract. This prosthesis 
has a flange by which it is sutured to 
the common bile duct to maintain its 
position. It also has a small opening 
into which a tiny catheter is inserted 
temporarily, so that cholangiograms 
can be taken and the biliary tract 
can be decompressed during the im­
mediate postoperative period (Fig. 2). 
The gallbladder, if present, is always 
removed to avoid the complication of 
cystic duct obstruction by tumour. 
The prosthesis was inserted through 
the strictured area into the obstructed 
right hepatic duct in all our patients.
Results
All patients had good palliation 
with relief of jaundice and pruritus, 
and those with malignant disease died
o
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FIG. 1—Three sizes of Vitallium
prosthesis. Note flange for securing to 
bile duct.
of metastases rather than the effects 
of biliary obstruction (Table I).
Reoperation was necessary twice — 
once to advance a tube that had mi­
grated distally and once to clean a 
prosthesis that was obstructed by fib­
rin mixed with Candida fungus col­
onies. No recurrence occurred follow­
ing treatment with amphotericin B. 
Tubes retrieved at autopsy were free 
of concretions. Survival in the 11 pa­
tients with cholangiocarcinoma ranged 
from 2 to 34 months (median 18 
months). Only one patient received 
radiotherapy and she lived 24 months.
Discussion
The procedure of choice for the 
treatment of carcinoma of the hepatic 
ducts is surgical resection as described 
by Longmire and associates1 and 
Evander and associates.6 This is rarely 
feasible; reported series are small and 
follow-up is short.7-10 Resection is lim­
ited by invasion of portal venous and 
arterial structures when the tumour is 
situated in the porta hepatis. Extensive 
surgical procedures in this area are 
associated with high mortality and 
morbidity.
Since these tumours tend to grow 
slowly, with many patients surviving 
a year or longer, the major problem 
for the surgeon is to provide palliation 
for the intense jaundice and associated 
itching. A number of methods to es-
FIG. 2—Postoperative cholangiogram. 
Dye injected through catheter shows 
early filling of left duct with slower 
filling of right ductal system.
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tablish biliary drainage are now avail­
able. For the elderly or the patient 
who is considered a high operative 
risk, percutaneous placement of cath­
eters through bile-duct tumours can 
be carried out to establish external 
drainage or combined internal and 
external drainage.1113 The percutane­
ous placement of a permanent pros­
thesis through a tumour without an 
external catheter has also been re­
ported.14,15 Occlusion or dislodge- 
ment, or both, of the catheters is not 
uncommon.12 A number of options are 
open to the surgeon at operation if 
the tumour is not resectable. Ter- 
blanche and associates16 have reported 
good results with a U-tube made of 
firm plastic which prevents obstruc­
tion due to the pressure of advancing 
tumour. This tube has the advantage 
of being fixed so that it cannot be 
dislodged and can be replaced by 
“railroading” should it become ob­
structed.
Cameron and associates15 have used 
transhepatic Silastic stents in 20 pa­
tients with malignant strictures, 10 of 
which involved the bifurcation of the 
bile duct. Five patients survived more 
than 1 year and two for more than 2 
years. This catheter can easily be 
changed should obstruction occur. In­
ternal drainage with cholangiojejuno­
stomy, as described by Longmire and 
associates1 and Ragins and associates,17 
may be used. We have performed this
operation when insertion of a metal 
prosthesis was impossible.
Placement of a Vitallium tube 
through a cholangiocarcinoma which 
has been dilated with Bake’s dilators 
offers the most effective palliation. 
Our experience confirms that of 
others,4,5'18 that decompression of the 
right ductal system alone is usually 
sufficient to relieve jaundice. Obstruc­
tion of the tube has occurred only 
once — by a “fungus ball”. Two pa­
tients have had tubes in place for 5 
and 14 years respectively without 
cholangitis or jaundice. The use of 
metal prostheses for the repair of 
biliary strictures is sometimes com­
plicated by obstruction by concretions. 
One might speculate that in patients 
with stricture following operation for 
gallstones, the bile is of a different 
composition from that in patients 
with cholangiocarcinoma.
We believe that the absence of ex­
ternal drainage tubes has been a factor 
in the improved quality of life of 
these patients.
The gross appearance of cholangio­
carcinoma and sclerosing cholangitis 
is similar and histologic proof of the 
diagnosis of bile-duct carcinoma high 
in the porta hepatis may be difficult 
to obtain. One would hesitate to carry 
out an extensive procedure for a non- 
neoplastic lesion in this area. Insertion 
of the Vitallium prosthesis is relatively 
simple and, in our hands, effective as
shown in two long-surviving patients 
who must have non-neoplastic lesions. 
Recent studies suggest that radiother- 
apy9,i9,2o an(j chemotherapy21-22 may be 
effective in treating cholangiocarcino­
ma. If this proves to be true then the 
combination of a Vitallium prosthesis 
and adjuvant therapy should be a de­
sirable method of treatment.
The operation is simple. It is not 
much more extensive than exploration 
of the common bile duct. The proce­
dure is well tolerated and is particu­
larly useful in elderly and poor-risk 
patients who are candidates for oper­
ation.
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ACTION
In v itro  studies indicate that the bacterial action o f CLAFORAN (cefotaxime sodium ), a 
sem isynthetic cephalosporin antib iotic, results from  inh ib ition  o f cell wa ll synthesis.
INDICATIONS AND CLINICAL USES
CLAFORAN (cefotaxime sodium ) m ay be indicated fo r the trea tm ent of in fections 
caused by susceptible strains o f the designated m icro-organism s in the diseases listed 
below :
Lower respiratory tract infections: pneumonia and lung abscess caused by 
Streptococcus pneum oniae  (form erly Diplococcus pneum oniae), other Streptococci 
(excluding [Enterococci, e.g.,S. faecalis), S taphylococcus aureus (penicillinase and 
non-penic illinase producing), Escherichia co/i. H em ophilus influenzae, (including 
am picillin -resistant strains), and unspecified Klebsiella  species.
Urinary tract infections: caused by Escherichia coli, unspecified Klebsiella species 
(inc lud ing K. pneum oniae), Proteus m irabilis, indole -positive Proteus, Serratia 
m arcescens and Staphylococcus epidermidis. Also, uncom plicated gonorrhea caused 
by N. gonorrhoeae  including penicillin-resistant strains.
Bacteremia/Septicemia: caused by Escherichia coli, unspecified Klebsiella strains and 
Serratia marcescens.
Skin infections: caused by Staphylococcus aureus  (penicillinase and non-penicillinase 
producing), S. epiderm idis. Group A Streptococci, Escherichia co/i, Proteus m irabilis  
and indole-positive Proteus.
Intra-abdominal infections: caused by Escherichia coli, and unspecified Klebsiella  
species.
Gynecological infections: including pelvic in flam m atory disease, endom etritis  and 
pelv ic ce llu litis  caused by E. coli. Group A Streptococci and Staphylococcus 
ep iderm id is, anaerobic bacteria including unspecified Peptococcus and 
Peptostreptococcus  strains and some strains o f Bacteroides frag His. In several cases, 
a lthough clin ica l cures were achieved, bacteriological fo llow -up  was not available. 
C lin ical experience w ith  CLAFORAN in anaerobic in fections is lim ited. CLAFORAN has 
been used w ith  some success in wound and in tra-abdom inal infections against some 
strains o f unidentified Bacteroides and anaerobic cocci.
CLAFORAN has been show n to be active against som e strains o f Pseudomonas.
In the trea tm ent of in fections encountered in im m unosuppressed and granulocytopenic 
patients, results of therapy w ith  cefotaxim e have not been impressive.
CLAFORAN should not be considered in the trea tm ent o f enterococcal in fections, i.e. 
Strep, faecalis.
Specim ens fo r  bacterio logic culture should be obtained p rio r to  therapy in order to 
iso late and identify  the causative organisms and to  determ ine the ir susceptib ilities to 
CLAFORAN. Therapy m ay be instituted before results o f susceptib ility  studies are 
know n; an tib io tic  treatm ent should be re-evaluated once these results become 
available.
CONTRAINDICATIONS
CLAFORAN is contraindicated in patients who have shown hypersensitivity to 
ce fo taxim e sodium , the cephalosporin, or the pen ic illin  g roups o f antib iotics.
WARNINGS
Before therapy w ith  CLAFORAN is instituted, it m ust be determ ined w hether the patient 
has had previous hypersensitivity reactions to cefotaxim e, cephalosporins, penicillins 
o r other drugs. CLAFORAN should be given w ith  caution to  patients w ith  Type 1 
hype rsensitiv ity  reactions to penicillin. A ntib io tics, includ ing CLAFORAN should be 
adm in istered w ith  caution to patients who have dem onstrated some form  o f allergy, 
pa rticu la rly  to  drugs. If an allergic reaction to CLAFORAN occurs, the drug should be 
d iscontinued and the p.atient treated w ith  the usual agents (e.g. epinephrine, 
an tih istam ine, pressor am ines or corticosteroids).
PRECAUTIONS
Pregnancy: The safety o f CLAFORAN (cefotaxime sodium ) in pregnancy has not been 
established. Consequently, use o f the drug in pregnant w om en requires tha t the likely 
benefit from  the  drug be weighed against the possible risk to  the m other and fetus. 
Nursing Mothers: CLAFORAN is excreted in hum an m ilk in lo w  concentrations. Caution 
shou ld be exercised when the drug is adm inistered to  nursing mothers.
Pediatric Use 'r he safety and effectiveness o f CLAFORAN in in fants and children have 
no t yet been established. It has, however, been used in ch ild ren  at a dosage range o f 
100-150 m g /k g /d a y  in 2-4 d iv ided doses.
Kidney: A lthough CLAFORAN rarely produces alterations in kidney function, evaluation 
o f  renal status is recommended, especially in severely ill patients receiving high doses. 
Patients w ith  m arkedly im paired renal function should be placed on the special dosage 
schedule recom mended under DOSAGE AND ADMINISTRATION, because norm al 
doses in these individuals are likely to  produce excessive serum  concentration of the 
m etabolites.
P rolonged use o f CLAFORAN m ay result in the overgrow th  o f nonsusceptible 
organism s. Constant observation o f the patient's cond ition  is essential. If superinfection 
occurs, therapy should be discontinued and appropria te measures taken.
Positive d irect Coomb's test is known to  develop in ind iv idua ls  during trea tm ent w ith 
the cephalosporin group o f antib iotics, including cefotaxim e sodium.
In labora to ry tests a false positive reaction to  glucose m ay occur w ith  reducing 
substances but not w ith  the use o f specific glucose oxydase methods.
USUAL ADULT DOSAGE OF CLAFORAN (CEFOTAXIME SODIUM)
Daily Oo m
Type of Infection (grama) Froqooftcy and Root*
Uncomplicated Gonorrhea 1 1 gram IM (single dose)
Uncomplicated infections 
such as pneumococcal 
pneumonia or acute urinary 
tract infection
2 1 gram every 12 hours 
IM or IV
Moderately severe 
infections
3-4 1 gram every 6-8 hours 
IM or IV
Severe infections 4-6 1 gram every 4-6 hours 
IM or IV
Infections commonly 
needing antibiotics in 
higher dosage 
(e.g., septicemia)
6-8 2 grams every 6-8 hours IV
Life-threatening infections up to 12 2 grams every 4 hours IV
THE M AXIM UM  DAILY DOSAGE SHOULD NOT EXCEED 12 GRAMS.
Adm inistra tion o f CLAFORAN should be continued for a m in im um  o f 48 to 72 hours 
after the patient defervesces or after evidence of bacterial eradication has been 
obtained; a m in im um  o f 10 days o f treatm ent is recommended fo r infections caused by 
Group A beta-hem olytic Streptococci in order to guard against the risk o f rheum atic 
fever or g lom eru lonephritis ; frequent bacteriologic and clinical appraisal is necessary 
during therapy o f chronic urinary tract infections and m ay be required fo r several 
m onths after therapy has been com pleted; persistent infections m ay require prolonged 
treatment. Doses less than those recom mended shou ld no t be employed.
DOSAGE FOR PATIENTS WITH IMPAIRED RENAL FUNCTION
In patients w ith  estimated creatin ine clearance o f less than 20 m l/m in /1 .7 3 m 2 the dose 
of CLAFORAN m ust be halved (see PRECAUTIONS). If serum creatinine values alone are 
available, the fo llow ing  fo rm ula  (based on sex, we ight and age o f the patient) m ay be 
used to convert these values in to creatinine clearance.
Males: Weight (kg) x (140 -  age)
72 x serum creatinine
Females: 0.85 x above value
RECONSTITUTION
The fo llow ing  table is provided as a guide for reconstituting CLAFORAN (cefotaxime 
sodium ) fo r both in tram uscular and intravenous adm inistration.
STRENGTH
Intramuscular
500 mg vial
1 g vial
2 g vial
Intravenous
500 mg vial
1 g vial
2 g vial
•Shake to dissolve.
AMOUNT OF APPROXIMATE APPROXIMATE
DILUENT TO WITHDRAWABLE AVERAGE
BE ADDED VOLUME CONCENTRATION
(ml)* (ml) (mg/ml)
2 2.2 230
3 3.4 300
5 6.0 330
10 10.2 50
10 10.4 95
10 11.0 180
Parenteral drug products should be inspected visually fo r particulate m atter and 
d iscoloration p rio r to adm in istration. Solutions of CLAFORAN range from  ligh t ye llow  
to amber, depending on concentration and diluent used. The dry pow der as we ll as 
solutions tend to  darken, depending on storage conditions.
For intramuscular use: CLAFORAN should be reconstituted only w ith  Sterile Water fo r 
Injection in accordance w ith  the volum es recommended in the preceding table.
For intravenous bolus use: 500 mg, 1 gram and 2 gram vials should be reconstituted 
w ith  at least 10 m l of any o f the solutions recommended under COMPATIBILITY/ 
STABILITY.
For intravenous infusion use: 1 o r 2 gram s o f CLAFORAN may be reconstituted
with 50 or 100 ml of any of the solutions recommended under COMPATIBILITY/STABILITY.
ADMINISTRATION
Intramuscular: CLAFORAN (cefotaxime sodium) should be in jected we ll w ith in  the body 
o f a relative ly large muscle such as the upper outer quadrant of the buttock (i.e., gluteus 
maxim us); aspiration is necessary to  avoid inadvertent in jection in to a blood vessel. 
Intravenous: The in travenous route is preferable fo r patients w ith  bacteremia, bacterial 
septicemia, o r other severe o r life-threatening infections, or fo r patients w ho may be 
poor risks because o f lowered resistance resulting from  such deb ilita ting cond itions as 
m alnutrition , trauma, surgery, diabetes, heart failure, o r malignancy, particu larly if 
shock is present or im pending.
For bolus adm in istration a solution containing 1 gram or 2 grams o f CLAFORAN can be 
in jected over a period o f three to  five minutes. Using an infusion system, it m ay also be 
given over a longer period o f tim e through the tubing system by which the patient may 
be receiving other in travenous solutions. Butterfly® or scalp vein type needles are 
preferred fo r th is  type o f in fusion. However, during in fusion of the solution containing 
CLAFORAN, it is advisable to  discontinue tem porarily the adm inistration o f other 
solutions at the same site.
ADVERSE REACTIONS
The m ost frequent adverse reactions encountered are:
Local (5%) -  in jection site in flam m ation w ith  in travenous adm in istration. Pain, 
in dura tion  and tenderness after in tram uscular in jection.
Hypersensitivity (1.8%) -  Rash, pruritus, fever.
Gastrointestinal (1.7%) -  Colitis (not pseudom em branous), diarrhea, nausea, and 
vom iting . A  few  cases o f pseudom embranous co litis  have been reported.
Hemic and Lymphatic System -  M ild reversible leukopenia, granulocytopenia and 
throm bocytopen ia  have been reported. Some patients developed positive direct 
C oom b 's test during trea tm ent w ith  CLAFORAN (cefotaxim e sodium).
Genitourinary System -  M oniliasis, vaginitis.
Central Nervous System (0.2%) -  Headache.
Liver -  Transient elevations in SGOT, SGPT, serum  LDH, and serum alkaline 
phosphatase levels have been reported.
Kidney -  Increased serum  creatinine and BUN have occasionally been observed.
SYMPTOMS AND TREATMENT OF OVERDOSAGE
Since no case o f overdosage has been reported to  date w ith  CLAFORAN, no specific 
in fo rm a tion  on sym ptom s or treatm ent is available. Treatm ent o f overdosage should be 
sym ptom atic.
DOSAGE AND ADMINISTRATION
CLAFORAN (cefotaxime sodium ) m ay be adm in istered in travenously or 
in tram uscu la rly  after reconstitu tion (see table w ith  recom m ended mode of 
reconstitu tion  according to route o f adm in istration). Dosage and route o f adm inistration 
shou ld  be determ ined by susceptib ility of the causative organisms, severity o f the 
in fection  and cond ition o f the patient.
COMPATIBILITY AND STABILITY
CLAFORAN (cefotaxime sodium ) m ay be reconstituted w ith  any o f the fo llow ing  and 
should be used freshly prepared:
Sterile Water fo r Injection 
Sodium Chloride Injection B.P.
5% Dextrose Injection B.P.
Dextrose and Sodium  Chloride Injection 
Compound Sodium  Lactate Injection B.P.
If a solution m ust be stored, on ly  the solution prepared w ith  Sterile Water fo r Injection 
m ay be kept under refrigera tion (below 5°C) fo r not longer than 24 hours. Any unused 
solutions should be discarded.
CLAFORAN is com patib le w ith  1 % lignocaine. Only freshly prepared solutions should 
be used. CLAFORAN solutions exh ib it m axim um  stability in the pH 5-7 range.
A solution o f 1 gram o f CLAFORAN in 14 ml o f Sterile Water fo r Injection is isotonic. 
Solutions o f CLAFORAN m ust not be admixed w ith  am inoglycoside solutions. If 
CLAFORAN and am inoglycosides are to be administered to the same patient, they must 
be adm inistered separately and not as a mixed injection.
DOSAGE FORMS
CLAFORAN (cefotaxime sodium ) is supplied as a sterile, wh ite to  pale ye llow  powder, in 
vials containing 500 mg, 1.0 gram and 2.0 grams o f cefotaxime sodium  (expressed as 
acid on a d ry basis).
CLAFORAN in the dry state should be stored at room  temperature (below 30°C), 
protected from  ligh t and heat. Solutions of CLAFORAN range from  ligh t ye llow  to 
amber, depending on concentration and the diluent used. The solutions tend to darken 
depending on storage cond itions and should be protected from  elevated tem peratures 
and excessive light.
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